Project
Mucociliary differentiation, bronchial epithelial cells, human (Ross 2007)
Navigation
Downloads
Results for MECP2
Z-value: 1.83
Motif logo
Transcription factors associated with MECP2
| Gene Symbol | Gene ID | Gene Info |
|---|---|---|
|
MECP2
|
ENSG00000169057.15 | methyl-CpG binding protein 2 |
Activity-expression correlation:
| Gene | Promoter | Pearson corr. coef. | P-value | Plot |
|---|---|---|---|---|
| MECP2 | hg19_v2_chrX_-_153363125_153363182 | 0.24 | 2.1e-01 | Click! |
Activity profile of MECP2 motif
Sorted Z-values of MECP2 motif
| Promoter | Log-likelihood | Transcript | Gene | Gene Info |
|---|---|---|---|---|
| chr18_+_33877654 | 7.12 |
ENST00000257209.4
ENST00000445677.1 ENST00000590592.1 ENST00000359247.4 |
FHOD3
|
formin homology 2 domain containing 3 |
| chr19_-_51471362 | 7.12 |
ENST00000376853.4
ENST00000424910.2 |
KLK6
|
kallikrein-related peptidase 6 |
| chr19_-_51471381 | 6.84 |
ENST00000594641.1
|
KLK6
|
kallikrein-related peptidase 6 |
| chr13_-_20806440 | 5.77 |
ENST00000400066.3
ENST00000400065.3 ENST00000356192.6 |
GJB6
|
gap junction protein, beta 6, 30kDa |
| chr19_-_51472222 | 5.64 |
ENST00000376851.3
|
KLK6
|
kallikrein-related peptidase 6 |
| chr1_-_17307173 | 5.48 |
ENST00000438542.1
ENST00000375535.3 |
MFAP2
|
microfibrillar-associated protein 2 |
| chr19_-_51472031 | 5.26 |
ENST00000391808.1
|
KLK6
|
kallikrein-related peptidase 6 |
| chr17_+_70117153 | 5.16 |
ENST00000245479.2
|
SOX9
|
SRY (sex determining region Y)-box 9 |
| chr21_-_44496441 | 5.10 |
ENST00000359624.3
ENST00000352178.5 |
CBS
|
cystathionine-beta-synthase |
| chr1_+_150522222 | 4.89 |
ENST00000369039.5
|
ADAMTSL4
|
ADAMTS-like 4 |
| chr2_+_23608064 | 4.68 |
ENST00000486442.1
|
KLHL29
|
kelch-like family member 29 |
| chr1_-_6545502 | 4.55 |
ENST00000535355.1
|
PLEKHG5
|
pleckstrin homology domain containing, family G (with RhoGef domain) member 5 |
| chr20_-_56284816 | 4.52 |
ENST00000395819.3
ENST00000341744.3 |
PMEPA1
|
prostate transmembrane protein, androgen induced 1 |
| chr9_+_131182697 | 4.26 |
ENST00000372838.4
ENST00000411852.1 |
CERCAM
|
cerebral endothelial cell adhesion molecule |
| chr2_-_224903995 | 4.18 |
ENST00000409304.1
ENST00000454956.1 ENST00000258405.4 |
SERPINE2
|
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 2 |
| chr2_-_235405679 | 4.05 |
ENST00000390645.2
|
ARL4C
|
ADP-ribosylation factor-like 4C |
| chr10_+_28966271 | 4.04 |
ENST00000375533.3
|
BAMBI
|
BMP and activin membrane-bound inhibitor |
| chr12_-_47473642 | 4.02 |
ENST00000266581.4
|
AMIGO2
|
adhesion molecule with Ig-like domain 2 |
| chr18_-_28681950 | 4.01 |
ENST00000251081.6
|
DSC2
|
desmocollin 2 |
| chr2_-_31360887 | 3.98 |
ENST00000420311.2
ENST00000356174.3 ENST00000324589.5 |
GALNT14
|
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 14 (GalNAc-T14) |
| chr8_+_86376081 | 3.86 |
ENST00000285379.5
|
CA2
|
carbonic anhydrase II |
| chr17_+_74381343 | 3.85 |
ENST00000392496.3
|
SPHK1
|
sphingosine kinase 1 |
| chr20_-_43280361 | 3.56 |
ENST00000372874.4
|
ADA
|
adenosine deaminase |
| chr22_+_51112800 | 3.52 |
ENST00000414786.2
|
SHANK3
|
SH3 and multiple ankyrin repeat domains 3 |
| chr12_-_51785182 | 3.50 |
ENST00000356317.3
ENST00000603188.1 ENST00000604847.1 ENST00000604506.1 |
GALNT6
|
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 6 (GalNAc-T6) |
| chr2_+_70142232 | 3.46 |
ENST00000540449.1
|
MXD1
|
MAX dimerization protein 1 |
| chr4_-_57522470 | 3.41 |
ENST00000503639.3
|
HOPX
|
HOP homeobox |
| chr12_-_47473707 | 3.39 |
ENST00000429635.1
|
AMIGO2
|
adhesion molecule with Ig-like domain 2 |
| chr4_-_57522598 | 3.36 |
ENST00000553379.2
|
HOPX
|
HOP homeobox |
| chr1_-_20812690 | 3.36 |
ENST00000375078.3
|
CAMK2N1
|
calcium/calmodulin-dependent protein kinase II inhibitor 1 |
| chr20_-_43280325 | 3.36 |
ENST00000537820.1
|
ADA
|
adenosine deaminase |
| chr2_+_95691417 | 3.36 |
ENST00000309988.4
|
MAL
|
mal, T-cell differentiation protein |
| chr13_-_60738003 | 3.32 |
ENST00000400330.1
ENST00000400324.4 |
DIAPH3
|
diaphanous-related formin 3 |
| chr12_-_76425368 | 3.27 |
ENST00000602540.1
|
PHLDA1
|
pleckstrin homology-like domain, family A, member 1 |
| chr6_-_4135693 | 3.25 |
ENST00000495548.1
ENST00000380125.2 ENST00000465828.1 |
ECI2
|
enoyl-CoA delta isomerase 2 |
| chr17_+_74380683 | 3.22 |
ENST00000592299.1
ENST00000590959.1 ENST00000323374.4 |
SPHK1
|
sphingosine kinase 1 |
| chr4_+_4388805 | 3.21 |
ENST00000504171.1
|
NSG1
|
Homo sapiens neuron specific gene family member 1 (NSG1), transcript variant 3, mRNA. |
| chr5_-_77944648 | 3.21 |
ENST00000380345.2
|
LHFPL2
|
lipoma HMGIC fusion partner-like 2 |
| chr22_-_37915535 | 3.17 |
ENST00000403299.1
|
CARD10
|
caspase recruitment domain family, member 10 |
| chr2_+_95691445 | 3.04 |
ENST00000353004.3
ENST00000354078.3 ENST00000349807.3 |
MAL
|
mal, T-cell differentiation protein |
| chr12_-_47473425 | 3.02 |
ENST00000550413.1
|
AMIGO2
|
adhesion molecule with Ig-like domain 2 |
| chr12_-_47473557 | 2.99 |
ENST00000321382.3
|
AMIGO2
|
adhesion molecule with Ig-like domain 2 |
| chr16_-_85784718 | 2.96 |
ENST00000602766.1
|
C16orf74
|
chromosome 16 open reading frame 74 |
| chr6_-_4135825 | 2.95 |
ENST00000380118.3
ENST00000413766.2 ENST00000361538.2 |
ECI2
|
enoyl-CoA delta isomerase 2 |
| chr15_-_91537723 | 2.95 |
ENST00000394249.3
ENST00000559811.1 ENST00000442656.2 ENST00000557905.1 ENST00000361919.3 |
PRC1
|
protein regulator of cytokinesis 1 |
| chr4_-_57522673 | 2.94 |
ENST00000381255.3
ENST00000317745.7 ENST00000555760.2 ENST00000556614.2 |
HOPX
|
HOP homeobox |
| chr20_+_361890 | 2.94 |
ENST00000449710.1
ENST00000422053.2 |
TRIB3
|
tribbles pseudokinase 3 |
| chr11_-_2160611 | 2.91 |
ENST00000416167.2
|
IGF2
|
insulin-like growth factor 2 (somatomedin A) |
| chr5_-_72744336 | 2.89 |
ENST00000499003.3
|
FOXD1
|
forkhead box D1 |
| chr21_-_16437126 | 2.87 |
ENST00000318948.4
|
NRIP1
|
nuclear receptor interacting protein 1 |
| chr8_+_22022800 | 2.79 |
ENST00000397814.3
|
BMP1
|
bone morphogenetic protein 1 |
| chr19_-_1513188 | 2.79 |
ENST00000330475.4
|
ADAMTSL5
|
ADAMTS-like 5 |
| chr17_-_80009650 | 2.76 |
ENST00000310496.4
|
RFNG
|
RFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase |
| chr6_-_2903514 | 2.75 |
ENST00000380698.4
|
SERPINB9
|
serpin peptidase inhibitor, clade B (ovalbumin), member 9 |
| chr6_+_86159821 | 2.74 |
ENST00000369651.3
|
NT5E
|
5'-nucleotidase, ecto (CD73) |
| chr14_+_100070869 | 2.67 |
ENST00000502101.2
|
RP11-543C4.1
|
RP11-543C4.1 |
| chr7_+_48128816 | 2.67 |
ENST00000395564.4
|
UPP1
|
uridine phosphorylase 1 |
| chr15_+_69706643 | 2.65 |
ENST00000352331.4
ENST00000260363.4 |
KIF23
|
kinesin family member 23 |
| chr10_-_17659234 | 2.64 |
ENST00000466335.1
|
PTPLA
|
protein tyrosine phosphatase-like (proline instead of catalytic arginine), member A |
| chr15_-_83953466 | 2.63 |
ENST00000345382.2
|
BNC1
|
basonuclin 1 |
| chr19_+_2096868 | 2.61 |
ENST00000395296.1
ENST00000395301.3 |
IZUMO4
|
IZUMO family member 4 |
| chr19_-_51472823 | 2.60 |
ENST00000310157.2
|
KLK6
|
kallikrein-related peptidase 6 |
| chr21_-_44495964 | 2.60 |
ENST00000398168.1
ENST00000398165.3 |
CBS
|
cystathionine-beta-synthase |
| chr20_+_6748311 | 2.58 |
ENST00000378827.4
|
BMP2
|
bone morphogenetic protein 2 |
| chr20_+_62694834 | 2.57 |
ENST00000415602.1
|
TCEA2
|
transcription elongation factor A (SII), 2 |
| chr12_-_54813229 | 2.56 |
ENST00000293379.4
|
ITGA5
|
integrin, alpha 5 (fibronectin receptor, alpha polypeptide) |
| chr16_-_85784634 | 2.56 |
ENST00000284245.4
ENST00000602914.1 |
C16orf74
|
chromosome 16 open reading frame 74 |
| chr12_-_124018252 | 2.55 |
ENST00000376874.4
|
RILPL1
|
Rab interacting lysosomal protein-like 1 |
| chr21_-_16437255 | 2.55 |
ENST00000400199.1
ENST00000400202.1 |
NRIP1
|
nuclear receptor interacting protein 1 |
| chr11_-_65667997 | 2.54 |
ENST00000312562.2
ENST00000534222.1 |
FOSL1
|
FOS-like antigen 1 |
| chr4_-_103266355 | 2.52 |
ENST00000424970.2
|
SLC39A8
|
solute carrier family 39 (zinc transporter), member 8 |
| chr4_-_80994471 | 2.52 |
ENST00000295465.4
|
ANTXR2
|
anthrax toxin receptor 2 |
| chr19_+_8429031 | 2.51 |
ENST00000301455.2
ENST00000541807.1 ENST00000393962.2 |
ANGPTL4
|
angiopoietin-like 4 |
| chr3_-_52090461 | 2.51 |
ENST00000296483.6
ENST00000495880.1 |
DUSP7
|
dual specificity phosphatase 7 |
| chr11_+_849816 | 2.50 |
ENST00000527644.1
|
TSPAN4
|
tetraspanin 4 |
| chr6_-_131384412 | 2.50 |
ENST00000445890.2
ENST00000368128.2 ENST00000337057.3 |
EPB41L2
|
erythrocyte membrane protein band 4.1-like 2 |
| chr7_-_27135591 | 2.49 |
ENST00000343060.4
ENST00000355633.5 |
HOXA1
|
homeobox A1 |
| chr9_+_139560197 | 2.48 |
ENST00000371698.3
|
EGFL7
|
EGF-like-domain, multiple 7 |
| chr16_+_66638685 | 2.45 |
ENST00000565003.1
|
CMTM3
|
CKLF-like MARVEL transmembrane domain containing 3 |
| chr3_-_52567792 | 2.44 |
ENST00000307092.4
ENST00000422318.2 ENST00000459839.1 |
NT5DC2
|
5'-nucleotidase domain containing 2 |
| chr7_+_40174565 | 2.39 |
ENST00000309930.5
ENST00000401647.2 ENST00000335693.4 ENST00000413931.1 ENST00000416370.1 ENST00000540834.1 |
C7orf10
|
succinylCoA:glutarate-CoA transferase |
| chr19_+_531713 | 2.39 |
ENST00000215574.4
|
CDC34
|
cell division cycle 34 |
| chr13_-_20767037 | 2.39 |
ENST00000382848.4
|
GJB2
|
gap junction protein, beta 2, 26kDa |
| chr7_-_98741714 | 2.38 |
ENST00000361125.1
|
SMURF1
|
SMAD specific E3 ubiquitin protein ligase 1 |
| chr2_+_64681103 | 2.37 |
ENST00000464281.1
|
LGALSL
|
lectin, galactoside-binding-like |
| chr19_+_35645618 | 2.36 |
ENST00000392218.2
ENST00000543307.1 ENST00000392219.2 ENST00000541435.2 ENST00000590686.1 ENST00000342879.3 ENST00000588699.1 |
FXYD5
|
FXYD domain containing ion transport regulator 5 |
| chr8_-_124428569 | 2.36 |
ENST00000521903.1
|
ATAD2
|
ATPase family, AAA domain containing 2 |
| chr14_-_75422280 | 2.35 |
ENST00000238607.6
ENST00000553716.1 |
PGF
|
placental growth factor |
| chr6_+_86159765 | 2.34 |
ENST00000369646.3
ENST00000257770.3 |
NT5E
|
5'-nucleotidase, ecto (CD73) |
| chr6_+_31371337 | 2.34 |
ENST00000449934.2
ENST00000421350.1 |
MICA
|
MHC class I polypeptide-related sequence A |
| chr1_-_17304771 | 2.34 |
ENST00000375534.3
|
MFAP2
|
microfibrillar-associated protein 2 |
| chr19_+_532049 | 2.33 |
ENST00000606136.1
|
CDC34
|
cell division cycle 34 |
| chr19_+_39903185 | 2.32 |
ENST00000409794.3
|
PLEKHG2
|
pleckstrin homology domain containing, family G (with RhoGef domain) member 2 |
| chr19_+_45281118 | 2.32 |
ENST00000270279.3
ENST00000341505.4 |
CBLC
|
Cbl proto-oncogene C, E3 ubiquitin protein ligase |
| chr16_-_420338 | 2.31 |
ENST00000450882.1
ENST00000441883.1 ENST00000447696.1 ENST00000389675.2 |
MRPL28
|
mitochondrial ribosomal protein L28 |
| chr5_-_1524015 | 2.30 |
ENST00000283415.3
|
LPCAT1
|
lysophosphatidylcholine acyltransferase 1 |
| chr2_-_72375167 | 2.30 |
ENST00000001146.2
|
CYP26B1
|
cytochrome P450, family 26, subfamily B, polypeptide 1 |
| chr13_-_60737898 | 2.28 |
ENST00000377908.2
ENST00000400319.1 ENST00000400320.1 ENST00000267215.4 |
DIAPH3
|
diaphanous-related formin 3 |
| chr9_-_123639304 | 2.25 |
ENST00000436309.1
|
PHF19
|
PHD finger protein 19 |
| chr11_+_69924639 | 2.21 |
ENST00000538023.1
ENST00000398543.2 |
ANO1
|
anoctamin 1, calcium activated chloride channel |
| chr10_+_94833642 | 2.21 |
ENST00000224356.4
ENST00000394139.1 |
CYP26A1
|
cytochrome P450, family 26, subfamily A, polypeptide 1 |
| chr19_-_19051927 | 2.18 |
ENST00000600077.1
|
HOMER3
|
homer homolog 3 (Drosophila) |
| chr2_-_10220538 | 2.17 |
ENST00000381813.4
|
CYS1
|
cystin 1 |
| chr19_+_1407733 | 2.16 |
ENST00000592453.1
|
DAZAP1
|
DAZ associated protein 1 |
| chr14_-_91720224 | 2.16 |
ENST00000238699.3
ENST00000531499.2 |
GPR68
|
G protein-coupled receptor 68 |
| chr10_+_50822480 | 2.16 |
ENST00000455728.2
|
CHAT
|
choline O-acetyltransferase |
| chr8_-_10588010 | 2.16 |
ENST00000304501.1
|
SOX7
|
SRY (sex determining region Y)-box 7 |
| chr1_-_204121013 | 2.15 |
ENST00000367201.3
|
ETNK2
|
ethanolamine kinase 2 |
| chr12_-_2986107 | 2.15 |
ENST00000359843.3
ENST00000342628.2 ENST00000361953.3 |
FOXM1
|
forkhead box M1 |
| chr11_+_842928 | 2.14 |
ENST00000397408.1
|
TSPAN4
|
tetraspanin 4 |
| chr7_-_98741642 | 2.12 |
ENST00000361368.2
|
SMURF1
|
SMAD specific E3 ubiquitin protein ligase 1 |
| chr8_+_145202939 | 2.12 |
ENST00000423230.2
ENST00000398656.4 |
MROH1
|
maestro heat-like repeat family member 1 |
| chr19_+_10216899 | 2.11 |
ENST00000428358.1
ENST00000393796.4 ENST00000253107.7 ENST00000556468.1 ENST00000393793.1 |
PPAN-P2RY11
PPAN
|
PPAN-P2RY11 readthrough peter pan homolog (Drosophila) |
| chr11_+_119076745 | 2.10 |
ENST00000264033.4
|
CBL
|
Cbl proto-oncogene, E3 ubiquitin protein ligase |
| chr9_+_128509663 | 2.10 |
ENST00000373489.5
ENST00000373483.2 |
PBX3
|
pre-B-cell leukemia homeobox 3 |
| chr21_-_44846999 | 2.08 |
ENST00000270162.6
|
SIK1
|
salt-inducible kinase 1 |
| chr11_+_450255 | 2.08 |
ENST00000308020.5
|
PTDSS2
|
phosphatidylserine synthase 2 |
| chr9_-_136344197 | 2.07 |
ENST00000414172.1
ENST00000371897.4 |
SLC2A6
|
solute carrier family 2 (facilitated glucose transporter), member 6 |
| chr7_+_102715573 | 2.06 |
ENST00000434153.1
|
ARMC10
|
armadillo repeat containing 10 |
| chr15_+_81071684 | 2.06 |
ENST00000220244.3
ENST00000394685.3 ENST00000356249.5 |
KIAA1199
|
KIAA1199 |
| chr20_-_60942361 | 2.05 |
ENST00000252999.3
|
LAMA5
|
laminin, alpha 5 |
| chr2_-_235405168 | 2.05 |
ENST00000339728.3
|
ARL4C
|
ADP-ribosylation factor-like 4C |
| chr16_-_87903079 | 2.04 |
ENST00000261622.4
|
SLC7A5
|
solute carrier family 7 (amino acid transporter light chain, L system), member 5 |
| chr1_-_6321035 | 2.04 |
ENST00000377893.2
|
GPR153
|
G protein-coupled receptor 153 |
| chr7_-_24797032 | 2.03 |
ENST00000409970.1
ENST00000409775.3 |
DFNA5
|
deafness, autosomal dominant 5 |
| chr9_-_123639445 | 2.03 |
ENST00000312189.6
|
PHF19
|
PHD finger protein 19 |
| chr16_-_90085824 | 2.01 |
ENST00000002501.6
|
DBNDD1
|
dysbindin (dystrobrevin binding protein 1) domain containing 1 |
| chr19_+_16187816 | 2.00 |
ENST00000588410.1
|
TPM4
|
tropomyosin 4 |
| chr16_-_84651647 | 2.00 |
ENST00000564057.1
|
COTL1
|
coactosin-like 1 (Dictyostelium) |
| chr17_+_65374075 | 1.99 |
ENST00000581322.1
|
PITPNC1
|
phosphatidylinositol transfer protein, cytoplasmic 1 |
| chr8_-_10697281 | 1.98 |
ENST00000524114.1
ENST00000553390.1 ENST00000554914.1 |
PINX1
SOX7
SOX7
|
PIN2/TERF1 interacting, telomerase inhibitor 1 SRY (sex determining region Y)-box 7 Transcription factor SOX-7; Uncharacterized protein; cDNA FLJ58508, highly similar to Transcription factor SOX-7 |
| chr19_+_10381769 | 1.98 |
ENST00000423829.2
ENST00000588645.1 |
ICAM1
|
intercellular adhesion molecule 1 |
| chr17_+_6544328 | 1.98 |
ENST00000570330.1
|
TXNDC17
|
thioredoxin domain containing 17 |
| chr16_+_66638567 | 1.98 |
ENST00000567572.1
|
CMTM3
|
CKLF-like MARVEL transmembrane domain containing 3 |
| chr15_+_69706585 | 1.98 |
ENST00000559279.1
ENST00000395392.2 |
KIF23
|
kinesin family member 23 |
| chr17_-_27278445 | 1.97 |
ENST00000268756.3
ENST00000584685.1 |
PHF12
|
PHD finger protein 12 |
| chr17_-_43209862 | 1.97 |
ENST00000322765.5
|
PLCD3
|
phospholipase C, delta 3 |
| chr19_-_15343191 | 1.97 |
ENST00000221730.3
|
EPHX3
|
epoxide hydrolase 3 |
| chr11_-_65667884 | 1.97 |
ENST00000448083.2
ENST00000531493.1 ENST00000532401.1 |
FOSL1
|
FOS-like antigen 1 |
| chr12_+_27485889 | 1.97 |
ENST00000311001.5
ENST00000261178.5 ENST00000266503.5 |
ARNTL2
|
aryl hydrocarbon receptor nuclear translocator-like 2 |
| chr20_+_25176318 | 1.97 |
ENST00000354989.5
ENST00000360031.2 ENST00000376652.4 ENST00000439162.1 ENST00000433417.1 ENST00000417467.1 ENST00000433259.2 ENST00000427553.1 ENST00000435520.1 ENST00000418890.1 |
ENTPD6
|
ectonucleoside triphosphate diphosphohydrolase 6 (putative) |
| chr9_+_116638562 | 1.95 |
ENST00000374126.5
ENST00000288466.7 |
ZNF618
|
zinc finger protein 618 |
| chr19_-_19051993 | 1.95 |
ENST00000594794.1
ENST00000355887.6 ENST00000392351.3 ENST00000596482.1 |
HOMER3
|
homer homolog 3 (Drosophila) |
| chr4_+_75310851 | 1.95 |
ENST00000395748.3
ENST00000264487.2 |
AREG
|
amphiregulin |
| chr22_-_26986045 | 1.95 |
ENST00000442495.1
ENST00000440953.1 ENST00000450022.1 ENST00000338754.4 |
TPST2
|
tyrosylprotein sulfotransferase 2 |
| chr11_+_46402744 | 1.94 |
ENST00000533952.1
|
MDK
|
midkine (neurite growth-promoting factor 2) |
| chr2_-_46385 | 1.94 |
ENST00000327669.4
|
FAM110C
|
family with sequence similarity 110, member C |
| chr18_-_21242774 | 1.94 |
ENST00000322980.9
|
ANKRD29
|
ankyrin repeat domain 29 |
| chr10_+_11865347 | 1.94 |
ENST00000277570.5
|
PROSER2
|
proline and serine-rich protein 2 |
| chr11_-_2160180 | 1.94 |
ENST00000381406.4
|
IGF2
|
insulin-like growth factor 2 (somatomedin A) |
| chr7_+_99156011 | 1.93 |
ENST00000320583.5
ENST00000357864.2 |
ZNF655
|
zinc finger protein 655 |
| chr1_-_231175964 | 1.93 |
ENST00000366654.4
|
FAM89A
|
family with sequence similarity 89, member A |
| chr21_-_44495919 | 1.92 |
ENST00000398158.1
|
CBS
|
cystathionine-beta-synthase |
| chr16_+_2479390 | 1.92 |
ENST00000397066.4
|
CCNF
|
cyclin F |
| chr9_+_132815985 | 1.91 |
ENST00000372410.3
|
GPR107
|
G protein-coupled receptor 107 |
| chr12_+_53491220 | 1.91 |
ENST00000548547.1
ENST00000301464.3 |
IGFBP6
|
insulin-like growth factor binding protein 6 |
| chr16_+_66638616 | 1.90 |
ENST00000564060.1
ENST00000565922.1 |
CMTM3
|
CKLF-like MARVEL transmembrane domain containing 3 |
| chr11_-_125366089 | 1.90 |
ENST00000366139.3
ENST00000278919.3 |
FEZ1
|
fasciculation and elongation protein zeta 1 (zygin I) |
| chr15_+_39873268 | 1.89 |
ENST00000397591.2
ENST00000260356.5 |
THBS1
|
thrombospondin 1 |
| chr9_-_136344237 | 1.88 |
ENST00000432868.1
ENST00000371899.4 |
SLC2A6
|
solute carrier family 2 (facilitated glucose transporter), member 6 |
| chr7_+_48128854 | 1.87 |
ENST00000436673.1
ENST00000429491.2 |
UPP1
|
uridine phosphorylase 1 |
| chr7_-_50861129 | 1.87 |
ENST00000439044.1
ENST00000402497.1 ENST00000335866.3 |
GRB10
|
growth factor receptor-bound protein 10 |
| chr4_+_75311019 | 1.86 |
ENST00000502307.1
|
AREG
|
amphiregulin |
| chr7_-_148580563 | 1.86 |
ENST00000476773.1
|
EZH2
|
enhancer of zeste homolog 2 (Drosophila) |
| chr4_+_1723197 | 1.86 |
ENST00000485989.2
ENST00000313288.4 |
TACC3
|
transforming, acidic coiled-coil containing protein 3 |
| chr17_+_6544356 | 1.86 |
ENST00000574838.1
|
TXNDC17
|
thioredoxin domain containing 17 |
| chr1_+_165796753 | 1.85 |
ENST00000367879.4
|
UCK2
|
uridine-cytidine kinase 2 |
| chr8_+_22022653 | 1.85 |
ENST00000354870.5
ENST00000397816.3 ENST00000306349.8 |
BMP1
|
bone morphogenetic protein 1 |
| chr19_-_49015050 | 1.84 |
ENST00000600059.1
|
LMTK3
|
lemur tyrosine kinase 3 |
| chr11_+_43964055 | 1.84 |
ENST00000528572.1
|
C11orf96
|
chromosome 11 open reading frame 96 |
| chr1_+_25071848 | 1.84 |
ENST00000374379.4
|
CLIC4
|
chloride intracellular channel 4 |
| chr12_+_27485785 | 1.84 |
ENST00000544915.1
|
ARNTL2
|
aryl hydrocarbon receptor nuclear translocator-like 2 |
| chr6_+_20403997 | 1.84 |
ENST00000535432.1
|
E2F3
|
E2F transcription factor 3 |
| chr13_+_110959598 | 1.83 |
ENST00000360467.5
|
COL4A2
|
collagen, type IV, alpha 2 |
| chr19_-_47249679 | 1.82 |
ENST00000263280.6
|
STRN4
|
striatin, calmodulin binding protein 4 |
| chr5_-_60140089 | 1.82 |
ENST00000507047.1
ENST00000438340.1 ENST00000425382.1 ENST00000508821.1 |
ELOVL7
|
ELOVL fatty acid elongase 7 |
| chr7_+_100797726 | 1.82 |
ENST00000429457.1
|
AP1S1
|
adaptor-related protein complex 1, sigma 1 subunit |
| chr2_+_33172221 | 1.82 |
ENST00000354476.3
|
LTBP1
|
latent transforming growth factor beta binding protein 1 |
| chr9_-_19127474 | 1.82 |
ENST00000380465.3
ENST00000380464.3 ENST00000411567.1 ENST00000276914.2 |
PLIN2
|
perilipin 2 |
| chr10_+_124221036 | 1.81 |
ENST00000368984.3
|
HTRA1
|
HtrA serine peptidase 1 |
| chr5_-_60140009 | 1.81 |
ENST00000505959.1
|
ELOVL7
|
ELOVL fatty acid elongase 7 |
| chr15_+_90744533 | 1.81 |
ENST00000411539.2
|
SEMA4B
|
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4B |
| chr17_+_62223320 | 1.81 |
ENST00000580828.1
ENST00000582965.1 |
SNORA76
|
small nucleolar RNA, H/ACA box 76 |
| chr7_-_50860565 | 1.80 |
ENST00000403097.1
|
GRB10
|
growth factor receptor-bound protein 10 |
| chr12_-_122238464 | 1.80 |
ENST00000546227.1
|
RHOF
|
ras homolog family member F (in filopodia) |
| chr4_-_80993717 | 1.79 |
ENST00000307333.7
|
ANTXR2
|
anthrax toxin receptor 2 |
| chr10_-_103347883 | 1.79 |
ENST00000339310.3
ENST00000370158.3 ENST00000299206.4 ENST00000456836.2 ENST00000413344.1 ENST00000429502.1 ENST00000430045.1 ENST00000370172.1 ENST00000436284.2 ENST00000370162.3 |
POLL
|
polymerase (DNA directed), lambda |
| chr9_+_137218362 | 1.79 |
ENST00000481739.1
|
RXRA
|
retinoid X receptor, alpha |
| chr7_+_150811705 | 1.79 |
ENST00000335367.3
|
AGAP3
|
ArfGAP with GTPase domain, ankyrin repeat and PH domain 3 |
| chr11_-_71159380 | 1.78 |
ENST00000525346.1
ENST00000531364.1 ENST00000529990.1 ENST00000527316.1 ENST00000407721.2 |
DHCR7
|
7-dehydrocholesterol reductase |
| chr11_+_842808 | 1.78 |
ENST00000397397.2
ENST00000397411.2 ENST00000397396.1 |
TSPAN4
|
tetraspanin 4 |
| chr12_+_22778291 | 1.78 |
ENST00000545979.1
|
ETNK1
|
ethanolamine kinase 1 |
| chr2_+_102314161 | 1.78 |
ENST00000425019.1
|
MAP4K4
|
mitogen-activated protein kinase kinase kinase kinase 4 |
| chr16_-_420514 | 1.77 |
ENST00000199706.8
|
MRPL28
|
mitochondrial ribosomal protein L28 |
| chr11_+_46403303 | 1.76 |
ENST00000407067.1
ENST00000395565.1 |
MDK
|
midkine (neurite growth-promoting factor 2) |
| chr6_-_131384373 | 1.76 |
ENST00000392427.3
ENST00000525271.1 ENST00000527411.1 |
EPB41L2
|
erythrocyte membrane protein band 4.1-like 2 |
| chr19_-_15343773 | 1.76 |
ENST00000435261.1
ENST00000594042.1 |
EPHX3
|
epoxide hydrolase 3 |
| chr20_+_42295745 | 1.76 |
ENST00000396863.4
ENST00000217026.4 |
MYBL2
|
v-myb avian myeloblastosis viral oncogene homolog-like 2 |
| chr12_-_28123206 | 1.75 |
ENST00000542963.1
ENST00000535992.1 |
PTHLH
|
parathyroid hormone-like hormone |
| chr12_-_57634475 | 1.75 |
ENST00000393825.1
|
NDUFA4L2
|
NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 4-like 2 |
Network of associatons between targets according to the STRING database.
First level regulatory network of MECP2
Gene Ontology Analysis
Gene overrepresentation in biological_process category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 3.2 | 9.6 | GO:0006535 | cysteine biosynthetic process from serine(GO:0006535) |
| 2.4 | 7.1 | GO:0046521 | sphingoid catabolic process(GO:0046521) |
| 2.2 | 6.7 | GO:0006154 | adenosine catabolic process(GO:0006154) inosine biosynthetic process(GO:0046103) |
| 1.9 | 1.9 | GO:0043491 | protein kinase B signaling(GO:0043491) |
| 1.7 | 6.9 | GO:0006218 | uridine catabolic process(GO:0006218) |
| 1.7 | 5.2 | GO:0060516 | primary prostatic bud elongation(GO:0060516) |
| 1.7 | 5.0 | GO:0042938 | dipeptide transport(GO:0042938) |
| 1.6 | 4.7 | GO:1902534 | single-organism membrane invagination(GO:1902534) |
| 1.4 | 5.6 | GO:0016103 | diterpenoid catabolic process(GO:0016103) retinoic acid catabolic process(GO:0034653) |
| 1.4 | 5.4 | GO:0046086 | adenosine biosynthetic process(GO:0046086) |
| 1.3 | 29.7 | GO:0016540 | protein autoprocessing(GO:0016540) |
| 1.3 | 7.9 | GO:0030421 | defecation(GO:0030421) |
| 1.2 | 1.2 | GO:0036072 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
| 1.2 | 1.2 | GO:0032808 | lacrimal gland development(GO:0032808) |
| 1.1 | 4.4 | GO:0000912 | assembly of actomyosin apparatus involved in cytokinesis(GO:0000912) actomyosin contractile ring assembly(GO:0000915) actomyosin contractile ring organization(GO:0044837) |
| 1.1 | 3.3 | GO:1904772 | hepatocyte homeostasis(GO:0036333) response to tetrachloromethane(GO:1904772) |
| 1.1 | 3.3 | GO:0045210 | FasL biosynthetic process(GO:0045210) |
| 1.1 | 5.3 | GO:0021773 | striatal medium spiny neuron differentiation(GO:0021773) |
| 1.0 | 1.0 | GO:0090149 | mitochondrial membrane fission(GO:0090149) |
| 0.9 | 3.7 | GO:0072268 | pattern specification involved in metanephros development(GO:0072268) |
| 0.9 | 2.8 | GO:0042270 | protection from natural killer cell mediated cytotoxicity(GO:0042270) |
| 0.9 | 5.4 | GO:0007296 | vitellogenesis(GO:0007296) |
| 0.9 | 6.2 | GO:0010757 | negative regulation of plasminogen activation(GO:0010757) |
| 0.9 | 1.7 | GO:2000097 | regulation of smooth muscle cell-matrix adhesion(GO:2000097) |
| 0.9 | 2.6 | GO:0051086 | chaperone mediated protein folding independent of cofactor(GO:0051086) |
| 0.9 | 5.2 | GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
| 0.9 | 4.3 | GO:0036324 | vascular endothelial growth factor receptor-2 signaling pathway(GO:0036324) |
| 0.8 | 6.6 | GO:0003065 | positive regulation of heart rate by epinephrine(GO:0003065) |
| 0.8 | 2.4 | GO:0007498 | mesoderm development(GO:0007498) |
| 0.8 | 2.4 | GO:2001245 | regulation of phosphatidylcholine biosynthetic process(GO:2001245) |
| 0.8 | 7.3 | GO:0048050 | post-embryonic eye morphogenesis(GO:0048050) |
| 0.8 | 2.4 | GO:0045229 | cell envelope organization(GO:0043163) external encapsulating structure organization(GO:0045229) |
| 0.8 | 2.4 | GO:0046586 | regulation of calcium-dependent cell-cell adhesion(GO:0046586) |
| 0.8 | 3.1 | GO:0003308 | negative regulation of Wnt signaling pathway involved in heart development(GO:0003308) |
| 0.8 | 3.1 | GO:0046035 | CMP salvage(GO:0006238) CMP biosynthetic process(GO:0009224) CMP metabolic process(GO:0046035) |
| 0.8 | 0.8 | GO:0001954 | positive regulation of cell-matrix adhesion(GO:0001954) |
| 0.8 | 0.8 | GO:0048073 | regulation of eye pigmentation(GO:0048073) |
| 0.8 | 3.8 | GO:0010986 | positive regulation of lipoprotein particle clearance(GO:0010986) |
| 0.8 | 1.5 | GO:0033091 | positive regulation of immature T cell proliferation(GO:0033091) |
| 0.7 | 3.7 | GO:0033490 | cholesterol biosynthetic process via desmosterol(GO:0033489) cholesterol biosynthetic process via lathosterol(GO:0033490) |
| 0.7 | 1.4 | GO:2001020 | regulation of response to DNA damage stimulus(GO:2001020) |
| 0.7 | 2.1 | GO:0031938 | regulation of chromatin silencing at telomere(GO:0031938) |
| 0.7 | 1.4 | GO:0048512 | rhythmic behavior(GO:0007622) circadian behavior(GO:0048512) |
| 0.7 | 7.7 | GO:0060753 | regulation of mast cell chemotaxis(GO:0060753) |
| 0.7 | 2.1 | GO:0051300 | spindle pole body duplication(GO:0030474) spindle pole body organization(GO:0051300) spindle pole body localization(GO:0070631) establishment of spindle pole body localization(GO:0070632) spindle pole body localization to nuclear envelope(GO:0071789) establishment of spindle pole body localization to nuclear envelope(GO:0071790) |
| 0.7 | 2.1 | GO:0097187 | dentinogenesis(GO:0097187) |
| 0.7 | 2.0 | GO:0006478 | peptidyl-tyrosine sulfation(GO:0006478) |
| 0.7 | 2.0 | GO:0000412 | histone peptidyl-prolyl isomerization(GO:0000412) |
| 0.7 | 0.7 | GO:0046102 | inosine metabolic process(GO:0046102) |
| 0.7 | 2.0 | GO:0046947 | hydroxylysine metabolic process(GO:0046946) hydroxylysine biosynthetic process(GO:0046947) |
| 0.7 | 3.3 | GO:0009440 | cyanate metabolic process(GO:0009439) cyanate catabolic process(GO:0009440) |
| 0.7 | 2.0 | GO:0051780 | mevalonate transport(GO:0015728) behavioral response to nutrient(GO:0051780) |
| 0.7 | 5.9 | GO:0086073 | bundle of His cell-Purkinje myocyte adhesion involved in cell communication(GO:0086073) |
| 0.6 | 1.9 | GO:1904481 | response to tetrahydrofolate(GO:1904481) cellular response to tetrahydrofolate(GO:1904482) |
| 0.6 | 1.9 | GO:0045013 | carbon catabolite repression of transcription(GO:0045013) negative regulation of transcription by glucose(GO:0045014) |
| 0.6 | 0.6 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
| 0.6 | 1.9 | GO:1901350 | cell-cell signaling involved in cell-cell junction organization(GO:1901350) |
| 0.6 | 5.5 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
| 0.6 | 1.8 | GO:0071921 | establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
| 0.6 | 5.4 | GO:0019368 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
| 0.6 | 1.2 | GO:0060057 | apoptotic process involved in mammary gland involution(GO:0060057) positive regulation of apoptotic process involved in mammary gland involution(GO:0060058) positive regulation of apoptotic process involved in morphogenesis(GO:1902339) regulation of mammary gland involution(GO:1903519) positive regulation of mammary gland involution(GO:1903521) positive regulation of apoptotic process involved in development(GO:1904747) |
| 0.6 | 0.6 | GO:0045626 | negative regulation of T-helper 1 cell differentiation(GO:0045626) |
| 0.6 | 0.6 | GO:1903423 | positive regulation of synaptic vesicle endocytosis(GO:1900244) positive regulation of synaptic vesicle recycling(GO:1903423) |
| 0.6 | 0.6 | GO:0072102 | glomerulus morphogenesis(GO:0072102) glomerulus vasculature morphogenesis(GO:0072103) glomerular capillary formation(GO:0072104) |
| 0.6 | 1.7 | GO:0035879 | plasma membrane lactate transport(GO:0035879) |
| 0.6 | 2.9 | GO:0060574 | intestinal epithelial cell maturation(GO:0060574) |
| 0.6 | 6.9 | GO:0061087 | positive regulation of histone H3-K27 methylation(GO:0061087) |
| 0.6 | 2.9 | GO:0007159 | leukocyte cell-cell adhesion(GO:0007159) |
| 0.6 | 1.7 | GO:0043418 | homocysteine catabolic process(GO:0043418) |
| 0.6 | 3.4 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
| 0.6 | 1.7 | GO:0000294 | nuclear-transcribed mRNA catabolic process, endonucleolytic cleavage-dependent decay(GO:0000294) |
| 0.6 | 2.3 | GO:1904566 | response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904565) cellular response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904566) |
| 0.6 | 2.8 | GO:0048817 | negative regulation of hair follicle maturation(GO:0048817) |
| 0.6 | 4.5 | GO:0042695 | thelarche(GO:0042695) mammary gland branching involved in thelarche(GO:0060744) |
| 0.6 | 2.2 | GO:0044752 | response to human chorionic gonadotropin(GO:0044752) |
| 0.6 | 1.7 | GO:0036466 | synaptic vesicle recycling via endosome(GO:0036466) |
| 0.5 | 8.2 | GO:1904776 | regulation of protein localization to cell cortex(GO:1904776) positive regulation of protein localization to cell cortex(GO:1904778) |
| 0.5 | 3.3 | GO:0007386 | compartment pattern specification(GO:0007386) |
| 0.5 | 1.1 | GO:0000082 | G1/S transition of mitotic cell cycle(GO:0000082) |
| 0.5 | 2.1 | GO:0016334 | morphogenesis of follicular epithelium(GO:0016333) establishment or maintenance of polarity of follicular epithelium(GO:0016334) establishment of planar polarity of follicular epithelium(GO:0042247) |
| 0.5 | 1.6 | GO:0007057 | spindle assembly involved in female meiosis I(GO:0007057) |
| 0.5 | 1.1 | GO:0002159 | desmosome assembly(GO:0002159) |
| 0.5 | 1.6 | GO:0060370 | susceptibility to T cell mediated cytotoxicity(GO:0060370) |
| 0.5 | 4.2 | GO:0035583 | sequestering of TGFbeta in extracellular matrix(GO:0035583) |
| 0.5 | 1.6 | GO:0032877 | positive regulation of DNA endoreduplication(GO:0032877) |
| 0.5 | 1.0 | GO:0086042 | cardiac muscle cell-cardiac muscle cell adhesion(GO:0086042) |
| 0.5 | 3.1 | GO:0032252 | secretory granule localization(GO:0032252) |
| 0.5 | 2.1 | GO:0099640 | axo-dendritic protein transport(GO:0099640) |
| 0.5 | 2.6 | GO:0032792 | negative regulation of CREB transcription factor activity(GO:0032792) |
| 0.5 | 6.2 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
| 0.5 | 3.1 | GO:2000568 | memory T cell activation(GO:0035709) regulation of memory T cell activation(GO:2000567) positive regulation of memory T cell activation(GO:2000568) |
| 0.5 | 1.5 | GO:0010752 | regulation of cGMP-mediated signaling(GO:0010752) |
| 0.5 | 1.5 | GO:0014707 | branchiomeric skeletal muscle development(GO:0014707) |
| 0.5 | 2.0 | GO:0097368 | establishment of Sertoli cell barrier(GO:0097368) |
| 0.5 | 0.5 | GO:0090187 | positive regulation of pancreatic juice secretion(GO:0090187) |
| 0.5 | 3.0 | GO:0002225 | positive regulation of antimicrobial peptide production(GO:0002225) positive regulation of antimicrobial humoral response(GO:0002760) positive regulation of antibacterial peptide production(GO:0002803) |
| 0.5 | 5.5 | GO:0070574 | cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
| 0.5 | 3.0 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
| 0.5 | 1.5 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
| 0.5 | 0.5 | GO:0006826 | iron ion transport(GO:0006826) |
| 0.5 | 1.5 | GO:0052047 | interaction with other organism via secreted substance involved in symbiotic interaction(GO:0052047) |
| 0.5 | 1.5 | GO:0021793 | chemorepulsion of branchiomotor axon(GO:0021793) |
| 0.5 | 1.5 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
| 0.5 | 1.9 | GO:0035625 | epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathway(GO:0035625) |
| 0.5 | 7.3 | GO:0001542 | ovulation from ovarian follicle(GO:0001542) |
| 0.5 | 1.5 | GO:0048250 | mitochondrial iron ion transport(GO:0048250) |
| 0.5 | 1.9 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
| 0.5 | 1.4 | GO:0002384 | hepatic immune response(GO:0002384) |
| 0.5 | 2.4 | GO:0030035 | microspike assembly(GO:0030035) |
| 0.5 | 2.4 | GO:1904744 | positive regulation of telomeric DNA binding(GO:1904744) |
| 0.5 | 7.5 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
| 0.5 | 7.5 | GO:0045176 | apical protein localization(GO:0045176) |
| 0.5 | 1.4 | GO:1901860 | positive regulation of mitochondrial DNA metabolic process(GO:1901860) |
| 0.5 | 1.4 | GO:0019287 | isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
| 0.5 | 1.8 | GO:0015966 | diadenosine polyphosphate biosynthetic process(GO:0015960) diadenosine tetraphosphate metabolic process(GO:0015965) diadenosine tetraphosphate biosynthetic process(GO:0015966) |
| 0.5 | 3.7 | GO:2001206 | positive regulation of osteoclast development(GO:2001206) |
| 0.5 | 1.8 | GO:1903566 | positive regulation of protein localization to cilium(GO:1903566) |
| 0.5 | 7.4 | GO:0051639 | actin filament network formation(GO:0051639) |
| 0.5 | 1.4 | GO:0090235 | regulation of metaphase plate congression(GO:0090235) |
| 0.5 | 0.5 | GO:0016539 | intein-mediated protein splicing(GO:0016539) protein splicing(GO:0030908) |
| 0.5 | 0.9 | GO:2000646 | positive regulation of receptor catabolic process(GO:2000646) |
| 0.5 | 1.8 | GO:0021812 | neuronal-glial interaction involved in cerebral cortex radial glia guided migration(GO:0021812) |
| 0.5 | 1.8 | GO:1900042 | positive regulation of interleukin-2 secretion(GO:1900042) |
| 0.5 | 1.4 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
| 0.5 | 5.9 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
| 0.5 | 5.9 | GO:0010990 | regulation of SMAD protein complex assembly(GO:0010990) negative regulation of SMAD protein complex assembly(GO:0010991) |
| 0.4 | 1.8 | GO:0046061 | dATP catabolic process(GO:0046061) |
| 0.4 | 1.8 | GO:0002268 | follicular dendritic cell differentiation(GO:0002268) |
| 0.4 | 3.6 | GO:0038060 | nitric oxide-cGMP-mediated signaling pathway(GO:0038060) |
| 0.4 | 1.3 | GO:0051066 | dihydrobiopterin metabolic process(GO:0051066) |
| 0.4 | 1.3 | GO:0070898 | RNA polymerase III transcriptional preinitiation complex assembly(GO:0070898) |
| 0.4 | 2.2 | GO:0038026 | reelin-mediated signaling pathway(GO:0038026) |
| 0.4 | 1.7 | GO:0014846 | esophagus smooth muscle contraction(GO:0014846) |
| 0.4 | 11.4 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
| 0.4 | 1.7 | GO:0051754 | meiotic sister chromatid cohesion, centromeric(GO:0051754) |
| 0.4 | 2.6 | GO:0006021 | inositol biosynthetic process(GO:0006021) |
| 0.4 | 1.7 | GO:0010760 | negative regulation of macrophage chemotaxis(GO:0010760) |
| 0.4 | 1.3 | GO:0030200 | heparan sulfate proteoglycan catabolic process(GO:0030200) |
| 0.4 | 1.3 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
| 0.4 | 2.1 | GO:0090650 | response to oxygen-glucose deprivation(GO:0090649) cellular response to oxygen-glucose deprivation(GO:0090650) |
| 0.4 | 2.9 | GO:0033625 | positive regulation of integrin activation(GO:0033625) |
| 0.4 | 0.4 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
| 0.4 | 1.2 | GO:1900220 | semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis(GO:1900220) |
| 0.4 | 0.4 | GO:1990138 | neuron projection extension(GO:1990138) |
| 0.4 | 1.2 | GO:0018262 | isopeptide cross-linking via N6-(L-isoglutamyl)-L-lysine(GO:0018153) isopeptide cross-linking(GO:0018262) |
| 0.4 | 1.6 | GO:0003409 | optic cup structural organization(GO:0003409) |
| 0.4 | 2.1 | GO:0033078 | extrathymic T cell differentiation(GO:0033078) |
| 0.4 | 5.7 | GO:0035878 | nail development(GO:0035878) |
| 0.4 | 0.4 | GO:0010807 | regulation of synaptic vesicle priming(GO:0010807) |
| 0.4 | 1.2 | GO:2000393 | negative regulation of lamellipodium morphogenesis(GO:2000393) |
| 0.4 | 2.4 | GO:1903527 | positive regulation of membrane tubulation(GO:1903527) |
| 0.4 | 0.4 | GO:0051495 | positive regulation of cytoskeleton organization(GO:0051495) |
| 0.4 | 0.4 | GO:0003221 | right ventricular cardiac muscle tissue morphogenesis(GO:0003221) |
| 0.4 | 1.6 | GO:0046967 | cytosol to ER transport(GO:0046967) |
| 0.4 | 3.2 | GO:0060017 | parathyroid gland development(GO:0060017) |
| 0.4 | 0.4 | GO:0003197 | endocardial cushion development(GO:0003197) |
| 0.4 | 1.2 | GO:0042700 | luteinizing hormone signaling pathway(GO:0042700) |
| 0.4 | 1.9 | GO:0090402 | oncogene-induced cell senescence(GO:0090402) |
| 0.4 | 3.1 | GO:0050689 | negative regulation of defense response to virus by host(GO:0050689) |
| 0.4 | 0.8 | GO:1904253 | positive regulation of bile acid biosynthetic process(GO:0070859) positive regulation of bile acid metabolic process(GO:1904253) |
| 0.4 | 1.2 | GO:2000777 | positive regulation of proteasomal ubiquitin-dependent protein catabolic process involved in cellular response to hypoxia(GO:2000777) |
| 0.4 | 1.5 | GO:0090170 | regulation of Golgi inheritance(GO:0090170) |
| 0.4 | 3.8 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
| 0.4 | 1.1 | GO:0048627 | myoblast development(GO:0048627) |
| 0.4 | 1.5 | GO:0045065 | cytotoxic T cell differentiation(GO:0045065) |
| 0.4 | 0.4 | GO:0032425 | positive regulation of mismatch repair(GO:0032425) |
| 0.4 | 2.2 | GO:0052551 | response to defense-related nitric oxide production by other organism involved in symbiotic interaction(GO:0052551) response to defense-related host nitric oxide production(GO:0052565) |
| 0.4 | 2.6 | GO:0060992 | response to fungicide(GO:0060992) |
| 0.4 | 1.1 | GO:0060988 | lipid tube assembly(GO:0060988) |
| 0.4 | 0.7 | GO:1904783 | positive regulation of NMDA glutamate receptor activity(GO:1904783) |
| 0.4 | 1.1 | GO:2000412 | activation of MAPK activity involved in innate immune response(GO:0035419) positive regulation of tumor necrosis factor (ligand) superfamily member 11 production(GO:2000309) positive regulation of thymocyte migration(GO:2000412) |
| 0.4 | 1.1 | GO:0035624 | receptor transactivation(GO:0035624) |
| 0.4 | 1.8 | GO:0071802 | negative regulation of podosome assembly(GO:0071802) |
| 0.4 | 0.4 | GO:0043449 | cellular alkene metabolic process(GO:0043449) |
| 0.4 | 5.8 | GO:0030949 | positive regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030949) |
| 0.4 | 1.1 | GO:0002934 | desmosome organization(GO:0002934) |
| 0.4 | 2.9 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
| 0.4 | 2.1 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
| 0.4 | 1.4 | GO:0015783 | GDP-fucose transport(GO:0015783) purine nucleotide-sugar transport(GO:0036079) |
| 0.4 | 3.2 | GO:0015705 | iodide transport(GO:0015705) |
| 0.3 | 1.4 | GO:0009257 | 10-formyltetrahydrofolate biosynthetic process(GO:0009257) |
| 0.3 | 1.4 | GO:1902462 | regulation of mesenchymal stem cell proliferation(GO:1902460) positive regulation of mesenchymal stem cell proliferation(GO:1902462) |
| 0.3 | 0.7 | GO:0090526 | regulation of gluconeogenesis involved in cellular glucose homeostasis(GO:0090526) |
| 0.3 | 1.4 | GO:0045950 | negative regulation of mitotic recombination(GO:0045950) |
| 0.3 | 2.1 | GO:0016479 | negative regulation of transcription from RNA polymerase I promoter(GO:0016479) |
| 0.3 | 2.8 | GO:1903358 | regulation of Golgi organization(GO:1903358) |
| 0.3 | 2.4 | GO:2001181 | positive regulation of interleukin-10 secretion(GO:2001181) |
| 0.3 | 1.4 | GO:1902626 | assembly of large subunit precursor of preribosome(GO:1902626) |
| 0.3 | 0.3 | GO:1904339 | negative regulation of dopaminergic neuron differentiation(GO:1904339) |
| 0.3 | 1.4 | GO:0071163 | DNA replication preinitiation complex assembly(GO:0071163) |
| 0.3 | 0.3 | GO:0043000 | Golgi to plasma membrane CFTR protein transport(GO:0043000) |
| 0.3 | 1.0 | GO:0031064 | negative regulation of histone deacetylation(GO:0031064) |
| 0.3 | 1.0 | GO:0008355 | olfactory learning(GO:0008355) |
| 0.3 | 2.0 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
| 0.3 | 1.0 | GO:0039019 | pronephric nephron development(GO:0039019) |
| 0.3 | 1.0 | GO:0070510 | regulation of histone H4-K20 methylation(GO:0070510) positive regulation of histone H4-K20 methylation(GO:0070512) |
| 0.3 | 2.0 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
| 0.3 | 2.0 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
| 0.3 | 3.3 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
| 0.3 | 1.3 | GO:0070384 | Harderian gland development(GO:0070384) |
| 0.3 | 1.3 | GO:1901382 | chorionic trophoblast cell proliferation(GO:0097360) regulation of chorionic trophoblast cell proliferation(GO:1901382) |
| 0.3 | 0.3 | GO:1900222 | negative regulation of beta-amyloid clearance(GO:1900222) |
| 0.3 | 2.6 | GO:0032815 | negative regulation of natural killer cell activation(GO:0032815) |
| 0.3 | 3.9 | GO:0042532 | negative regulation of tyrosine phosphorylation of STAT protein(GO:0042532) |
| 0.3 | 1.6 | GO:0030948 | negative regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030948) |
| 0.3 | 3.8 | GO:0033227 | dsRNA transport(GO:0033227) |
| 0.3 | 0.9 | GO:0046900 | tetrahydrofolylpolyglutamate metabolic process(GO:0046900) |
| 0.3 | 0.9 | GO:0019511 | peptidyl-proline hydroxylation(GO:0019511) |
| 0.3 | 0.6 | GO:0035411 | catenin import into nucleus(GO:0035411) |
| 0.3 | 1.9 | GO:0001661 | conditioned taste aversion(GO:0001661) |
| 0.3 | 0.3 | GO:0071468 | cellular response to acidic pH(GO:0071468) |
| 0.3 | 2.2 | GO:0021842 | directional guidance of interneurons involved in migration from the subpallium to the cortex(GO:0021840) chemorepulsion involved in interneuron migration from the subpallium to the cortex(GO:0021842) |
| 0.3 | 1.9 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
| 0.3 | 2.2 | GO:0098967 | exocytic insertion of neurotransmitter receptor to plasma membrane(GO:0098881) exocytic insertion of neurotransmitter receptor to postsynaptic membrane(GO:0098967) |
| 0.3 | 8.1 | GO:0034380 | high-density lipoprotein particle assembly(GO:0034380) |
| 0.3 | 5.0 | GO:0051382 | kinetochore assembly(GO:0051382) |
| 0.3 | 1.2 | GO:0045875 | negative regulation of sister chromatid cohesion(GO:0045875) |
| 0.3 | 2.8 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
| 0.3 | 2.2 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
| 0.3 | 1.5 | GO:0002543 | activation of blood coagulation via clotting cascade(GO:0002543) |
| 0.3 | 0.9 | GO:0061073 | ciliary body morphogenesis(GO:0061073) |
| 0.3 | 0.9 | GO:0035674 | tricarboxylic acid transmembrane transport(GO:0035674) |
| 0.3 | 0.9 | GO:0036058 | filtration diaphragm assembly(GO:0036058) slit diaphragm assembly(GO:0036060) |
| 0.3 | 1.5 | GO:1901503 | ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) ether biosynthetic process(GO:1901503) |
| 0.3 | 0.6 | GO:0000303 | response to superoxide(GO:0000303) |
| 0.3 | 0.6 | GO:0071109 | superior temporal gyrus development(GO:0071109) |
| 0.3 | 3.3 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
| 0.3 | 1.2 | GO:1904046 | negative regulation of vascular endothelial growth factor production(GO:1904046) |
| 0.3 | 1.5 | GO:0010609 | mRNA localization resulting in posttranscriptional regulation of gene expression(GO:0010609) |
| 0.3 | 1.2 | GO:1990834 | response to odorant(GO:1990834) |
| 0.3 | 1.2 | GO:0035752 | lysosomal lumen pH elevation(GO:0035752) |
| 0.3 | 0.6 | GO:0032481 | positive regulation of type I interferon production(GO:0032481) |
| 0.3 | 1.2 | GO:1903644 | regulation of chaperone-mediated protein folding(GO:1903644) |
| 0.3 | 1.2 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
| 0.3 | 1.5 | GO:1905040 | vestibulocochlear nerve structural organization(GO:0021649) positive regulation of cytokine activity(GO:0060301) ganglion morphogenesis(GO:0061552) endothelial tip cell fate specification(GO:0097102) VEGF-activated neuropilin signaling pathway involved in axon guidance(GO:1902378) dorsal root ganglion morphogenesis(GO:1904835) otic placode development(GO:1905040) |
| 0.3 | 4.2 | GO:2000587 | negative regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000587) |
| 0.3 | 1.5 | GO:0019470 | 4-hydroxyproline catabolic process(GO:0019470) |
| 0.3 | 1.8 | GO:0009099 | branched-chain amino acid biosynthetic process(GO:0009082) leucine biosynthetic process(GO:0009098) valine biosynthetic process(GO:0009099) |
| 0.3 | 0.6 | GO:1902463 | protein localization to cell leading edge(GO:1902463) |
| 0.3 | 7.4 | GO:0001829 | trophectodermal cell differentiation(GO:0001829) |
| 0.3 | 1.5 | GO:0071051 | polyadenylation-dependent snoRNA 3'-end processing(GO:0071051) |
| 0.3 | 1.5 | GO:0055011 | atrial cardiac muscle cell differentiation(GO:0055011) atrial cardiac muscle cell development(GO:0055014) |
| 0.3 | 0.3 | GO:1903625 | negative regulation of DNA catabolic process(GO:1903625) |
| 0.3 | 1.2 | GO:0021798 | forebrain dorsal/ventral pattern formation(GO:0021798) |
| 0.3 | 1.8 | GO:0009052 | pentose-phosphate shunt, non-oxidative branch(GO:0009052) |
| 0.3 | 1.2 | GO:0071400 | cellular response to oleic acid(GO:0071400) |
| 0.3 | 0.9 | GO:1903031 | regulation of microtubule plus-end binding(GO:1903031) positive regulation of microtubule plus-end binding(GO:1903033) |
| 0.3 | 1.2 | GO:0002545 | chronic inflammatory response to non-antigenic stimulus(GO:0002545) regulation of chronic inflammatory response to non-antigenic stimulus(GO:0002880) |
| 0.3 | 4.3 | GO:0010839 | negative regulation of keratinocyte proliferation(GO:0010839) |
| 0.3 | 0.3 | GO:0010360 | negative regulation of anion channel activity(GO:0010360) |
| 0.3 | 2.6 | GO:0048752 | semicircular canal morphogenesis(GO:0048752) |
| 0.3 | 3.4 | GO:0030043 | actin filament fragmentation(GO:0030043) |
| 0.3 | 0.3 | GO:0061086 | negative regulation of histone H3-K27 methylation(GO:0061086) |
| 0.3 | 1.7 | GO:0038031 | non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
| 0.3 | 1.1 | GO:0036109 | alpha-linolenic acid metabolic process(GO:0036109) |
| 0.3 | 0.9 | GO:0042450 | arginine biosynthetic process via ornithine(GO:0042450) |
| 0.3 | 0.9 | GO:0070970 | interleukin-2 secretion(GO:0070970) |
| 0.3 | 0.6 | GO:0030505 | inorganic diphosphate transport(GO:0030505) |
| 0.3 | 0.6 | GO:0061643 | chemorepulsion of axon(GO:0061643) |
| 0.3 | 0.9 | GO:0034970 | histone H3-R2 methylation(GO:0034970) |
| 0.3 | 1.7 | GO:2001137 | positive regulation of endocytic recycling(GO:2001137) |
| 0.3 | 1.1 | GO:0060020 | Bergmann glial cell differentiation(GO:0060020) |
| 0.3 | 0.8 | GO:0006788 | heme oxidation(GO:0006788) |
| 0.3 | 1.4 | GO:0033274 | response to vitamin B2(GO:0033274) heterochromatin maintenance(GO:0070829) |
| 0.3 | 0.6 | GO:0009093 | cysteine catabolic process(GO:0009093) L-cysteine catabolic process(GO:0019448) L-cysteine metabolic process(GO:0046439) |
| 0.3 | 1.1 | GO:0036510 | trimming of terminal mannose on C branch(GO:0036510) |
| 0.3 | 2.2 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
| 0.3 | 1.1 | GO:0007198 | adenylate cyclase-inhibiting serotonin receptor signaling pathway(GO:0007198) |
| 0.3 | 1.1 | GO:0010710 | regulation of collagen catabolic process(GO:0010710) |
| 0.3 | 0.8 | GO:0060613 | fat pad development(GO:0060613) |
| 0.3 | 0.3 | GO:0072709 | cellular response to sorbitol(GO:0072709) |
| 0.3 | 1.4 | GO:0044571 | [2Fe-2S] cluster assembly(GO:0044571) |
| 0.3 | 0.8 | GO:0044210 | 'de novo' CTP biosynthetic process(GO:0044210) |
| 0.3 | 1.1 | GO:0071894 | histone H2B conserved C-terminal lysine ubiquitination(GO:0071894) |
| 0.3 | 1.1 | GO:0021636 | trigeminal nerve morphogenesis(GO:0021636) trigeminal nerve structural organization(GO:0021637) semaphorin-plexin signaling pathway involved in axon guidance(GO:1902287) |
| 0.3 | 4.4 | GO:0051608 | histamine transport(GO:0051608) |
| 0.3 | 0.5 | GO:0090050 | positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) |
| 0.3 | 3.0 | GO:0060022 | hard palate development(GO:0060022) |
| 0.3 | 1.1 | GO:0030920 | N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
| 0.3 | 3.3 | GO:0098887 | neurotransmitter receptor transport, endosome to postsynaptic membrane(GO:0098887) |
| 0.3 | 1.9 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
| 0.3 | 0.8 | GO:0070482 | response to oxygen levels(GO:0070482) |
| 0.3 | 1.4 | GO:0035617 | stress granule disassembly(GO:0035617) |
| 0.3 | 1.1 | GO:0000432 | regulation of transcription from RNA polymerase II promoter by glucose(GO:0000430) positive regulation of transcription from RNA polymerase II promoter by glucose(GO:0000432) |
| 0.3 | 1.1 | GO:0071484 | cellular response to light intensity(GO:0071484) |
| 0.3 | 1.1 | GO:0006668 | sphinganine-1-phosphate metabolic process(GO:0006668) |
| 0.3 | 1.1 | GO:0035087 | siRNA loading onto RISC involved in RNA interference(GO:0035087) |
| 0.3 | 6.2 | GO:0070831 | basement membrane assembly(GO:0070831) |
| 0.3 | 0.8 | GO:0050894 | determination of affect(GO:0050894) |
| 0.3 | 2.4 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
| 0.3 | 1.1 | GO:0051541 | elastin metabolic process(GO:0051541) |
| 0.3 | 1.3 | GO:0071477 | hypotonic salinity response(GO:0042539) cellular hypotonic salinity response(GO:0071477) |
| 0.3 | 0.5 | GO:0007172 | signal complex assembly(GO:0007172) |
| 0.3 | 6.8 | GO:0033540 | fatty acid beta-oxidation using acyl-CoA oxidase(GO:0033540) |
| 0.3 | 0.8 | GO:0060054 | positive regulation of epithelial cell proliferation involved in wound healing(GO:0060054) |
| 0.3 | 0.8 | GO:0015920 | lipopolysaccharide transport(GO:0015920) |
| 0.3 | 1.6 | GO:0070813 | hydrogen sulfide metabolic process(GO:0070813) |
| 0.3 | 3.1 | GO:0036010 | protein localization to endosome(GO:0036010) |
| 0.3 | 1.3 | GO:0044339 | canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
| 0.3 | 1.6 | GO:0000727 | double-strand break repair via break-induced replication(GO:0000727) |
| 0.3 | 1.0 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
| 0.3 | 1.0 | GO:1904398 | positive regulation of neuromuscular junction development(GO:1904398) |
| 0.3 | 0.8 | GO:0014022 | neural plate elongation(GO:0014022) convergent extension involved in neural plate elongation(GO:0022007) |
| 0.3 | 0.3 | GO:0030311 | poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
| 0.3 | 2.6 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
| 0.3 | 1.3 | GO:0051918 | negative regulation of fibrinolysis(GO:0051918) |
| 0.3 | 1.8 | GO:0070561 | vitamin D receptor signaling pathway(GO:0070561) |
| 0.3 | 2.5 | GO:0006189 | 'de novo' IMP biosynthetic process(GO:0006189) |
| 0.3 | 2.3 | GO:0031444 | slow-twitch skeletal muscle fiber contraction(GO:0031444) |
| 0.3 | 1.3 | GO:0046391 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
| 0.3 | 0.3 | GO:0051961 | negative regulation of nervous system development(GO:0051961) |
| 0.3 | 2.3 | GO:0010616 | negative regulation of cardiac muscle adaptation(GO:0010616) negative regulation of cardiac muscle hypertrophy in response to stress(GO:1903243) |
| 0.3 | 1.3 | GO:0006436 | tryptophanyl-tRNA aminoacylation(GO:0006436) |
| 0.3 | 3.5 | GO:0006054 | N-acetylneuraminate metabolic process(GO:0006054) |
| 0.3 | 2.3 | GO:0051798 | positive regulation of hair follicle development(GO:0051798) |
| 0.2 | 1.2 | GO:0032218 | riboflavin transport(GO:0032218) |
| 0.2 | 1.0 | GO:0046104 | thymidine metabolic process(GO:0046104) pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
| 0.2 | 0.7 | GO:0043137 | DNA replication, removal of RNA primer(GO:0043137) |
| 0.2 | 0.2 | GO:0032637 | interleukin-8 production(GO:0032637) |
| 0.2 | 0.5 | GO:0021555 | midbrain-hindbrain boundary morphogenesis(GO:0021555) |
| 0.2 | 0.7 | GO:2000145 | regulation of cell motility(GO:2000145) |
| 0.2 | 0.2 | GO:0007223 | Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
| 0.2 | 0.5 | GO:1900126 | negative regulation of hyaluronan biosynthetic process(GO:1900126) |
| 0.2 | 0.5 | GO:0003415 | chondrocyte hypertrophy(GO:0003415) |
| 0.2 | 2.2 | GO:0061042 | vascular wound healing(GO:0061042) |
| 0.2 | 0.2 | GO:0044209 | AMP salvage(GO:0044209) |
| 0.2 | 0.5 | GO:0009133 | nucleoside diphosphate biosynthetic process(GO:0009133) |
| 0.2 | 1.0 | GO:1900193 | regulation of oocyte maturation(GO:1900193) |
| 0.2 | 0.2 | GO:0000305 | response to oxygen radical(GO:0000305) |
| 0.2 | 0.7 | GO:0016999 | antibiotic metabolic process(GO:0016999) |
| 0.2 | 2.6 | GO:1905049 | negative regulation of metallopeptidase activity(GO:1905049) |
| 0.2 | 0.5 | GO:0051461 | positive regulation of corticotropin secretion(GO:0051461) |
| 0.2 | 1.2 | GO:0002536 | respiratory burst involved in inflammatory response(GO:0002536) regulation of respiratory burst involved in inflammatory response(GO:0060264) negative regulation of respiratory burst involved in inflammatory response(GO:0060266) |
| 0.2 | 0.2 | GO:1903588 | negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903588) |
| 0.2 | 2.6 | GO:0015760 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
| 0.2 | 0.7 | GO:0051088 | PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
| 0.2 | 0.7 | GO:0046338 | phosphatidylethanolamine catabolic process(GO:0046338) |
| 0.2 | 0.2 | GO:1903438 | regulation of cytokinetic process(GO:0032954) regulation of mitotic cytokinetic process(GO:1903436) positive regulation of mitotic cytokinetic process(GO:1903438) positive regulation of mitotic cytokinesis(GO:1903490) |
| 0.2 | 1.6 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
| 0.2 | 3.2 | GO:0006975 | DNA damage induced protein phosphorylation(GO:0006975) |
| 0.2 | 0.7 | GO:0038195 | urokinase plasminogen activator signaling pathway(GO:0038195) |
| 0.2 | 1.2 | GO:0035519 | protein K29-linked ubiquitination(GO:0035519) |
| 0.2 | 0.9 | GO:0072144 | mesangial cell development(GO:0072143) glomerular mesangial cell development(GO:0072144) |
| 0.2 | 0.2 | GO:1901079 | positive regulation of relaxation of muscle(GO:1901079) |
| 0.2 | 0.7 | GO:0035690 | cellular response to drug(GO:0035690) |
| 0.2 | 0.2 | GO:0060027 | convergent extension involved in gastrulation(GO:0060027) |
| 0.2 | 0.5 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
| 0.2 | 1.6 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
| 0.2 | 7.9 | GO:0046627 | negative regulation of insulin receptor signaling pathway(GO:0046627) |
| 0.2 | 0.7 | GO:0042853 | L-alanine metabolic process(GO:0042851) L-alanine catabolic process(GO:0042853) |
| 0.2 | 5.9 | GO:0035767 | endothelial cell chemotaxis(GO:0035767) |
| 0.2 | 1.1 | GO:1901097 | negative regulation of autophagosome maturation(GO:1901097) |
| 0.2 | 0.7 | GO:0045659 | regulation of neutrophil differentiation(GO:0045658) negative regulation of neutrophil differentiation(GO:0045659) |
| 0.2 | 0.4 | GO:0014038 | regulation of Schwann cell differentiation(GO:0014038) |
| 0.2 | 0.7 | GO:0006423 | cysteinyl-tRNA aminoacylation(GO:0006423) |
| 0.2 | 1.1 | GO:0003322 | pancreatic A cell development(GO:0003322) |
| 0.2 | 0.7 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
| 0.2 | 0.7 | GO:0086092 | regulation of the force of heart contraction by cardiac conduction(GO:0086092) |
| 0.2 | 1.8 | GO:0044130 | negative regulation of growth of symbiont in host(GO:0044130) |
| 0.2 | 5.7 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
| 0.2 | 0.2 | GO:0032912 | negative regulation of transforming growth factor beta2 production(GO:0032912) |
| 0.2 | 2.6 | GO:0010867 | positive regulation of triglyceride biosynthetic process(GO:0010867) |
| 0.2 | 1.5 | GO:0035965 | cardiolipin acyl-chain remodeling(GO:0035965) |
| 0.2 | 1.3 | GO:0033152 | immunoglobulin V(D)J recombination(GO:0033152) |
| 0.2 | 0.2 | GO:1901991 | negative regulation of cell cycle phase transition(GO:1901988) negative regulation of mitotic cell cycle phase transition(GO:1901991) |
| 0.2 | 1.1 | GO:0001315 | age-dependent response to oxidative stress(GO:0001306) age-dependent response to reactive oxygen species(GO:0001315) regulation of systemic arterial blood pressure by acetylcholine(GO:0003068) vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure(GO:0003069) regulation of systemic arterial blood pressure by neurotransmitter(GO:0003070) age-dependent general metabolic decline(GO:0007571) |
| 0.2 | 0.4 | GO:0050717 | positive regulation of interleukin-1 alpha secretion(GO:0050717) |
| 0.2 | 0.2 | GO:0060221 | retinal rod cell differentiation(GO:0060221) |
| 0.2 | 1.1 | GO:0017185 | peptidyl-lysine hydroxylation(GO:0017185) |
| 0.2 | 0.9 | GO:0072344 | rescue of stalled ribosome(GO:0072344) |
| 0.2 | 0.9 | GO:0034441 | plasma lipoprotein particle oxidation(GO:0034441) |
| 0.2 | 0.4 | GO:1904978 | regulation of endosome organization(GO:1904978) |
| 0.2 | 3.6 | GO:0090344 | negative regulation of cell aging(GO:0090344) |
| 0.2 | 2.1 | GO:0046940 | nucleoside monophosphate phosphorylation(GO:0046940) |
| 0.2 | 0.2 | GO:0002522 | leukocyte migration involved in immune response(GO:0002522) |
| 0.2 | 0.4 | GO:1903206 | negative regulation of response to reactive oxygen species(GO:1901032) negative regulation of hydrogen peroxide-induced cell death(GO:1903206) |
| 0.2 | 0.4 | GO:0043321 | regulation of natural killer cell degranulation(GO:0043321) positive regulation of natural killer cell degranulation(GO:0043323) |
| 0.2 | 0.2 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
| 0.2 | 0.8 | GO:0030822 | positive regulation of cyclic nucleotide catabolic process(GO:0030807) positive regulation of cAMP catabolic process(GO:0030822) positive regulation of purine nucleotide catabolic process(GO:0033123) |
| 0.2 | 1.5 | GO:0055059 | asymmetric neuroblast division(GO:0055059) |
| 0.2 | 0.8 | GO:2000286 | receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
| 0.2 | 2.1 | GO:0035413 | positive regulation of catenin import into nucleus(GO:0035413) |
| 0.2 | 0.6 | GO:0002439 | chronic inflammatory response to antigenic stimulus(GO:0002439) |
| 0.2 | 0.2 | GO:0060268 | negative regulation of respiratory burst(GO:0060268) |
| 0.2 | 0.6 | GO:0033341 | regulation of collagen binding(GO:0033341) |
| 0.2 | 0.4 | GO:0044828 | negative regulation by host of viral genome replication(GO:0044828) |
| 0.2 | 0.4 | GO:0033121 | regulation of cyclic nucleotide catabolic process(GO:0030805) regulation of cAMP catabolic process(GO:0030820) regulation of purine nucleotide catabolic process(GO:0033121) |
| 0.2 | 0.8 | GO:0032455 | nerve growth factor processing(GO:0032455) |
| 0.2 | 0.8 | GO:0001828 | inner cell mass cellular morphogenesis(GO:0001828) |
| 0.2 | 1.0 | GO:1905098 | negative regulation of guanyl-nucleotide exchange factor activity(GO:1905098) |
| 0.2 | 1.4 | GO:0007256 | activation of JNKK activity(GO:0007256) |
| 0.2 | 0.2 | GO:1900122 | positive regulation of receptor binding(GO:1900122) |
| 0.2 | 0.6 | GO:0044376 | RNA polymerase II complex import to nucleus(GO:0044376) RNA polymerase III complex localization to nucleus(GO:1990022) |
| 0.2 | 1.0 | GO:0016321 | female meiosis chromosome segregation(GO:0016321) |
| 0.2 | 0.2 | GO:1902187 | negative regulation of viral release from host cell(GO:1902187) |
| 0.2 | 3.0 | GO:0038065 | collagen-activated signaling pathway(GO:0038065) |
| 0.2 | 0.6 | GO:0060720 | spongiotrophoblast cell proliferation(GO:0060720) regulation of spongiotrophoblast cell proliferation(GO:0060721) cell proliferation involved in embryonic placenta development(GO:0060722) regulation of cell proliferation involved in embryonic placenta development(GO:0060723) |
| 0.2 | 2.2 | GO:0045078 | positive regulation of interferon-gamma biosynthetic process(GO:0045078) |
| 0.2 | 3.8 | GO:1901897 | regulation of relaxation of cardiac muscle(GO:1901897) |
| 0.2 | 0.6 | GO:1905205 | positive regulation of connective tissue replacement(GO:1905205) |
| 0.2 | 1.6 | GO:0071545 | inositol phosphate catabolic process(GO:0071545) |
| 0.2 | 1.4 | GO:0097028 | dendritic cell differentiation(GO:0097028) |
| 0.2 | 0.8 | GO:0015722 | canalicular bile acid transport(GO:0015722) |
| 0.2 | 0.2 | GO:0003241 | growth involved in heart morphogenesis(GO:0003241) |
| 0.2 | 1.4 | GO:1903232 | melanosome assembly(GO:1903232) |
| 0.2 | 1.2 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
| 0.2 | 2.0 | GO:0018231 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
| 0.2 | 1.2 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
| 0.2 | 1.6 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
| 0.2 | 0.8 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
| 0.2 | 0.6 | GO:0071651 | positive regulation of chemokine (C-C motif) ligand 5 production(GO:0071651) |
| 0.2 | 1.0 | GO:0048749 | compound eye development(GO:0048749) |
| 0.2 | 0.6 | GO:2000687 | negative regulation of rubidium ion transport(GO:2000681) negative regulation of rubidium ion transmembrane transporter activity(GO:2000687) |
| 0.2 | 4.1 | GO:0001780 | neutrophil homeostasis(GO:0001780) |
| 0.2 | 0.6 | GO:0036071 | N-glycan fucosylation(GO:0036071) |
| 0.2 | 1.7 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
| 0.2 | 0.6 | GO:0098502 | DNA dephosphorylation(GO:0098502) |
| 0.2 | 4.1 | GO:0006907 | pinocytosis(GO:0006907) |
| 0.2 | 1.2 | GO:0006574 | valine catabolic process(GO:0006574) |
| 0.2 | 0.8 | GO:0085032 | modulation of signal transduction in other organism(GO:0044501) modulation by symbiont of host signal transduction pathway(GO:0052027) modulation of signal transduction in other organism involved in symbiotic interaction(GO:0052250) modulation by symbiont of host I-kappaB kinase/NF-kappaB cascade(GO:0085032) |
| 0.2 | 3.5 | GO:0034656 | nucleobase-containing small molecule catabolic process(GO:0034656) |
| 0.2 | 0.8 | GO:2001295 | malonyl-CoA biosynthetic process(GO:2001295) |
| 0.2 | 0.8 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
| 0.2 | 0.4 | GO:0021785 | branchiomotor neuron axon guidance(GO:0021785) |
| 0.2 | 0.4 | GO:0035459 | cargo loading into vesicle(GO:0035459) |
| 0.2 | 0.6 | GO:0038098 | sequestering of BMP from receptor via BMP binding(GO:0038098) |
| 0.2 | 11.1 | GO:0007157 | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0007157) |
| 0.2 | 1.1 | GO:0090116 | C-5 methylation of cytosine(GO:0090116) |
| 0.2 | 1.1 | GO:0006642 | triglyceride mobilization(GO:0006642) |
| 0.2 | 0.2 | GO:1902523 | positive regulation of protein K63-linked ubiquitination(GO:1902523) |
| 0.2 | 1.1 | GO:0033623 | regulation of integrin activation(GO:0033623) |
| 0.2 | 0.4 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
| 0.2 | 0.6 | GO:0042040 | molybdenum incorporation into molybdenum-molybdopterin complex(GO:0018315) metal incorporation into metallo-molybdopterin complex(GO:0042040) glycine receptor clustering(GO:0072579) |
| 0.2 | 0.8 | GO:0070317 | negative regulation of G0 to G1 transition(GO:0070317) |
| 0.2 | 0.2 | GO:0045669 | positive regulation of osteoblast differentiation(GO:0045669) |
| 0.2 | 2.4 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
| 0.2 | 2.6 | GO:0035092 | sperm chromatin condensation(GO:0035092) |
| 0.2 | 0.2 | GO:0050653 | chondroitin sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0050653) |
| 0.2 | 2.6 | GO:2000786 | positive regulation of autophagosome assembly(GO:2000786) |
| 0.2 | 1.5 | GO:0046836 | glycolipid transport(GO:0046836) |
| 0.2 | 1.5 | GO:0045780 | positive regulation of bone resorption(GO:0045780) positive regulation of bone remodeling(GO:0046852) |
| 0.2 | 0.4 | GO:0071963 | establishment or maintenance of cell polarity regulating cell shape(GO:0071963) |
| 0.2 | 0.2 | GO:1902527 | positive regulation of protein monoubiquitination(GO:1902527) |
| 0.2 | 3.9 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
| 0.2 | 2.8 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
| 0.2 | 0.7 | GO:0060071 | Wnt signaling pathway, planar cell polarity pathway(GO:0060071) |
| 0.2 | 0.9 | GO:0019720 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) |
| 0.2 | 0.5 | GO:0007008 | outer mitochondrial membrane organization(GO:0007008) protein import into mitochondrial outer membrane(GO:0045040) establishment of protein localization to mitochondrial membrane(GO:0090151) |
| 0.2 | 0.7 | GO:0097527 | necroptotic signaling pathway(GO:0097527) |
| 0.2 | 0.4 | GO:1905123 | regulation of glucosylceramidase activity(GO:1905123) |
| 0.2 | 0.2 | GO:0007292 | female gamete generation(GO:0007292) |
| 0.2 | 1.3 | GO:0010571 | positive regulation of nuclear cell cycle DNA replication(GO:0010571) |
| 0.2 | 0.9 | GO:0031959 | mineralocorticoid receptor signaling pathway(GO:0031959) |
| 0.2 | 0.5 | GO:0043504 | mitochondrial DNA repair(GO:0043504) |
| 0.2 | 1.1 | GO:0033210 | leptin-mediated signaling pathway(GO:0033210) |
| 0.2 | 4.3 | GO:0035589 | G-protein coupled purinergic nucleotide receptor signaling pathway(GO:0035589) |
| 0.2 | 1.1 | GO:0070537 | histone H2A K63-linked deubiquitination(GO:0070537) |
| 0.2 | 1.6 | GO:0090394 | negative regulation of excitatory postsynaptic potential(GO:0090394) |
| 0.2 | 0.4 | GO:1902568 | positive regulation of eosinophil degranulation(GO:0043311) positive regulation of eosinophil activation(GO:1902568) |
| 0.2 | 0.4 | GO:0036151 | phosphatidylcholine acyl-chain remodeling(GO:0036151) |
| 0.2 | 3.0 | GO:0090129 | positive regulation of synapse maturation(GO:0090129) |
| 0.2 | 4.1 | GO:2000811 | negative regulation of anoikis(GO:2000811) |
| 0.2 | 2.8 | GO:0034356 | NAD biosynthesis via nicotinamide riboside salvage pathway(GO:0034356) |
| 0.2 | 0.2 | GO:0061052 | negative regulation of cell growth involved in cardiac muscle cell development(GO:0061052) |
| 0.2 | 2.5 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
| 0.2 | 0.7 | GO:0055064 | chloride ion homeostasis(GO:0055064) |
| 0.2 | 0.7 | GO:1900533 | medium-chain fatty-acyl-CoA catabolic process(GO:0036114) long-chain fatty-acyl-CoA catabolic process(GO:0036116) palmitic acid metabolic process(GO:1900533) palmitic acid biosynthetic process(GO:1900535) |
| 0.2 | 0.7 | GO:0010165 | response to X-ray(GO:0010165) |
| 0.2 | 1.8 | GO:0045109 | intermediate filament organization(GO:0045109) |
| 0.2 | 1.4 | GO:0060707 | trophoblast giant cell differentiation(GO:0060707) |
| 0.2 | 0.3 | GO:0061762 | CAMKK-AMPK signaling cascade(GO:0061762) |
| 0.2 | 0.5 | GO:0019242 | methylglyoxal biosynthetic process(GO:0019242) |
| 0.2 | 0.2 | GO:1904862 | inhibitory synapse assembly(GO:1904862) |
| 0.2 | 9.4 | GO:0050690 | regulation of defense response to virus by virus(GO:0050690) |
| 0.2 | 0.2 | GO:1902897 | regulation of postsynaptic density protein 95 clustering(GO:1902897) |
| 0.2 | 1.2 | GO:1900264 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
| 0.2 | 0.5 | GO:0070885 | negative regulation of calcineurin-NFAT signaling cascade(GO:0070885) |
| 0.2 | 2.9 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
| 0.2 | 2.2 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
| 0.2 | 0.3 | GO:0005988 | lactose metabolic process(GO:0005988) lactose biosynthetic process(GO:0005989) |
| 0.2 | 0.7 | GO:0046073 | dTMP biosynthetic process(GO:0006231) dTMP metabolic process(GO:0046073) |
| 0.2 | 0.5 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
| 0.2 | 1.7 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
| 0.2 | 0.9 | GO:0021937 | cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation(GO:0021937) |
| 0.2 | 1.2 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
| 0.2 | 0.5 | GO:0006480 | N-terminal protein amino acid methylation(GO:0006480) N-terminal peptidyl-alanine methylation(GO:0018011) N-terminal peptidyl-alanine trimethylation(GO:0018012) N-terminal peptidyl-glycine methylation(GO:0018013) N-terminal peptidyl-proline dimethylation(GO:0018016) peptidyl-alanine modification(GO:0018194) N-terminal peptidyl-proline methylation(GO:0035568) N-terminal peptidyl-serine methylation(GO:0035570) N-terminal peptidyl-serine dimethylation(GO:0035572) N-terminal peptidyl-serine trimethylation(GO:0035573) |
| 0.2 | 0.2 | GO:2000157 | regulation of protein K48-linked deubiquitination(GO:1903093) negative regulation of protein K48-linked deubiquitination(GO:1903094) negative regulation of ubiquitin-specific protease activity(GO:2000157) |
| 0.2 | 3.0 | GO:0006388 | tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
| 0.2 | 1.0 | GO:0061668 | mitochondrial ribosome assembly(GO:0061668) |
| 0.2 | 0.2 | GO:1902969 | mitotic DNA replication(GO:1902969) |
| 0.2 | 0.2 | GO:0006004 | fucose metabolic process(GO:0006004) |
| 0.2 | 1.4 | GO:0030578 | PML body organization(GO:0030578) |
| 0.2 | 0.3 | GO:1905247 | regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902959) positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902961) regulation of aspartic-type peptidase activity(GO:1905245) positive regulation of aspartic-type peptidase activity(GO:1905247) |
| 0.2 | 0.2 | GO:1904869 | regulation of protein localization to Cajal body(GO:1904869) positive regulation of protein localization to Cajal body(GO:1904871) |
| 0.2 | 1.3 | GO:0090208 | positive regulation of triglyceride metabolic process(GO:0090208) |
| 0.2 | 0.3 | GO:0018352 | protein-pyridoxal-5-phosphate linkage(GO:0018352) |
| 0.2 | 0.5 | GO:0042727 | flavin-containing compound biosynthetic process(GO:0042727) |
| 0.2 | 1.5 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
| 0.2 | 0.8 | GO:0030047 | actin modification(GO:0030047) |
| 0.2 | 0.7 | GO:0045586 | regulation of gamma-delta T cell differentiation(GO:0045586) |
| 0.2 | 0.5 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
| 0.2 | 0.5 | GO:0097107 | postsynaptic density assembly(GO:0097107) |
| 0.2 | 2.5 | GO:0000338 | protein deneddylation(GO:0000338) |
| 0.2 | 1.7 | GO:0035376 | sterol import(GO:0035376) cholesterol import(GO:0070508) |
| 0.2 | 1.0 | GO:0051012 | microtubule sliding(GO:0051012) |
| 0.2 | 1.2 | GO:0006616 | SRP-dependent cotranslational protein targeting to membrane, translocation(GO:0006616) |
| 0.2 | 0.3 | GO:0032525 | somite rostral/caudal axis specification(GO:0032525) |
| 0.2 | 2.5 | GO:0034063 | stress granule assembly(GO:0034063) |
| 0.2 | 1.0 | GO:0099525 | presynaptic dense core granule exocytosis(GO:0099525) |
| 0.2 | 0.5 | GO:0019074 | viral genome packaging(GO:0019072) viral RNA genome packaging(GO:0019074) |
| 0.2 | 2.6 | GO:0051645 | Golgi localization(GO:0051645) |
| 0.2 | 0.3 | GO:0036269 | swimming behavior(GO:0036269) |
| 0.2 | 0.8 | GO:0061034 | olfactory bulb mitral cell layer development(GO:0061034) |
| 0.2 | 0.3 | GO:0051136 | regulation of NK T cell differentiation(GO:0051136) |
| 0.2 | 0.3 | GO:0006591 | ornithine metabolic process(GO:0006591) putrescine biosynthetic process from ornithine(GO:0033387) |
| 0.2 | 0.8 | GO:0045198 | establishment of epithelial cell apical/basal polarity(GO:0045198) |
| 0.2 | 0.2 | GO:0032911 | negative regulation of transforming growth factor beta1 production(GO:0032911) |
| 0.2 | 0.3 | GO:0031630 | regulation of synaptic vesicle fusion to presynaptic membrane(GO:0031630) |
| 0.2 | 0.7 | GO:1900045 | negative regulation of histone ubiquitination(GO:0033183) negative regulation of protein K63-linked ubiquitination(GO:1900045) regulation of histone H2A K63-linked ubiquitination(GO:1901314) negative regulation of histone H2A K63-linked ubiquitination(GO:1901315) negative regulation of protein polyubiquitination(GO:1902915) |
| 0.2 | 0.2 | GO:1900102 | negative regulation of endoplasmic reticulum unfolded protein response(GO:1900102) |
| 0.2 | 0.7 | GO:0070640 | calcitriol biosynthetic process from calciol(GO:0036378) vitamin D3 metabolic process(GO:0070640) |
| 0.2 | 0.2 | GO:1904956 | regulation of midbrain dopaminergic neuron differentiation(GO:1904956) |
| 0.2 | 0.2 | GO:1904238 | pericyte cell differentiation(GO:1904238) |
| 0.2 | 0.3 | GO:0002143 | tRNA wobble position uridine thiolation(GO:0002143) |
| 0.2 | 0.3 | GO:0019364 | NADP catabolic process(GO:0006742) pyridine nucleotide catabolic process(GO:0019364) |
| 0.2 | 1.1 | GO:0010940 | positive regulation of necrotic cell death(GO:0010940) |
| 0.2 | 0.2 | GO:0090118 | receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport(GO:0090118) |
| 0.2 | 1.3 | GO:0090009 | primitive streak formation(GO:0090009) |
| 0.2 | 0.8 | GO:0098876 | vesicle-mediated transport to the plasma membrane(GO:0098876) |
| 0.2 | 0.3 | GO:0090521 | glomerular visceral epithelial cell migration(GO:0090521) |
| 0.2 | 0.6 | GO:0072369 | regulation of lipid transport by positive regulation of transcription from RNA polymerase II promoter(GO:0072369) |
| 0.2 | 1.3 | GO:1902902 | negative regulation of autophagosome assembly(GO:1902902) |
| 0.2 | 1.3 | GO:0043320 | natural killer cell degranulation(GO:0043320) |
| 0.2 | 0.8 | GO:0031536 | positive regulation of exit from mitosis(GO:0031536) |
| 0.2 | 0.6 | GO:1903803 | glutamine secretion(GO:0010585) L-glutamine import(GO:0036229) L-glutamine import into cell(GO:1903803) |
| 0.2 | 2.4 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
| 0.2 | 0.6 | GO:0031120 | snRNA pseudouridine synthesis(GO:0031120) |
| 0.2 | 0.6 | GO:0021592 | fourth ventricle development(GO:0021592) |
| 0.2 | 0.5 | GO:1901873 | regulation of post-translational protein modification(GO:1901873) |
| 0.2 | 0.9 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
| 0.2 | 0.9 | GO:1900756 | protein processing in phagocytic vesicle(GO:1900756) regulation of protein processing in phagocytic vesicle(GO:1903921) positive regulation of protein processing in phagocytic vesicle(GO:1903923) |
| 0.2 | 0.9 | GO:0034472 | snRNA 3'-end processing(GO:0034472) |
| 0.2 | 1.1 | GO:0017187 | peptidyl-glutamic acid carboxylation(GO:0017187) protein carboxylation(GO:0018214) |
| 0.2 | 0.5 | GO:0098838 | reduced folate transmembrane transport(GO:0098838) |
| 0.2 | 3.6 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
| 0.2 | 1.7 | GO:0015939 | pantothenate metabolic process(GO:0015939) |
| 0.2 | 2.5 | GO:0097062 | dendritic spine maintenance(GO:0097062) |
| 0.2 | 0.8 | GO:0018364 | peptidyl-glutamine methylation(GO:0018364) |
| 0.2 | 1.1 | GO:0060295 | regulation of cilium movement involved in cell motility(GO:0060295) regulation of cilium beat frequency involved in ciliary motility(GO:0060296) regulation of cilium-dependent cell motility(GO:1902019) |
| 0.2 | 0.8 | GO:0045110 | intermediate filament bundle assembly(GO:0045110) |
| 0.2 | 0.5 | GO:0034427 | nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5'(GO:0034427) |
| 0.2 | 0.2 | GO:2000410 | regulation of thymocyte migration(GO:2000410) |
| 0.2 | 0.5 | GO:0070120 | ciliary neurotrophic factor-mediated signaling pathway(GO:0070120) |
| 0.2 | 6.8 | GO:0051310 | metaphase plate congression(GO:0051310) |
| 0.2 | 1.2 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
| 0.2 | 6.7 | GO:1901998 | toxin transport(GO:1901998) |
| 0.2 | 0.2 | GO:1902256 | apoptotic process involved in outflow tract morphogenesis(GO:0003275) regulation of apoptotic process involved in outflow tract morphogenesis(GO:1902256) |
| 0.2 | 0.5 | GO:0035897 | proteolysis in other organism(GO:0035897) |
| 0.2 | 0.8 | GO:2000312 | regulation of kainate selective glutamate receptor activity(GO:2000312) |
| 0.2 | 0.5 | GO:0046294 | formaldehyde catabolic process(GO:0046294) |
| 0.2 | 0.3 | GO:0051106 | positive regulation of DNA ligation(GO:0051106) |
| 0.2 | 1.2 | GO:0006044 | N-acetylglucosamine metabolic process(GO:0006044) |
| 0.1 | 0.4 | GO:0043627 | response to estrogen(GO:0043627) |
| 0.1 | 0.6 | GO:0034141 | positive regulation of toll-like receptor 3 signaling pathway(GO:0034141) |
| 0.1 | 0.1 | GO:0090266 | regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090266) regulation of mitotic spindle checkpoint(GO:1903504) |
| 0.1 | 2.1 | GO:0009263 | deoxyribonucleotide biosynthetic process(GO:0009263) |
| 0.1 | 0.3 | GO:0042481 | regulation of odontogenesis(GO:0042481) |
| 0.1 | 0.4 | GO:0006425 | glutaminyl-tRNA aminoacylation(GO:0006425) |
| 0.1 | 0.4 | GO:2001171 | positive regulation of ATP biosynthetic process(GO:2001171) |
| 0.1 | 0.7 | GO:2000504 | positive regulation of blood vessel remodeling(GO:2000504) |
| 0.1 | 1.8 | GO:0032968 | positive regulation of transcription elongation from RNA polymerase II promoter(GO:0032968) |
| 0.1 | 0.4 | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
| 0.1 | 0.6 | GO:0032485 | Ral protein signal transduction(GO:0032484) regulation of Ral protein signal transduction(GO:0032485) |
| 0.1 | 3.2 | GO:0045116 | protein neddylation(GO:0045116) |
| 0.1 | 0.6 | GO:0002086 | diaphragm contraction(GO:0002086) |
| 0.1 | 0.3 | GO:0051095 | regulation of helicase activity(GO:0051095) positive regulation of helicase activity(GO:0051096) |
| 0.1 | 0.9 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
| 0.1 | 0.1 | GO:0071046 | nuclear ncRNA surveillance(GO:0071029) nuclear polyadenylation-dependent rRNA catabolic process(GO:0071035) nuclear polyadenylation-dependent ncRNA catabolic process(GO:0071046) |
| 0.1 | 0.4 | GO:1904582 | regulation of intracellular mRNA localization(GO:1904580) positive regulation of intracellular mRNA localization(GO:1904582) |
| 0.1 | 2.3 | GO:0019388 | galactose catabolic process(GO:0019388) |
| 0.1 | 0.4 | GO:0031455 | glycine betaine biosynthetic process from choline(GO:0019285) glycine betaine metabolic process(GO:0031455) glycine betaine biosynthetic process(GO:0031456) |
| 0.1 | 3.5 | GO:0050919 | negative chemotaxis(GO:0050919) |
| 0.1 | 0.3 | GO:0072528 | pyrimidine-containing compound biosynthetic process(GO:0072528) |
| 0.1 | 0.4 | GO:0021913 | regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification(GO:0021913) |
| 0.1 | 0.1 | GO:2000049 | positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
| 0.1 | 0.3 | GO:0010801 | negative regulation of peptidyl-threonine phosphorylation(GO:0010801) |
| 0.1 | 1.3 | GO:0060019 | radial glial cell differentiation(GO:0060019) |
| 0.1 | 1.1 | GO:0007144 | female meiosis I(GO:0007144) |
| 0.1 | 0.6 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
| 0.1 | 1.6 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
| 0.1 | 0.3 | GO:0045824 | negative regulation of innate immune response(GO:0045824) |
| 0.1 | 1.4 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
| 0.1 | 1.6 | GO:0021942 | radial glia guided migration of Purkinje cell(GO:0021942) |
| 0.1 | 0.4 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
| 0.1 | 1.3 | GO:0090646 | mitochondrial tRNA processing(GO:0090646) |
| 0.1 | 1.4 | GO:0042420 | dopamine catabolic process(GO:0042420) |
| 0.1 | 0.6 | GO:0032962 | positive regulation of inositol trisphosphate biosynthetic process(GO:0032962) |
| 0.1 | 0.7 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
| 0.1 | 1.3 | GO:2001241 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
| 0.1 | 0.4 | GO:0034471 | endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000472) rRNA 5'-end processing(GO:0000967) ncRNA 5'-end processing(GO:0034471) |
| 0.1 | 0.7 | GO:0016078 | tRNA catabolic process(GO:0016078) |
| 0.1 | 0.7 | GO:0071229 | cellular response to acid chemical(GO:0071229) |
| 0.1 | 0.7 | GO:0072003 | kidney rudiment formation(GO:0072003) |
| 0.1 | 0.4 | GO:0048203 | vesicle targeting, trans-Golgi to endosome(GO:0048203) |
| 0.1 | 0.8 | GO:0007028 | cytoplasm organization(GO:0007028) |
| 0.1 | 0.4 | GO:0015684 | ferrous iron transport(GO:0015684) ferrous iron transmembrane transport(GO:1903874) |
| 0.1 | 0.1 | GO:0022616 | DNA strand elongation(GO:0022616) |
| 0.1 | 2.6 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
| 0.1 | 0.7 | GO:0044565 | dendritic cell proliferation(GO:0044565) |
| 0.1 | 1.2 | GO:0046618 | drug export(GO:0046618) |
| 0.1 | 1.1 | GO:0060716 | labyrinthine layer blood vessel development(GO:0060716) |
| 0.1 | 0.4 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
| 0.1 | 0.5 | GO:0030539 | male genitalia development(GO:0030539) |
| 0.1 | 0.3 | GO:1901857 | positive regulation of cellular respiration(GO:1901857) |
| 0.1 | 0.4 | GO:0035281 | pre-miRNA export from nucleus(GO:0035281) |
| 0.1 | 2.0 | GO:0035020 | regulation of Rac protein signal transduction(GO:0035020) |
| 0.1 | 0.1 | GO:0031990 | mRNA export from nucleus in response to heat stress(GO:0031990) |
| 0.1 | 0.4 | GO:1900025 | negative regulation of substrate adhesion-dependent cell spreading(GO:1900025) |
| 0.1 | 0.1 | GO:0009826 | unidimensional cell growth(GO:0009826) |
| 0.1 | 2.3 | GO:0007100 | mitotic centrosome separation(GO:0007100) |
| 0.1 | 0.7 | GO:0051697 | protein delipidation(GO:0051697) |
| 0.1 | 1.3 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
| 0.1 | 2.1 | GO:0090224 | regulation of spindle organization(GO:0090224) |
| 0.1 | 0.5 | GO:0006474 | N-terminal protein amino acid acetylation(GO:0006474) |
| 0.1 | 0.4 | GO:0000117 | regulation of transcription involved in G2/M transition of mitotic cell cycle(GO:0000117) |
| 0.1 | 0.3 | GO:0085020 | protein K6-linked ubiquitination(GO:0085020) |
| 0.1 | 2.7 | GO:0090110 | cargo loading into COPII-coated vesicle(GO:0090110) |
| 0.1 | 0.1 | GO:0050691 | regulation of defense response to virus by host(GO:0050691) |
| 0.1 | 0.5 | GO:0006857 | oligopeptide transport(GO:0006857) |
| 0.1 | 1.1 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
| 0.1 | 1.1 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
| 0.1 | 0.1 | GO:0045448 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
| 0.1 | 1.8 | GO:0046784 | viral mRNA export from host cell nucleus(GO:0046784) |
| 0.1 | 3.0 | GO:0006465 | signal peptide processing(GO:0006465) |
| 0.1 | 0.4 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
| 0.1 | 0.3 | GO:0046512 | diol biosynthetic process(GO:0034312) sphingosine biosynthetic process(GO:0046512) |
| 0.1 | 0.7 | GO:0036093 | male germ cell proliferation(GO:0002176) germ cell proliferation(GO:0036093) |
| 0.1 | 5.0 | GO:0018146 | keratan sulfate biosynthetic process(GO:0018146) |
| 0.1 | 0.4 | GO:0002378 | immunoglobulin biosynthetic process(GO:0002378) |
| 0.1 | 0.4 | GO:0038003 | opioid receptor signaling pathway(GO:0038003) |
| 0.1 | 0.5 | GO:0003431 | growth plate cartilage chondrocyte development(GO:0003431) |
| 0.1 | 3.1 | GO:0071243 | cellular response to arsenic-containing substance(GO:0071243) |
| 0.1 | 2.3 | GO:0043248 | proteasome assembly(GO:0043248) |
| 0.1 | 0.5 | GO:1990168 | protein K33-linked deubiquitination(GO:1990168) |
| 0.1 | 2.6 | GO:0048268 | clathrin coat assembly(GO:0048268) |
| 0.1 | 3.1 | GO:0006509 | membrane protein ectodomain proteolysis(GO:0006509) |
| 0.1 | 0.8 | GO:1903861 | regulation of dendrite extension(GO:1903859) positive regulation of dendrite extension(GO:1903861) |
| 0.1 | 0.6 | GO:1904274 | tricellular tight junction assembly(GO:1904274) |
| 0.1 | 0.4 | GO:0009443 | pyridoxal 5'-phosphate salvage(GO:0009443) |
| 0.1 | 1.5 | GO:0045717 | negative regulation of fatty acid biosynthetic process(GO:0045717) |
| 0.1 | 0.8 | GO:2000323 | negative regulation of glucocorticoid receptor signaling pathway(GO:2000323) |
| 0.1 | 0.5 | GO:0001778 | plasma membrane repair(GO:0001778) |
| 0.1 | 1.1 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
| 0.1 | 0.5 | GO:1903575 | cornified envelope assembly(GO:1903575) |
| 0.1 | 0.1 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
| 0.1 | 0.4 | GO:0071409 | cellular response to cycloheximide(GO:0071409) |
| 0.1 | 0.4 | GO:0048241 | epinephrine transport(GO:0048241) |
| 0.1 | 0.8 | GO:0010968 | regulation of microtubule nucleation(GO:0010968) |
| 0.1 | 0.5 | GO:0050965 | detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
| 0.1 | 0.3 | GO:0072429 | response to intra-S DNA damage checkpoint signaling(GO:0072429) |
| 0.1 | 0.3 | GO:0034227 | tRNA thio-modification(GO:0034227) |
| 0.1 | 0.8 | GO:0044070 | regulation of anion transport(GO:0044070) |
| 0.1 | 1.5 | GO:0006002 | fructose 6-phosphate metabolic process(GO:0006002) |
| 0.1 | 1.1 | GO:0070131 | positive regulation of mitochondrial translation(GO:0070131) |
| 0.1 | 1.2 | GO:2000507 | positive regulation of energy homeostasis(GO:2000507) |
| 0.1 | 0.4 | GO:0051643 | endoplasmic reticulum localization(GO:0051643) |
| 0.1 | 1.4 | GO:0043249 | erythrocyte maturation(GO:0043249) |
| 0.1 | 1.7 | GO:0071318 | cellular response to ATP(GO:0071318) |
| 0.1 | 0.1 | GO:0032963 | collagen metabolic process(GO:0032963) |
| 0.1 | 0.4 | GO:0019417 | sulfur oxidation(GO:0019417) |
| 0.1 | 1.2 | GO:0019532 | oxalate transport(GO:0019532) |
| 0.1 | 0.1 | GO:0060525 | prostate glandular acinus development(GO:0060525) |
| 0.1 | 0.4 | GO:1902499 | positive regulation of protein autoubiquitination(GO:1902499) |
| 0.1 | 1.0 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
| 0.1 | 0.9 | GO:0071281 | cellular response to iron ion(GO:0071281) |
| 0.1 | 0.5 | GO:0044342 | type B pancreatic cell proliferation(GO:0044342) |
| 0.1 | 1.5 | GO:0033622 | integrin activation(GO:0033622) |
| 0.1 | 1.1 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
| 0.1 | 2.9 | GO:0060334 | regulation of interferon-gamma-mediated signaling pathway(GO:0060334) |
| 0.1 | 3.2 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
| 0.1 | 0.7 | GO:0002281 | macrophage activation involved in immune response(GO:0002281) |
| 0.1 | 0.2 | GO:0046166 | glyceraldehyde-3-phosphate biosynthetic process(GO:0046166) |
| 0.1 | 1.5 | GO:0006787 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
| 0.1 | 1.2 | GO:0035385 | Roundabout signaling pathway(GO:0035385) |
| 0.1 | 1.7 | GO:1904754 | positive regulation of vascular associated smooth muscle cell migration(GO:1904754) |
| 0.1 | 0.7 | GO:2001224 | positive regulation of neuron migration(GO:2001224) |
| 0.1 | 0.2 | GO:0021557 | oculomotor nerve development(GO:0021557) |
| 0.1 | 0.4 | GO:1902490 | regulation of sperm capacitation(GO:1902490) |
| 0.1 | 0.5 | GO:1904627 | response to phorbol 13-acetate 12-myristate(GO:1904627) cellular response to phorbol 13-acetate 12-myristate(GO:1904628) |
| 0.1 | 0.1 | GO:0031126 | snoRNA 3'-end processing(GO:0031126) |
| 0.1 | 0.6 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
| 0.1 | 0.5 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
| 0.1 | 1.2 | GO:0006335 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
| 0.1 | 0.4 | GO:0070988 | demethylation(GO:0070988) |
| 0.1 | 0.2 | GO:0071043 | CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
| 0.1 | 0.1 | GO:1900110 | negative regulation of histone H3-K9 dimethylation(GO:1900110) |
| 0.1 | 1.8 | GO:0034315 | regulation of Arp2/3 complex-mediated actin nucleation(GO:0034315) |
| 0.1 | 0.5 | GO:0048295 | positive regulation of isotype switching to IgE isotypes(GO:0048295) |
| 0.1 | 0.3 | GO:0086100 | endothelin receptor signaling pathway(GO:0086100) |
| 0.1 | 0.8 | GO:0035986 | senescence-associated heterochromatin focus assembly(GO:0035986) |
| 0.1 | 0.5 | GO:1902722 | positive regulation of prolactin secretion(GO:1902722) |
| 0.1 | 0.3 | GO:0048675 | axon extension(GO:0048675) |
| 0.1 | 0.5 | GO:0036016 | response to interleukin-3(GO:0036015) cellular response to interleukin-3(GO:0036016) |
| 0.1 | 0.1 | GO:0003162 | atrioventricular node development(GO:0003162) |
| 0.1 | 0.1 | GO:0019860 | uracil metabolic process(GO:0019860) |
| 0.1 | 0.5 | GO:0014835 | myoblast differentiation involved in skeletal muscle regeneration(GO:0014835) |
| 0.1 | 0.9 | GO:1903429 | regulation of cell maturation(GO:1903429) |
| 0.1 | 1.0 | GO:0008655 | pyrimidine-containing compound salvage(GO:0008655) pyrimidine nucleoside salvage(GO:0043097) |
| 0.1 | 0.9 | GO:0051262 | protein tetramerization(GO:0051262) |
| 0.1 | 0.3 | GO:0015680 | intracellular copper ion transport(GO:0015680) |
| 0.1 | 0.1 | GO:0071603 | endothelial cell-cell adhesion(GO:0071603) |
| 0.1 | 1.0 | GO:0045654 | positive regulation of megakaryocyte differentiation(GO:0045654) |
| 0.1 | 0.6 | GO:0014807 | regulation of somitogenesis(GO:0014807) |
| 0.1 | 0.5 | GO:0007185 | transmembrane receptor protein tyrosine phosphatase signaling pathway(GO:0007185) |
| 0.1 | 0.3 | GO:1902037 | negative regulation of hematopoietic stem cell differentiation(GO:1902037) |
| 0.1 | 0.1 | GO:1902576 | negative regulation of nuclear cell cycle DNA replication(GO:1902576) |
| 0.1 | 0.3 | GO:0035509 | negative regulation of myosin-light-chain-phosphatase activity(GO:0035509) negative regulation of bicellular tight junction assembly(GO:1903347) |
| 0.1 | 2.3 | GO:0045747 | positive regulation of Notch signaling pathway(GO:0045747) |
| 0.1 | 0.7 | GO:0032185 | septin cytoskeleton organization(GO:0032185) |
| 0.1 | 0.8 | GO:0002329 | pre-B cell differentiation(GO:0002329) |
| 0.1 | 0.4 | GO:0045415 | negative regulation of interleukin-8 biosynthetic process(GO:0045415) |
| 0.1 | 0.1 | GO:2001184 | positive regulation of interleukin-12 secretion(GO:2001184) |
| 0.1 | 0.7 | GO:0017145 | stem cell division(GO:0017145) |
| 0.1 | 0.8 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
| 0.1 | 0.4 | GO:2000035 | regulation of stem cell division(GO:2000035) |
| 0.1 | 0.4 | GO:0071442 | positive regulation of histone H3-K14 acetylation(GO:0071442) |
| 0.1 | 0.8 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
| 0.1 | 1.4 | GO:2000042 | negative regulation of double-strand break repair via homologous recombination(GO:2000042) |
| 0.1 | 0.7 | GO:0071321 | cellular response to cGMP(GO:0071321) |
| 0.1 | 0.3 | GO:1900063 | regulation of peroxisome organization(GO:1900063) |
| 0.1 | 0.2 | GO:2000819 | regulation of nucleotide-excision repair(GO:2000819) |
| 0.1 | 0.5 | GO:0032074 | negative regulation of nuclease activity(GO:0032074) |
| 0.1 | 0.1 | GO:1904933 | regulation of cell proliferation in midbrain(GO:1904933) |
| 0.1 | 4.4 | GO:0045540 | regulation of cholesterol biosynthetic process(GO:0045540) |
| 0.1 | 0.4 | GO:0019918 | peptidyl-arginine methylation, to symmetrical-dimethyl arginine(GO:0019918) |
| 0.1 | 0.1 | GO:0003032 | detection of oxygen(GO:0003032) |
| 0.1 | 0.5 | GO:0032510 | endosome to lysosome transport via multivesicular body sorting pathway(GO:0032510) |
| 0.1 | 1.7 | GO:0032515 | negative regulation of phosphoprotein phosphatase activity(GO:0032515) |
| 0.1 | 1.4 | GO:0051775 | response to redox state(GO:0051775) |
| 0.1 | 0.2 | GO:0051660 | establishment of centrosome localization(GO:0051660) |
| 0.1 | 0.3 | GO:0039534 | negative regulation of MDA-5 signaling pathway(GO:0039534) |
| 0.1 | 0.6 | GO:0002870 | lymphocyte anergy(GO:0002249) regulation of T cell anergy(GO:0002667) T cell anergy(GO:0002870) regulation of lymphocyte anergy(GO:0002911) |
| 0.1 | 0.9 | GO:0030050 | vesicle transport along actin filament(GO:0030050) |
| 0.1 | 0.4 | GO:0010816 | substance P catabolic process(GO:0010814) calcitonin catabolic process(GO:0010816) endothelin maturation(GO:0034959) |
| 0.1 | 0.7 | GO:0006991 | response to sterol depletion(GO:0006991) SREBP signaling pathway(GO:0032933) cellular response to sterol depletion(GO:0071501) |
| 0.1 | 0.5 | GO:0006029 | proteoglycan metabolic process(GO:0006029) |
| 0.1 | 0.1 | GO:0032224 | positive regulation of synaptic transmission, cholinergic(GO:0032224) |
| 0.1 | 0.7 | GO:0061299 | retina vasculature morphogenesis in camera-type eye(GO:0061299) |
| 0.1 | 0.3 | GO:0006427 | histidyl-tRNA aminoacylation(GO:0006427) |
| 0.1 | 1.0 | GO:0071313 | cellular response to caffeine(GO:0071313) |
| 0.1 | 0.1 | GO:0030500 | regulation of bone mineralization(GO:0030500) |
| 0.1 | 0.2 | GO:0032079 | positive regulation of endodeoxyribonuclease activity(GO:0032079) |
| 0.1 | 0.4 | GO:1902766 | skeletal muscle satellite cell migration(GO:1902766) |
| 0.1 | 0.2 | GO:0044313 | protein K6-linked deubiquitination(GO:0044313) |
| 0.1 | 1.1 | GO:0048853 | forebrain morphogenesis(GO:0048853) |
| 0.1 | 0.3 | GO:0035425 | autocrine signaling(GO:0035425) |
| 0.1 | 0.7 | GO:0007506 | gonadal mesoderm development(GO:0007506) |
| 0.1 | 0.7 | GO:0045591 | positive regulation of regulatory T cell differentiation(GO:0045591) |
| 0.1 | 0.3 | GO:0042058 | regulation of epidermal growth factor receptor signaling pathway(GO:0042058) |
| 0.1 | 2.8 | GO:0042753 | positive regulation of circadian rhythm(GO:0042753) |
| 0.1 | 0.2 | GO:0060696 | regulation of phospholipid catabolic process(GO:0060696) |
| 0.1 | 2.2 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
| 0.1 | 1.1 | GO:0032464 | positive regulation of protein homooligomerization(GO:0032464) |
| 0.1 | 0.4 | GO:0045144 | meiotic sister chromatid segregation(GO:0045144) |
| 0.1 | 0.2 | GO:0019065 | receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
| 0.1 | 1.0 | GO:1903943 | regulation of hepatocyte apoptotic process(GO:1903943) negative regulation of hepatocyte apoptotic process(GO:1903944) |
| 0.1 | 0.2 | GO:1901842 | negative regulation of high voltage-gated calcium channel activity(GO:1901842) |
| 0.1 | 0.7 | GO:0002544 | chronic inflammatory response(GO:0002544) |
| 0.1 | 0.2 | GO:0010936 | negative regulation of macrophage cytokine production(GO:0010936) |
| 0.1 | 0.2 | GO:0030241 | skeletal muscle myosin thick filament assembly(GO:0030241) |
| 0.1 | 0.6 | GO:0016557 | peroxisome membrane biogenesis(GO:0016557) |
| 0.1 | 0.5 | GO:0042631 | cellular response to water deprivation(GO:0042631) |
| 0.1 | 0.7 | GO:2000821 | regulation of grooming behavior(GO:2000821) |
| 0.1 | 0.3 | GO:0060717 | chorion development(GO:0060717) |
| 0.1 | 0.5 | GO:0086046 | membrane depolarization during SA node cell action potential(GO:0086046) |
| 0.1 | 1.1 | GO:0017183 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
| 0.1 | 0.2 | GO:1904098 | regulation of protein O-linked glycosylation(GO:1904098) positive regulation of protein O-linked glycosylation(GO:1904100) |
| 0.1 | 0.3 | GO:1900111 | positive regulation of histone H3-K9 dimethylation(GO:1900111) |
| 0.1 | 2.3 | GO:0001893 | maternal placenta development(GO:0001893) |
| 0.1 | 0.1 | GO:0035026 | leading edge cell differentiation(GO:0035026) |
| 0.1 | 0.3 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
| 0.1 | 0.8 | GO:1902746 | regulation of lens fiber cell differentiation(GO:1902746) |
| 0.1 | 0.3 | GO:0071550 | death-inducing signaling complex assembly(GO:0071550) |
| 0.1 | 1.7 | GO:1990001 | inhibition of cysteine-type endopeptidase activity involved in apoptotic process(GO:1990001) |
| 0.1 | 0.1 | GO:0071878 | negative regulation of adrenergic receptor signaling pathway(GO:0071878) |
| 0.1 | 0.1 | GO:1902809 | regulation of skeletal muscle fiber differentiation(GO:1902809) |
| 0.1 | 0.6 | GO:0038172 | interleukin-33-mediated signaling pathway(GO:0038172) |
| 0.1 | 11.7 | GO:0070126 | mitochondrial translational termination(GO:0070126) |
| 0.1 | 0.4 | GO:0035909 | aorta morphogenesis(GO:0035909) |
| 0.1 | 0.7 | GO:0001866 | NK T cell proliferation(GO:0001866) |
| 0.1 | 0.7 | GO:0033235 | positive regulation of protein sumoylation(GO:0033235) |
| 0.1 | 0.5 | GO:0045204 | MAPK export from nucleus(GO:0045204) |
| 0.1 | 0.1 | GO:0014916 | regulation of lung blood pressure(GO:0014916) |
| 0.1 | 0.1 | GO:0060438 | trachea development(GO:0060438) |
| 0.1 | 0.7 | GO:0006909 | phagocytosis(GO:0006909) |
| 0.1 | 0.1 | GO:0010040 | response to iron(II) ion(GO:0010040) |
| 0.1 | 0.9 | GO:0006621 | protein retention in ER lumen(GO:0006621) maintenance of protein localization in endoplasmic reticulum(GO:0035437) |
| 0.1 | 0.3 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
| 0.1 | 1.4 | GO:0042136 | neurotransmitter biosynthetic process(GO:0042136) |
| 0.1 | 0.1 | GO:1900039 | positive regulation of cellular response to hypoxia(GO:1900039) |
| 0.1 | 1.5 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
| 0.1 | 2.1 | GO:0097421 | liver regeneration(GO:0097421) |
| 0.1 | 0.1 | GO:0006679 | glucosylceramide biosynthetic process(GO:0006679) |
| 0.1 | 0.3 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
| 0.1 | 0.3 | GO:0042364 | water-soluble vitamin biosynthetic process(GO:0042364) |
| 0.1 | 0.2 | GO:2001238 | positive regulation of extrinsic apoptotic signaling pathway(GO:2001238) |
| 0.1 | 0.3 | GO:0006428 | isoleucyl-tRNA aminoacylation(GO:0006428) |
| 0.1 | 2.9 | GO:0006376 | mRNA splice site selection(GO:0006376) |
| 0.1 | 0.1 | GO:1903903 | regulation of establishment of T cell polarity(GO:1903903) |
| 0.1 | 1.6 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
| 0.1 | 0.2 | GO:0000012 | single strand break repair(GO:0000012) |
| 0.1 | 0.5 | GO:0031397 | negative regulation of protein ubiquitination(GO:0031397) |
| 0.1 | 0.4 | GO:0001180 | transcription initiation from RNA polymerase I promoter for nuclear large rRNA transcript(GO:0001180) RNA polymerase I transcriptional preinitiation complex assembly(GO:0001188) RNA polymerase I transcriptional preinitiation complex assembly at the promoter for the nuclear large rRNA transcript(GO:0001189) |
| 0.1 | 0.2 | GO:0007343 | egg activation(GO:0007343) |
| 0.1 | 0.6 | GO:0019348 | dolichol metabolic process(GO:0019348) |
| 0.1 | 0.6 | GO:0090074 | negative regulation of protein homodimerization activity(GO:0090074) |
| 0.1 | 0.4 | GO:0007341 | penetration of zona pellucida(GO:0007341) |
| 0.1 | 0.4 | GO:0033512 | L-lysine catabolic process to acetyl-CoA via saccharopine(GO:0033512) |
| 0.1 | 0.8 | GO:0060068 | vagina development(GO:0060068) |
| 0.1 | 0.6 | GO:0000056 | ribosomal small subunit export from nucleus(GO:0000056) |
| 0.1 | 0.7 | GO:0000712 | resolution of meiotic recombination intermediates(GO:0000712) |
| 0.1 | 0.4 | GO:0045604 | regulation of epidermal cell differentiation(GO:0045604) |
| 0.1 | 0.6 | GO:0097411 | hypoxia-inducible factor-1alpha signaling pathway(GO:0097411) |
| 0.1 | 0.6 | GO:1904322 | response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
| 0.1 | 0.6 | GO:1901030 | positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901030) |
| 0.1 | 0.4 | GO:0008612 | peptidyl-lysine modification to peptidyl-hypusine(GO:0008612) |
| 0.1 | 7.1 | GO:0036498 | IRE1-mediated unfolded protein response(GO:0036498) |
| 0.1 | 0.6 | GO:0006206 | pyrimidine nucleobase metabolic process(GO:0006206) |
| 0.1 | 0.6 | GO:0072642 | interferon-alpha secretion(GO:0072642) regulation of interferon-alpha secretion(GO:1902739) positive regulation of interferon-alpha secretion(GO:1902741) |
| 0.1 | 0.4 | GO:0071494 | cellular response to UV-C(GO:0071494) |
| 0.1 | 1.6 | GO:0010647 | positive regulation of cell communication(GO:0010647) |
| 0.1 | 0.6 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
| 0.1 | 0.7 | GO:0070266 | necroptotic process(GO:0070266) |
| 0.1 | 0.6 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
| 0.1 | 0.3 | GO:0060743 | epithelial cell maturation involved in prostate gland development(GO:0060743) |
| 0.1 | 0.7 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
| 0.1 | 0.2 | GO:0010829 | negative regulation of glucose transport(GO:0010829) |
| 0.1 | 0.2 | GO:0010519 | negative regulation of phospholipase activity(GO:0010519) negative regulation of phospholipase A2 activity(GO:1900138) |
| 0.1 | 0.2 | GO:0060052 | neurofilament cytoskeleton organization(GO:0060052) |
| 0.1 | 0.8 | GO:0036155 | acylglycerol acyl-chain remodeling(GO:0036155) |
| 0.1 | 2.6 | GO:0032784 | regulation of DNA-templated transcription, elongation(GO:0032784) |
| 0.1 | 0.1 | GO:0060938 | cardiac fibroblast cell differentiation(GO:0060935) cardiac fibroblast cell development(GO:0060936) epicardium-derived cardiac fibroblast cell differentiation(GO:0060938) epicardium-derived cardiac fibroblast cell development(GO:0060939) epithelial to mesenchymal transition involved in cardiac fibroblast development(GO:0060940) |
| 0.1 | 0.6 | GO:0002943 | tRNA dihydrouridine synthesis(GO:0002943) |
| 0.1 | 0.1 | GO:0036124 | histone H3-K9 trimethylation(GO:0036124) |
| 0.1 | 0.5 | GO:0030202 | heparin metabolic process(GO:0030202) heparin biosynthetic process(GO:0030210) |
| 0.1 | 0.6 | GO:0061739 | protein lipidation involved in autophagosome assembly(GO:0061739) |
| 0.1 | 1.0 | GO:0006853 | carnitine shuttle(GO:0006853) |
| 0.1 | 0.3 | GO:0034287 | detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) detection of glucose(GO:0051594) |
| 0.1 | 6.7 | GO:0000079 | regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0000079) |
| 0.1 | 0.7 | GO:0030208 | dermatan sulfate metabolic process(GO:0030205) dermatan sulfate biosynthetic process(GO:0030208) |
| 0.1 | 0.4 | GO:0051195 | negative regulation of nucleotide catabolic process(GO:0030812) negative regulation of glycolytic process(GO:0045820) negative regulation of cofactor metabolic process(GO:0051195) negative regulation of coenzyme metabolic process(GO:0051198) |
| 0.1 | 0.1 | GO:0001554 | luteolysis(GO:0001554) |
| 0.1 | 3.7 | GO:0035329 | hippo signaling(GO:0035329) |
| 0.1 | 0.3 | GO:0003383 | apical constriction(GO:0003383) |
| 0.1 | 0.3 | GO:0002188 | translation reinitiation(GO:0002188) |
| 0.1 | 0.3 | GO:0009107 | lipoate biosynthetic process(GO:0009107) |
| 0.1 | 1.9 | GO:0034389 | lipid particle organization(GO:0034389) |
| 0.1 | 0.8 | GO:0015803 | branched-chain amino acid transport(GO:0015803) |
| 0.1 | 0.4 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
| 0.1 | 1.1 | GO:0051561 | positive regulation of mitochondrial calcium ion concentration(GO:0051561) |
| 0.1 | 0.2 | GO:0048304 | positive regulation of isotype switching to IgG isotypes(GO:0048304) |
| 0.1 | 0.5 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
| 0.1 | 0.8 | GO:0070933 | histone H4 deacetylation(GO:0070933) |
| 0.1 | 5.1 | GO:0016266 | O-glycan processing(GO:0016266) |
| 0.1 | 1.5 | GO:0003334 | keratinocyte development(GO:0003334) |
| 0.1 | 0.8 | GO:0008356 | asymmetric cell division(GO:0008356) |
| 0.1 | 0.3 | GO:0072553 | terminal button organization(GO:0072553) |
| 0.1 | 0.3 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
| 0.1 | 1.7 | GO:0007020 | microtubule nucleation(GO:0007020) |
| 0.1 | 0.8 | GO:0061470 | T follicular helper cell differentiation(GO:0061470) |
| 0.1 | 0.1 | GO:0000492 | small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
| 0.1 | 0.4 | GO:0043654 | recognition of apoptotic cell(GO:0043654) |
| 0.1 | 0.8 | GO:0033313 | meiotic cell cycle checkpoint(GO:0033313) |
| 0.1 | 0.5 | GO:0060316 | positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
| 0.1 | 0.3 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
| 0.1 | 1.3 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
| 0.1 | 2.9 | GO:1904659 | hexose transmembrane transport(GO:0035428) glucose transmembrane transport(GO:1904659) |
| 0.1 | 5.2 | GO:0030049 | muscle filament sliding(GO:0030049) actin-myosin filament sliding(GO:0033275) |
| 0.1 | 2.1 | GO:0002076 | osteoblast development(GO:0002076) |
| 0.1 | 0.1 | GO:0003050 | regulation of systemic arterial blood pressure by atrial natriuretic peptide(GO:0003050) |
| 0.1 | 0.1 | GO:0060392 | negative regulation of SMAD protein import into nucleus(GO:0060392) |
| 0.1 | 1.1 | GO:0038203 | TORC2 signaling(GO:0038203) |
| 0.1 | 0.3 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
| 0.1 | 1.0 | GO:0006449 | regulation of translational termination(GO:0006449) |
| 0.1 | 0.7 | GO:0010992 | ubiquitin homeostasis(GO:0010992) |
| 0.1 | 2.8 | GO:0008333 | endosome to lysosome transport(GO:0008333) |
| 0.1 | 0.2 | GO:2000374 | regulation of oxygen metabolic process(GO:2000374) |
| 0.1 | 0.3 | GO:0072656 | maintenance of protein location in mitochondrion(GO:0072656) |
| 0.1 | 0.3 | GO:0022417 | protein maturation by protein folding(GO:0022417) |
| 0.1 | 0.2 | GO:1901355 | response to rapamycin(GO:1901355) |
| 0.1 | 0.1 | GO:0070972 | protein localization to endoplasmic reticulum(GO:0070972) |
| 0.1 | 0.7 | GO:0031468 | nuclear envelope reassembly(GO:0031468) |
| 0.1 | 0.6 | GO:0071732 | cellular response to nitric oxide(GO:0071732) |
| 0.1 | 0.2 | GO:0022615 | protein import into peroxisome matrix, docking(GO:0016560) protein to membrane docking(GO:0022615) |
| 0.1 | 0.3 | GO:0045741 | positive regulation of epidermal growth factor-activated receptor activity(GO:0045741) |
| 0.1 | 0.3 | GO:1903412 | response to bile acid(GO:1903412) |
| 0.1 | 0.2 | GO:0015883 | FAD transport(GO:0015883) FAD transmembrane transport(GO:0035350) |
| 0.1 | 1.2 | GO:0045087 | innate immune response(GO:0045087) |
| 0.1 | 0.1 | GO:1904502 | positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031587) lipophagy(GO:0061724) regulation of lipophagy(GO:1904502) positive regulation of lipophagy(GO:1904504) |
| 0.1 | 0.2 | GO:0043686 | co-translational protein modification(GO:0043686) |
| 0.1 | 0.6 | GO:0048703 | embryonic viscerocranium morphogenesis(GO:0048703) |
| 0.1 | 0.6 | GO:0048845 | venous blood vessel morphogenesis(GO:0048845) |
| 0.1 | 5.8 | GO:0042273 | ribosomal large subunit biogenesis(GO:0042273) |
| 0.1 | 0.2 | GO:0048842 | positive regulation of axon extension involved in axon guidance(GO:0048842) |
| 0.1 | 0.5 | GO:0075713 | establishment of integrated proviral latency(GO:0075713) |
| 0.1 | 0.5 | GO:0015871 | choline transport(GO:0015871) |
| 0.1 | 0.2 | GO:0006114 | glycerol biosynthetic process(GO:0006114) |
| 0.1 | 0.2 | GO:1905224 | clathrin-coated pit assembly(GO:1905224) |
| 0.1 | 0.2 | GO:0006526 | arginine biosynthetic process(GO:0006526) |
| 0.1 | 0.2 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
| 0.1 | 0.2 | GO:0006360 | transcription from RNA polymerase I promoter(GO:0006360) |
| 0.1 | 0.4 | GO:0034378 | chylomicron assembly(GO:0034378) |
| 0.1 | 0.2 | GO:0018065 | protein-cofactor linkage(GO:0018065) |
| 0.1 | 0.2 | GO:0071670 | smooth muscle cell chemotaxis(GO:0071670) |
| 0.1 | 2.6 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
| 0.1 | 0.4 | GO:1903286 | regulation of potassium ion import(GO:1903286) |
| 0.1 | 0.6 | GO:0010592 | positive regulation of lamellipodium assembly(GO:0010592) |
| 0.1 | 0.1 | GO:2000643 | positive regulation of early endosome to late endosome transport(GO:2000643) |
| 0.1 | 0.3 | GO:1901029 | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
| 0.1 | 0.1 | GO:2001302 | lipoxin biosynthetic process(GO:2001301) lipoxin A4 metabolic process(GO:2001302) lipoxin A4 biosynthetic process(GO:2001303) |
| 0.1 | 1.3 | GO:0046475 | glycerophospholipid catabolic process(GO:0046475) |
| 0.1 | 5.7 | GO:0009301 | snRNA transcription(GO:0009301) snRNA transcription from RNA polymerase II promoter(GO:0042795) |
| 0.1 | 1.0 | GO:0048742 | regulation of skeletal muscle fiber development(GO:0048742) |
| 0.1 | 0.5 | GO:0014877 | response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
| 0.1 | 0.4 | GO:0006065 | UDP-glucuronate biosynthetic process(GO:0006065) UDP-glucuronate metabolic process(GO:0046398) |
| 0.1 | 0.7 | GO:0090002 | establishment of protein localization to plasma membrane(GO:0090002) |
| 0.1 | 0.1 | GO:0031508 | pericentric heterochromatin assembly(GO:0031508) |
| 0.1 | 1.6 | GO:0061003 | positive regulation of dendritic spine morphogenesis(GO:0061003) |
| 0.1 | 0.1 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
| 0.1 | 0.7 | GO:0000733 | DNA strand renaturation(GO:0000733) |
| 0.1 | 0.2 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
| 0.1 | 0.5 | GO:0042759 | long-chain fatty acid biosynthetic process(GO:0042759) |
| 0.1 | 1.1 | GO:0043552 | positive regulation of phosphatidylinositol 3-kinase activity(GO:0043552) |
| 0.1 | 0.1 | GO:0001836 | release of cytochrome c from mitochondria(GO:0001836) |
| 0.1 | 0.3 | GO:0051083 | 'de novo' cotranslational protein folding(GO:0051083) |
| 0.1 | 0.1 | GO:0015808 | L-alanine transport(GO:0015808) |
| 0.1 | 1.6 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
| 0.1 | 1.8 | GO:0031100 | organ regeneration(GO:0031100) |
| 0.1 | 0.3 | GO:0033132 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
| 0.1 | 0.9 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
| 0.1 | 0.5 | GO:0032926 | negative regulation of activin receptor signaling pathway(GO:0032926) |
| 0.1 | 0.2 | GO:0032776 | DNA methylation on cytosine(GO:0032776) |
| 0.1 | 0.1 | GO:0010762 | regulation of fibroblast migration(GO:0010762) |
| 0.1 | 0.4 | GO:0055129 | L-proline biosynthetic process(GO:0055129) |
| 0.1 | 0.8 | GO:0007021 | tubulin complex assembly(GO:0007021) |
| 0.1 | 0.4 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
| 0.1 | 0.2 | GO:0018171 | peptidyl-cysteine oxidation(GO:0018171) |
| 0.1 | 0.2 | GO:0000711 | meiotic DNA repair synthesis(GO:0000711) |
| 0.1 | 0.1 | GO:0032717 | negative regulation of interleukin-8 production(GO:0032717) |
| 0.1 | 1.0 | GO:0045124 | regulation of bone resorption(GO:0045124) |
| 0.1 | 0.2 | GO:0071529 | cementum mineralization(GO:0071529) |
| 0.1 | 1.2 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
| 0.1 | 0.3 | GO:0060348 | bone development(GO:0060348) |
| 0.1 | 0.3 | GO:0043031 | negative regulation of macrophage activation(GO:0043031) |
| 0.1 | 0.1 | GO:0045907 | positive regulation of vasoconstriction(GO:0045907) |
| 0.1 | 0.2 | GO:0006624 | vacuolar protein processing(GO:0006624) |
| 0.1 | 0.7 | GO:0030091 | protein repair(GO:0030091) |
| 0.1 | 0.1 | GO:0035947 | regulation of gluconeogenesis by regulation of transcription from RNA polymerase II promoter(GO:0035947) positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter(GO:0035948) |
| 0.1 | 0.1 | GO:0070459 | prolactin secretion(GO:0070459) |
| 0.1 | 0.7 | GO:0006309 | apoptotic DNA fragmentation(GO:0006309) |
| 0.1 | 1.0 | GO:0008299 | isoprenoid biosynthetic process(GO:0008299) |
| 0.1 | 0.3 | GO:0060628 | regulation of ER to Golgi vesicle-mediated transport(GO:0060628) |
| 0.1 | 0.6 | GO:0050857 | positive regulation of antigen receptor-mediated signaling pathway(GO:0050857) |
| 0.1 | 1.0 | GO:0042921 | glucocorticoid receptor signaling pathway(GO:0042921) |
| 0.1 | 0.2 | GO:0018201 | peptidyl-glycine modification(GO:0018201) |
| 0.1 | 0.3 | GO:0097498 | endothelial tube lumen extension(GO:0097498) |
| 0.1 | 0.1 | GO:0046958 | nonassociative learning(GO:0046958) |
| 0.1 | 0.2 | GO:0006406 | mRNA export from nucleus(GO:0006406) mRNA-containing ribonucleoprotein complex export from nucleus(GO:0071427) |
| 0.1 | 0.3 | GO:0033005 | positive regulation of mast cell activation(GO:0033005) |
| 0.1 | 0.5 | GO:0034349 | glial cell apoptotic process(GO:0034349) |
| 0.1 | 0.6 | GO:0039536 | negative regulation of RIG-I signaling pathway(GO:0039536) |
| 0.1 | 0.5 | GO:0006582 | melanin metabolic process(GO:0006582) |
| 0.1 | 1.1 | GO:0045776 | negative regulation of blood pressure(GO:0045776) |
| 0.1 | 1.0 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
| 0.1 | 0.1 | GO:0043376 | regulation of CD8-positive, alpha-beta T cell differentiation(GO:0043376) |
| 0.1 | 0.3 | GO:0043456 | regulation of pentose-phosphate shunt(GO:0043456) |
| 0.1 | 0.1 | GO:0071474 | cellular hyperosmotic response(GO:0071474) |
| 0.1 | 0.5 | GO:0010606 | positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
| 0.1 | 0.9 | GO:0006995 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
| 0.1 | 1.7 | GO:0035872 | nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway(GO:0035872) nucleotide-binding oligomerization domain containing signaling pathway(GO:0070423) |
| 0.1 | 0.3 | GO:0046826 | negative regulation of protein export from nucleus(GO:0046826) |
| 0.1 | 0.8 | GO:0006828 | manganese ion transport(GO:0006828) |
| 0.1 | 0.2 | GO:0018149 | peptide cross-linking(GO:0018149) |
| 0.1 | 0.1 | GO:0010663 | positive regulation of striated muscle cell apoptotic process(GO:0010663) positive regulation of cardiac muscle cell apoptotic process(GO:0010666) |
| 0.1 | 0.2 | GO:0070173 | regulation of enamel mineralization(GO:0070173) |
| 0.1 | 0.1 | GO:0006409 | tRNA export from nucleus(GO:0006409) tRNA transport(GO:0051031) tRNA-containing ribonucleoprotein complex export from nucleus(GO:0071431) |
| 0.1 | 0.2 | GO:0098746 | fast, calcium ion-dependent exocytosis of neurotransmitter(GO:0098746) |
| 0.1 | 0.3 | GO:0051898 | negative regulation of protein kinase B signaling(GO:0051898) |
| 0.1 | 0.3 | GO:0001756 | somitogenesis(GO:0001756) |
| 0.1 | 0.3 | GO:0000460 | maturation of 5.8S rRNA(GO:0000460) |
| 0.1 | 0.4 | GO:0001556 | oocyte maturation(GO:0001556) |
| 0.1 | 0.4 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
| 0.1 | 0.8 | GO:0051439 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle(GO:0051439) |
| 0.1 | 0.3 | GO:0014051 | gamma-aminobutyric acid secretion(GO:0014051) |
| 0.1 | 0.1 | GO:0030163 | protein catabolic process(GO:0030163) |
| 0.1 | 0.2 | GO:1904715 | negative regulation of chaperone-mediated autophagy(GO:1904715) |
| 0.1 | 0.8 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
| 0.1 | 0.2 | GO:1904823 | pyrimidine nucleobase transport(GO:0015855) purine nucleobase transmembrane transport(GO:1904823) |
| 0.1 | 0.1 | GO:0016571 | histone methylation(GO:0016571) histone lysine methylation(GO:0034968) |
| 0.1 | 0.4 | GO:0071315 | cellular response to morphine(GO:0071315) cellular response to isoquinoline alkaloid(GO:0071317) |
| 0.1 | 0.1 | GO:0051216 | cartilage development(GO:0051216) |
| 0.1 | 0.2 | GO:0070129 | regulation of mitochondrial translation(GO:0070129) |
| 0.1 | 0.2 | GO:0032462 | regulation of protein homooligomerization(GO:0032462) |
| 0.1 | 0.1 | GO:0086023 | adrenergic receptor signaling pathway involved in heart process(GO:0086023) |
| 0.1 | 0.1 | GO:0061418 | regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061418) |
| 0.1 | 0.2 | GO:0042908 | xenobiotic transport(GO:0042908) |
| 0.1 | 0.4 | GO:0075525 | viral translational termination-reinitiation(GO:0075525) |
| 0.1 | 0.2 | GO:0072093 | ureteric bud invasion(GO:0072092) metanephric renal vesicle formation(GO:0072093) |
| 0.1 | 0.4 | GO:0015812 | gamma-aminobutyric acid transport(GO:0015812) |
| 0.1 | 0.5 | GO:0034375 | high-density lipoprotein particle remodeling(GO:0034375) |
| 0.1 | 0.2 | GO:0097010 | eukaryotic translation initiation factor 4F complex assembly(GO:0097010) |
| 0.1 | 0.1 | GO:0060441 | epithelial tube branching involved in lung morphogenesis(GO:0060441) |
| 0.1 | 0.2 | GO:0061355 | Wnt protein secretion(GO:0061355) regulation of Wnt protein secretion(GO:0061356) positive regulation of Wnt protein secretion(GO:0061357) |
| 0.1 | 0.7 | GO:1903204 | negative regulation of oxidative stress-induced neuron death(GO:1903204) |
| 0.1 | 0.2 | GO:0035814 | negative regulation of renal sodium excretion(GO:0035814) |
| 0.1 | 0.6 | GO:0051764 | actin crosslink formation(GO:0051764) |
| 0.1 | 0.2 | GO:0015793 | glycerol transport(GO:0015793) |
| 0.1 | 1.1 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
| 0.1 | 0.1 | GO:2000562 | negative regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000562) |
| 0.1 | 0.2 | GO:0008065 | establishment of blood-nerve barrier(GO:0008065) |
| 0.1 | 0.1 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
| 0.1 | 0.3 | GO:0042074 | cell migration involved in gastrulation(GO:0042074) |
| 0.1 | 0.6 | GO:0046039 | GTP metabolic process(GO:0046039) |
| 0.1 | 1.1 | GO:0070536 | protein K63-linked deubiquitination(GO:0070536) |
| 0.1 | 0.5 | GO:0033962 | cytoplasmic mRNA processing body assembly(GO:0033962) |
| 0.1 | 0.1 | GO:1900226 | negative regulation of NLRP3 inflammasome complex assembly(GO:1900226) |
| 0.1 | 0.7 | GO:0009218 | pyrimidine ribonucleotide metabolic process(GO:0009218) |
| 0.1 | 1.8 | GO:0048008 | platelet-derived growth factor receptor signaling pathway(GO:0048008) |
| 0.1 | 0.1 | GO:0010225 | response to UV-C(GO:0010225) |
| 0.1 | 0.2 | GO:0071415 | cellular response to purine-containing compound(GO:0071415) |
| 0.1 | 0.9 | GO:0045742 | positive regulation of epidermal growth factor receptor signaling pathway(GO:0045742) |
| 0.1 | 0.7 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
| 0.1 | 0.1 | GO:0010286 | heat acclimation(GO:0010286) cellular heat acclimation(GO:0070370) |
| 0.1 | 1.2 | GO:0006656 | phosphatidylcholine biosynthetic process(GO:0006656) |
| 0.1 | 0.2 | GO:0046909 | intermembrane transport(GO:0046909) protein transport from ciliary membrane to plasma membrane(GO:1903445) |
| 0.1 | 0.1 | GO:0090141 | positive regulation of mitochondrial fission(GO:0090141) |
| 0.1 | 0.3 | GO:0014850 | response to muscle activity(GO:0014850) |
| 0.1 | 0.1 | GO:1902723 | negative regulation of skeletal muscle cell proliferation(GO:0014859) negative regulation of skeletal muscle satellite cell proliferation(GO:1902723) |
| 0.1 | 0.4 | GO:0032526 | response to retinoic acid(GO:0032526) |
| 0.1 | 0.5 | GO:0015074 | DNA integration(GO:0015074) |
| 0.1 | 0.4 | GO:1900623 | regulation of monocyte aggregation(GO:1900623) positive regulation of monocyte aggregation(GO:1900625) |
| 0.1 | 0.2 | GO:0002184 | cytoplasmic translational termination(GO:0002184) |
| 0.1 | 0.2 | GO:0031548 | regulation of brain-derived neurotrophic factor receptor signaling pathway(GO:0031548) |
| 0.1 | 0.2 | GO:0045667 | regulation of osteoblast differentiation(GO:0045667) |
| 0.1 | 0.4 | GO:0060689 | cell differentiation involved in salivary gland development(GO:0060689) |
| 0.1 | 1.1 | GO:0005980 | glycogen catabolic process(GO:0005980) |
| 0.1 | 0.1 | GO:0045643 | regulation of eosinophil differentiation(GO:0045643) positive regulation of eosinophil differentiation(GO:0045645) |
| 0.1 | 0.1 | GO:0032759 | TRAIL production(GO:0032639) regulation of TRAIL production(GO:0032679) positive regulation of TRAIL production(GO:0032759) |
| 0.1 | 0.2 | GO:0046501 | protoporphyrinogen IX biosynthetic process(GO:0006782) protoporphyrinogen IX metabolic process(GO:0046501) |
| 0.1 | 0.1 | GO:0036146 | cellular response to mycotoxin(GO:0036146) |
| 0.1 | 0.1 | GO:0035544 | negative regulation of SNARE complex assembly(GO:0035544) |
| 0.1 | 0.1 | GO:2000275 | regulation of oxidative phosphorylation uncoupler activity(GO:2000275) |
| 0.1 | 0.1 | GO:0000019 | regulation of mitotic recombination(GO:0000019) |
| 0.1 | 1.0 | GO:0060325 | face morphogenesis(GO:0060325) |
| 0.1 | 0.4 | GO:0070779 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
| 0.1 | 0.4 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
| 0.1 | 0.1 | GO:0036090 | cleavage furrow ingression(GO:0036090) |
| 0.1 | 0.1 | GO:1901656 | glycoside transport(GO:1901656) |
| 0.1 | 0.4 | GO:0034214 | protein hexamerization(GO:0034214) |
| 0.1 | 0.2 | GO:0060290 | transdifferentiation(GO:0060290) |
| 0.1 | 0.3 | GO:0048813 | dendrite morphogenesis(GO:0048813) |
| 0.1 | 0.1 | GO:0071806 | protein transmembrane transport(GO:0071806) |
| 0.1 | 0.2 | GO:0006422 | aspartyl-tRNA aminoacylation(GO:0006422) |
| 0.1 | 0.3 | GO:0015742 | alpha-ketoglutarate transport(GO:0015742) |
| 0.1 | 0.3 | GO:1903772 | regulation of viral budding via host ESCRT complex(GO:1903772) |
| 0.1 | 0.1 | GO:0002027 | regulation of heart rate(GO:0002027) |
| 0.1 | 0.2 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
| 0.1 | 2.2 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
| 0.1 | 0.2 | GO:2000483 | negative regulation of interleukin-8 secretion(GO:2000483) |
| 0.1 | 0.2 | GO:0006049 | UDP-N-acetylglucosamine catabolic process(GO:0006049) |
| 0.1 | 0.4 | GO:2000052 | positive regulation of non-canonical Wnt signaling pathway(GO:2000052) |
| 0.1 | 0.1 | GO:0035262 | gonad morphogenesis(GO:0035262) |
| 0.1 | 0.2 | GO:0008625 | extrinsic apoptotic signaling pathway via death domain receptors(GO:0008625) |
| 0.1 | 0.2 | GO:0098734 | macromolecule depalmitoylation(GO:0098734) |
| 0.0 | 0.1 | GO:0019919 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) |
| 0.0 | 0.5 | GO:0097396 | response to interleukin-17(GO:0097396) cellular response to interleukin-17(GO:0097398) |
| 0.0 | 0.8 | GO:0030866 | cortical actin cytoskeleton organization(GO:0030866) |
| 0.0 | 0.2 | GO:1900027 | regulation of ruffle assembly(GO:1900027) |
| 0.0 | 2.8 | GO:0034446 | substrate adhesion-dependent cell spreading(GO:0034446) |
| 0.0 | 0.8 | GO:0046856 | phosphatidylinositol dephosphorylation(GO:0046856) |
| 0.0 | 0.4 | GO:0051984 | positive regulation of chromosome segregation(GO:0051984) |
| 0.0 | 1.6 | GO:0016126 | sterol biosynthetic process(GO:0016126) |
| 0.0 | 0.2 | GO:1905097 | regulation of guanyl-nucleotide exchange factor activity(GO:1905097) |
| 0.0 | 0.0 | GO:0051893 | regulation of focal adhesion assembly(GO:0051893) regulation of cell-substrate junction assembly(GO:0090109) |
| 0.0 | 0.5 | GO:0007039 | protein catabolic process in the vacuole(GO:0007039) |
| 0.0 | 0.2 | GO:0051026 | chiasma assembly(GO:0051026) |
| 0.0 | 0.1 | GO:1902031 | regulation of NADP metabolic process(GO:1902031) |
| 0.0 | 0.1 | GO:1900225 | regulation of NLRP3 inflammasome complex assembly(GO:1900225) positive regulation of NLRP3 inflammasome complex assembly(GO:1900227) |
| 0.0 | 0.7 | GO:0072595 | maintenance of protein localization in organelle(GO:0072595) |
| 0.0 | 0.5 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
| 0.0 | 1.1 | GO:0000281 | mitotic cytokinesis(GO:0000281) |
| 0.0 | 1.7 | GO:0072583 | clathrin-mediated endocytosis(GO:0072583) |
| 0.0 | 0.1 | GO:0019985 | translesion synthesis(GO:0019985) |
| 0.0 | 0.5 | GO:0051412 | response to corticosterone(GO:0051412) |
| 0.0 | 0.3 | GO:0044062 | regulation of excretion(GO:0044062) |
| 0.0 | 1.4 | GO:1903959 | regulation of anion transmembrane transport(GO:1903959) |
| 0.0 | 0.2 | GO:0030262 | apoptotic nuclear changes(GO:0030262) |
| 0.0 | 1.9 | GO:0042059 | negative regulation of epidermal growth factor receptor signaling pathway(GO:0042059) |
| 0.0 | 0.3 | GO:0090218 | positive regulation of lipid kinase activity(GO:0090218) |
| 0.0 | 0.4 | GO:0097435 | fibril organization(GO:0097435) |
| 0.0 | 0.0 | GO:1902285 | semaphorin-plexin signaling pathway involved in neuron projection guidance(GO:1902285) |
| 0.0 | 0.2 | GO:0036506 | maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
| 0.0 | 0.1 | GO:0048478 | replication fork protection(GO:0048478) |
| 0.0 | 0.6 | GO:0010591 | regulation of lamellipodium assembly(GO:0010591) |
| 0.0 | 0.4 | GO:0042159 | lipoprotein catabolic process(GO:0042159) |
| 0.0 | 1.0 | GO:0033119 | negative regulation of RNA splicing(GO:0033119) |
| 0.0 | 0.1 | GO:0055081 | anion homeostasis(GO:0055081) |
| 0.0 | 0.2 | GO:0032495 | response to muramyl dipeptide(GO:0032495) |
| 0.0 | 0.3 | GO:2000152 | regulation of ubiquitin-specific protease activity(GO:2000152) |
| 0.0 | 0.3 | GO:0071763 | nuclear membrane organization(GO:0071763) |
| 0.0 | 0.1 | GO:0008212 | mineralocorticoid biosynthetic process(GO:0006705) mineralocorticoid metabolic process(GO:0008212) |
| 0.0 | 1.0 | GO:0032781 | positive regulation of ATPase activity(GO:0032781) |
| 0.0 | 0.6 | GO:0005513 | detection of calcium ion(GO:0005513) |
| 0.0 | 1.9 | GO:0015909 | long-chain fatty acid transport(GO:0015909) |
| 0.0 | 1.1 | GO:0046597 | negative regulation of viral entry into host cell(GO:0046597) |
| 0.0 | 0.1 | GO:0001994 | norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001994) |
| 0.0 | 0.3 | GO:0006366 | transcription from RNA polymerase II promoter(GO:0006366) |
| 0.0 | 0.2 | GO:0071955 | recycling endosome to Golgi transport(GO:0071955) |
| 0.0 | 0.6 | GO:0000289 | nuclear-transcribed mRNA poly(A) tail shortening(GO:0000289) |
| 0.0 | 0.2 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) |
| 0.0 | 0.2 | GO:0032345 | negative regulation of aldosterone metabolic process(GO:0032345) negative regulation of aldosterone biosynthetic process(GO:0032348) negative regulation of cortisol biosynthetic process(GO:2000065) |
| 0.0 | 0.1 | GO:0048213 | Golgi vesicle prefusion complex stabilization(GO:0048213) |
| 0.0 | 0.0 | GO:0006940 | regulation of smooth muscle contraction(GO:0006940) |
| 0.0 | 0.3 | GO:0051353 | positive regulation of oxidoreductase activity(GO:0051353) |
| 0.0 | 0.1 | GO:0010793 | regulation of mRNA export from nucleus(GO:0010793) |
| 0.0 | 0.1 | GO:0015770 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
| 0.0 | 0.1 | GO:0060729 | intestinal epithelial structure maintenance(GO:0060729) |
| 0.0 | 0.3 | GO:0061051 | regulation of cell growth involved in cardiac muscle cell development(GO:0061050) positive regulation of cell growth involved in cardiac muscle cell development(GO:0061051) |
| 0.0 | 0.1 | GO:0072679 | thymocyte migration(GO:0072679) |
| 0.0 | 0.6 | GO:0070914 | UV-damage excision repair(GO:0070914) |
| 0.0 | 0.2 | GO:0071344 | diphosphate metabolic process(GO:0071344) |
| 0.0 | 0.1 | GO:0031338 | regulation of vesicle fusion(GO:0031338) |
| 0.0 | 0.1 | GO:0000960 | mitochondrial RNA catabolic process(GO:0000957) regulation of mitochondrial RNA catabolic process(GO:0000960) |
| 0.0 | 0.5 | GO:0001919 | regulation of receptor recycling(GO:0001919) |
| 0.0 | 0.2 | GO:0045636 | positive regulation of melanocyte differentiation(GO:0045636) |
| 0.0 | 0.3 | GO:2000535 | regulation of entry of bacterium into host cell(GO:2000535) |
| 0.0 | 0.2 | GO:0060055 | angiogenesis involved in wound healing(GO:0060055) |
| 0.0 | 0.1 | GO:0042255 | ribosome assembly(GO:0042255) |
| 0.0 | 0.0 | GO:0045075 | interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
| 0.0 | 0.0 | GO:0021626 | hindbrain maturation(GO:0021578) central nervous system maturation(GO:0021626) |
| 0.0 | 0.1 | GO:0086097 | regulation of cholesterol esterification(GO:0010872) positive regulation of cholesterol esterification(GO:0010873) phospholipase C-activating angiotensin-activated signaling pathway(GO:0086097) |
| 0.0 | 0.2 | GO:0071569 | protein ufmylation(GO:0071569) protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
| 0.0 | 0.1 | GO:0014012 | peripheral nervous system axon regeneration(GO:0014012) |
| 0.0 | 0.1 | GO:0043486 | histone exchange(GO:0043486) |
| 0.0 | 0.4 | GO:0030252 | growth hormone secretion(GO:0030252) |
| 0.0 | 0.0 | GO:0090158 | endoplasmic reticulum membrane organization(GO:0090158) |
| 0.0 | 0.2 | GO:0090005 | negative regulation of establishment of protein localization to plasma membrane(GO:0090005) |
| 0.0 | 0.2 | GO:0043171 | peptide catabolic process(GO:0043171) |
| 0.0 | 2.7 | GO:0006027 | glycosaminoglycan catabolic process(GO:0006027) |
| 0.0 | 0.0 | GO:1900037 | regulation of cellular response to hypoxia(GO:1900037) |
| 0.0 | 0.1 | GO:0045226 | extracellular polysaccharide biosynthetic process(GO:0045226) extracellular polysaccharide metabolic process(GO:0046379) |
| 0.0 | 0.5 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
| 0.0 | 0.0 | GO:0048570 | notochord morphogenesis(GO:0048570) |
| 0.0 | 0.1 | GO:0031125 | rRNA 3'-end processing(GO:0031125) |
| 0.0 | 0.2 | GO:0070995 | NADPH oxidation(GO:0070995) |
| 0.0 | 0.1 | GO:1904562 | phosphatidylinositol 5-phosphate metabolic process(GO:1904562) |
| 0.0 | 0.3 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
| 0.0 | 0.1 | GO:0042489 | negative regulation of odontogenesis of dentin-containing tooth(GO:0042489) |
| 0.0 | 0.0 | GO:0034067 | protein localization to Golgi apparatus(GO:0034067) |
| 0.0 | 0.3 | GO:0090140 | regulation of mitochondrial fission(GO:0090140) |
| 0.0 | 0.1 | GO:2000234 | positive regulation of ribosome biogenesis(GO:0090070) positive regulation of rRNA processing(GO:2000234) |
| 0.0 | 0.3 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
| 0.0 | 1.4 | GO:0043280 | positive regulation of cysteine-type endopeptidase activity involved in apoptotic process(GO:0043280) |
| 0.0 | 0.2 | GO:0008616 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
| 0.0 | 0.2 | GO:1901033 | positive regulation of response to reactive oxygen species(GO:1901033) positive regulation of hydrogen peroxide-mediated programmed cell death(GO:1901300) |
| 0.0 | 0.2 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
| 0.0 | 0.1 | GO:0008063 | Toll signaling pathway(GO:0008063) |
| 0.0 | 0.1 | GO:1903146 | regulation of mitophagy(GO:1903146) |
| 0.0 | 0.1 | GO:0036344 | platelet formation(GO:0030220) platelet morphogenesis(GO:0036344) |
| 0.0 | 0.6 | GO:0071539 | protein localization to centrosome(GO:0071539) |
| 0.0 | 1.4 | GO:0030042 | actin filament depolymerization(GO:0030042) |
| 0.0 | 0.0 | GO:0030174 | regulation of DNA-dependent DNA replication initiation(GO:0030174) |
| 0.0 | 0.1 | GO:0015732 | prostaglandin transport(GO:0015732) |
| 0.0 | 0.2 | GO:0015888 | thiamine transport(GO:0015888) |
| 0.0 | 0.1 | GO:0021979 | hypothalamus cell differentiation(GO:0021979) |
| 0.0 | 0.1 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
| 0.0 | 0.2 | GO:0042374 | phylloquinone metabolic process(GO:0042374) phylloquinone catabolic process(GO:0042376) quinone catabolic process(GO:1901662) |
| 0.0 | 0.1 | GO:0021965 | spinal cord ventral commissure morphogenesis(GO:0021965) |
| 0.0 | 0.2 | GO:0035518 | histone H2A monoubiquitination(GO:0035518) |
| 0.0 | 1.3 | GO:0051646 | mitochondrion localization(GO:0051646) |
| 0.0 | 0.4 | GO:1902236 | negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902236) |
| 0.0 | 0.3 | GO:0048266 | behavioral response to pain(GO:0048266) |
| 0.0 | 0.9 | GO:0033146 | regulation of intracellular estrogen receptor signaling pathway(GO:0033146) |
| 0.0 | 0.7 | GO:0009435 | NAD biosynthetic process(GO:0009435) |
| 0.0 | 0.2 | GO:0035999 | tetrahydrofolate interconversion(GO:0035999) |
| 0.0 | 0.2 | GO:0090625 | mRNA cleavage involved in gene silencing by siRNA(GO:0090625) |
| 0.0 | 0.1 | GO:0070172 | positive regulation of tooth mineralization(GO:0070172) |
| 0.0 | 0.2 | GO:0048854 | brain morphogenesis(GO:0048854) |
| 0.0 | 0.1 | GO:0014856 | skeletal muscle satellite cell proliferation(GO:0014841) skeletal muscle cell proliferation(GO:0014856) |
| 0.0 | 0.1 | GO:0042756 | drinking behavior(GO:0042756) |
| 0.0 | 0.3 | GO:0046626 | regulation of insulin receptor signaling pathway(GO:0046626) |
| 0.0 | 0.1 | GO:0060823 | canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060823) |
| 0.0 | 0.3 | GO:0010644 | cell communication by electrical coupling(GO:0010644) |
| 0.0 | 0.8 | GO:0006368 | transcription elongation from RNA polymerase II promoter(GO:0006368) |
| 0.0 | 0.1 | GO:0007000 | nucleolus organization(GO:0007000) |
| 0.0 | 0.6 | GO:0009303 | rRNA transcription(GO:0009303) |
| 0.0 | 2.0 | GO:0006901 | vesicle coating(GO:0006901) vesicle targeting, rough ER to cis-Golgi(GO:0048207) COPII vesicle coating(GO:0048208) |
| 0.0 | 0.2 | GO:0038169 | somatostatin receptor signaling pathway(GO:0038169) somatostatin signaling pathway(GO:0038170) |
| 0.0 | 0.2 | GO:0032057 | negative regulation of translational initiation in response to stress(GO:0032057) |
| 0.0 | 0.1 | GO:0030282 | bone mineralization(GO:0030282) |
| 0.0 | 0.1 | GO:1903676 | regulation of cap-dependent translational initiation(GO:1903674) positive regulation of cap-dependent translational initiation(GO:1903676) |
| 0.0 | 0.0 | GO:0019673 | GDP-mannose metabolic process(GO:0019673) 'de novo' GDP-L-fucose biosynthetic process(GO:0042351) |
| 0.0 | 0.5 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
| 0.0 | 0.1 | GO:0097106 | postsynaptic density organization(GO:0097106) |
| 0.0 | 0.0 | GO:0043144 | snoRNA processing(GO:0043144) |
| 0.0 | 0.1 | GO:0006851 | mitochondrial calcium ion transport(GO:0006851) |
| 0.0 | 0.2 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
| 0.0 | 0.1 | GO:0007599 | hemostasis(GO:0007599) |
| 0.0 | 0.1 | GO:0042770 | signal transduction in response to DNA damage(GO:0042770) |
| 0.0 | 1.3 | GO:0048013 | ephrin receptor signaling pathway(GO:0048013) |
| 0.0 | 0.1 | GO:2000609 | regulation of thyroid hormone generation(GO:2000609) |
| 0.0 | 0.2 | GO:0006654 | phosphatidic acid biosynthetic process(GO:0006654) |
| 0.0 | 0.3 | GO:0031639 | plasminogen activation(GO:0031639) |
| 0.0 | 0.0 | GO:0019254 | carnitine metabolic process, CoA-linked(GO:0019254) |
| 0.0 | 0.1 | GO:1904529 | regulation of actin filament binding(GO:1904529) regulation of actin binding(GO:1904616) |
| 0.0 | 0.2 | GO:0016127 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
| 0.0 | 0.1 | GO:1904885 | beta-catenin destruction complex assembly(GO:1904885) |
| 0.0 | 0.1 | GO:0006710 | androgen catabolic process(GO:0006710) |
| 0.0 | 0.3 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
| 0.0 | 0.1 | GO:0033344 | cholesterol efflux(GO:0033344) |
| 0.0 | 0.5 | GO:0071470 | cellular response to osmotic stress(GO:0071470) |
| 0.0 | 0.4 | GO:0043631 | mRNA polyadenylation(GO:0006378) RNA polyadenylation(GO:0043631) |
| 0.0 | 0.9 | GO:0070192 | chromosome organization involved in meiotic cell cycle(GO:0070192) |
| 0.0 | 0.2 | GO:0001824 | blastocyst development(GO:0001824) |
| 0.0 | 0.5 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
| 0.0 | 0.2 | GO:1904222 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
| 0.0 | 0.3 | GO:1990035 | calcium ion import across plasma membrane(GO:0098703) calcium ion import into cell(GO:1990035) |
| 0.0 | 0.3 | GO:0002021 | response to dietary excess(GO:0002021) |
| 0.0 | 0.1 | GO:0015791 | polyol transport(GO:0015791) |
| 0.0 | 0.3 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
| 0.0 | 1.3 | GO:0030490 | maturation of SSU-rRNA(GO:0030490) |
| 0.0 | 0.4 | GO:0097340 | inhibition of cysteine-type endopeptidase activity(GO:0097340) zymogen inhibition(GO:0097341) |
| 0.0 | 0.2 | GO:2000172 | regulation of branching morphogenesis of a nerve(GO:2000172) |
| 0.0 | 0.0 | GO:0035524 | proline transmembrane transport(GO:0035524) |
| 0.0 | 0.2 | GO:0048820 | hair follicle maturation(GO:0048820) |
| 0.0 | 0.1 | GO:0035933 | glucocorticoid secretion(GO:0035933) regulation of glucocorticoid secretion(GO:2000849) |
| 0.0 | 2.0 | GO:0006998 | nuclear envelope organization(GO:0006998) |
| 0.0 | 0.1 | GO:0045199 | maintenance of apical/basal cell polarity(GO:0035090) maintenance of epithelial cell apical/basal polarity(GO:0045199) |
| 0.0 | 0.1 | GO:0030422 | production of siRNA involved in RNA interference(GO:0030422) |
| 0.0 | 0.1 | GO:0010390 | histone monoubiquitination(GO:0010390) |
| 0.0 | 0.0 | GO:0021521 | ventral spinal cord interneuron specification(GO:0021521) cell fate specification involved in pattern specification(GO:0060573) |
| 0.0 | 0.1 | GO:0015827 | tryptophan transport(GO:0015827) |
| 0.0 | 0.1 | GO:0072530 | purine-containing compound transmembrane transport(GO:0072530) |
| 0.0 | 0.2 | GO:0035278 | miRNA mediated inhibition of translation(GO:0035278) negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
| 0.0 | 0.1 | GO:0071392 | cellular response to estradiol stimulus(GO:0071392) |
| 0.0 | 1.0 | GO:0050832 | defense response to fungus(GO:0050832) |
| 0.0 | 0.0 | GO:1903056 | regulation of melanosome organization(GO:1903056) |
| 0.0 | 0.1 | GO:1900383 | regulation of synaptic plasticity by receptor localization to synapse(GO:1900383) |
| 0.0 | 0.3 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
| 0.0 | 0.2 | GO:0071526 | semaphorin-plexin signaling pathway(GO:0071526) |
| 0.0 | 0.1 | GO:0019064 | fusion of virus membrane with host plasma membrane(GO:0019064) membrane fusion involved in viral entry into host cell(GO:0039663) multi-organism membrane fusion(GO:0044800) |
| 0.0 | 0.2 | GO:0019236 | response to pheromone(GO:0019236) |
| 0.0 | 0.2 | GO:0090342 | regulation of cell aging(GO:0090342) |
| 0.0 | 0.1 | GO:0000350 | generation of catalytic spliceosome for second transesterification step(GO:0000350) |
| 0.0 | 0.1 | GO:0038007 | netrin-activated signaling pathway(GO:0038007) |
| 0.0 | 0.1 | GO:0010643 | cell communication by chemical coupling(GO:0010643) |
| 0.0 | 0.1 | GO:0035616 | histone H2B conserved C-terminal lysine deubiquitination(GO:0035616) |
| 0.0 | 0.3 | GO:0090200 | positive regulation of release of cytochrome c from mitochondria(GO:0090200) |
| 0.0 | 1.9 | GO:0070098 | chemokine-mediated signaling pathway(GO:0070098) |
| 0.0 | 0.1 | GO:0090400 | stress-induced premature senescence(GO:0090400) |
| 0.0 | 1.4 | GO:0006400 | tRNA modification(GO:0006400) |
| 0.0 | 0.1 | GO:0006579 | amino-acid betaine catabolic process(GO:0006579) |
| 0.0 | 0.6 | GO:0043001 | Golgi to plasma membrane protein transport(GO:0043001) |
| 0.0 | 0.1 | GO:0060478 | acrosomal vesicle exocytosis(GO:0060478) |
| 0.0 | 0.1 | GO:0032800 | receptor biosynthetic process(GO:0032800) |
| 0.0 | 0.1 | GO:0040016 | embryonic cleavage(GO:0040016) |
| 0.0 | 2.2 | GO:0006888 | ER to Golgi vesicle-mediated transport(GO:0006888) |
| 0.0 | 0.1 | GO:0032108 | negative regulation of response to extracellular stimulus(GO:0032105) negative regulation of response to nutrient levels(GO:0032108) |
| 0.0 | 0.9 | GO:0016056 | rhodopsin mediated signaling pathway(GO:0016056) |
| 0.0 | 0.2 | GO:0007189 | adenylate cyclase-activating G-protein coupled receptor signaling pathway(GO:0007189) |
| 0.0 | 0.5 | GO:0006751 | glutathione catabolic process(GO:0006751) |
| 0.0 | 0.2 | GO:0002227 | innate immune response in mucosa(GO:0002227) |
| 0.0 | 0.2 | GO:0000414 | regulation of histone H3-K36 methylation(GO:0000414) |
| 0.0 | 0.1 | GO:1901374 | acetate ester transport(GO:1901374) |
| 0.0 | 0.1 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
| 0.0 | 0.1 | GO:0060767 | epithelial cell proliferation involved in prostate gland development(GO:0060767) |
| 0.0 | 0.1 | GO:1901863 | positive regulation of striated muscle tissue development(GO:0045844) positive regulation of muscle organ development(GO:0048636) positive regulation of muscle tissue development(GO:1901863) |
| 0.0 | 0.2 | GO:0014029 | neural crest formation(GO:0014029) |
| 0.0 | 2.6 | GO:0002576 | platelet degranulation(GO:0002576) |
| 0.0 | 0.1 | GO:2000348 | regulation of CD40 signaling pathway(GO:2000348) |
| 0.0 | 0.1 | GO:1901386 | negative regulation of voltage-gated calcium channel activity(GO:1901386) |
| 0.0 | 0.3 | GO:2000401 | regulation of lymphocyte migration(GO:2000401) |
| 0.0 | 0.1 | GO:0009957 | epidermal cell fate specification(GO:0009957) |
| 0.0 | 3.8 | GO:0033209 | tumor necrosis factor-mediated signaling pathway(GO:0033209) |
| 0.0 | 0.1 | GO:0050703 | interleukin-1 alpha production(GO:0032610) interleukin-1 alpha secretion(GO:0050703) |
| 0.0 | 0.2 | GO:0042391 | regulation of membrane potential(GO:0042391) |
| 0.0 | 0.2 | GO:0072733 | response to staurosporine(GO:0072733) cellular response to staurosporine(GO:0072734) |
| 0.0 | 0.1 | GO:0098902 | regulation of membrane depolarization during action potential(GO:0098902) |
| 0.0 | 0.2 | GO:0060056 | mammary gland involution(GO:0060056) |
| 0.0 | 0.7 | GO:0072337 | modified amino acid transport(GO:0072337) |
| 0.0 | 0.1 | GO:2000001 | regulation of DNA damage checkpoint(GO:2000001) |
| 0.0 | 0.1 | GO:0010310 | regulation of hydrogen peroxide metabolic process(GO:0010310) |
| 0.0 | 0.2 | GO:0006578 | amino-acid betaine biosynthetic process(GO:0006578) |
| 0.0 | 0.0 | GO:0045324 | endosome transport via multivesicular body sorting pathway(GO:0032509) late endosome to vacuole transport(GO:0045324) |
| 0.0 | 0.0 | GO:0002643 | regulation of tolerance induction(GO:0002643) |
| 0.0 | 0.1 | GO:0038166 | angiotensin-activated signaling pathway(GO:0038166) |
| 0.0 | 0.0 | GO:0071681 | response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
| 0.0 | 0.1 | GO:0046498 | S-adenosylhomocysteine metabolic process(GO:0046498) |
| 0.0 | 0.1 | GO:0050684 | regulation of mRNA processing(GO:0050684) |
| 0.0 | 0.0 | GO:0033484 | nitric oxide homeostasis(GO:0033484) |
| 0.0 | 0.1 | GO:0048265 | response to pain(GO:0048265) |
| 0.0 | 0.0 | GO:0002042 | cell migration involved in sprouting angiogenesis(GO:0002042) |
| 0.0 | 0.1 | GO:0032196 | transposition(GO:0032196) |
| 0.0 | 0.0 | GO:2000301 | negative regulation of synaptic vesicle exocytosis(GO:2000301) |
| 0.0 | 0.1 | GO:0021631 | optic nerve morphogenesis(GO:0021631) optic nerve structural organization(GO:0021633) |
| 0.0 | 0.0 | GO:2001170 | negative regulation of ATP biosynthetic process(GO:2001170) |
| 0.0 | 0.9 | GO:1902402 | signal transduction involved in mitotic cell cycle checkpoint(GO:0072413) signal transduction involved in mitotic DNA damage checkpoint(GO:1902402) signal transduction involved in mitotic DNA integrity checkpoint(GO:1902403) |
| 0.0 | 0.1 | GO:0060324 | face development(GO:0060324) |
| 0.0 | 0.1 | GO:0007197 | adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway(GO:0007197) |
| 0.0 | 0.0 | GO:0071286 | cellular response to magnesium ion(GO:0071286) |
| 0.0 | 0.0 | GO:0046015 | regulation of transcription by glucose(GO:0046015) |
| 0.0 | 0.2 | GO:0050859 | negative regulation of B cell receptor signaling pathway(GO:0050859) |
| 0.0 | 0.0 | GO:0045915 | positive regulation of catecholamine metabolic process(GO:0045915) positive regulation of dopamine metabolic process(GO:0045964) |
| 0.0 | 0.1 | GO:0016561 | protein import into peroxisome matrix, translocation(GO:0016561) |
| 0.0 | 0.2 | GO:0010470 | regulation of gastrulation(GO:0010470) |
| 0.0 | 0.2 | GO:0033619 | membrane protein proteolysis(GO:0033619) |
| 0.0 | 0.2 | GO:1900116 | extracellular regulation of signal transduction(GO:1900115) extracellular negative regulation of signal transduction(GO:1900116) |
| 0.0 | 0.0 | GO:0001881 | receptor recycling(GO:0001881) |
| 0.0 | 2.1 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
| 0.0 | 0.1 | GO:0072663 | protein targeting to peroxisome(GO:0006625) peroxisomal transport(GO:0043574) protein localization to peroxisome(GO:0072662) establishment of protein localization to peroxisome(GO:0072663) |
| 0.0 | 0.5 | GO:0030199 | collagen fibril organization(GO:0030199) |
| 0.0 | 0.1 | GO:0014831 | intestine smooth muscle contraction(GO:0014827) gastro-intestinal system smooth muscle contraction(GO:0014831) |
| 0.0 | 0.1 | GO:0016926 | protein desumoylation(GO:0016926) |
| 0.0 | 0.1 | GO:2000484 | positive regulation of interleukin-8 secretion(GO:2000484) |
| 0.0 | 0.1 | GO:0043313 | regulation of neutrophil degranulation(GO:0043313) |
| 0.0 | 0.1 | GO:0006500 | N-terminal protein palmitoylation(GO:0006500) |
| 0.0 | 0.1 | GO:0050884 | neuromuscular process controlling posture(GO:0050884) |
| 0.0 | 0.3 | GO:0007052 | mitotic spindle organization(GO:0007052) |
| 0.0 | 0.0 | GO:0034329 | cell junction assembly(GO:0034329) |
| 0.0 | 0.0 | GO:1903580 | positive regulation of nucleoside metabolic process(GO:0045979) positive regulation of ATP metabolic process(GO:1903580) |
| 0.0 | 0.1 | GO:0030261 | chromosome condensation(GO:0030261) |
| 0.0 | 0.1 | GO:0097327 | response to antineoplastic agent(GO:0097327) |
| 0.0 | 0.2 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
| 0.0 | 0.1 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
| 0.0 | 0.1 | GO:0048875 | chemical homeostasis within a tissue(GO:0048875) |
| 0.0 | 0.4 | GO:0006469 | negative regulation of protein kinase activity(GO:0006469) |
| 0.0 | 0.0 | GO:0032096 | negative regulation of response to food(GO:0032096) negative regulation of appetite(GO:0032099) |
| 0.0 | 0.5 | GO:0046580 | negative regulation of Ras protein signal transduction(GO:0046580) negative regulation of small GTPase mediated signal transduction(GO:0051058) |
| 0.0 | 0.0 | GO:0045578 | negative regulation of B cell differentiation(GO:0045578) |
| 0.0 | 0.0 | GO:0090037 | positive regulation of protein kinase C signaling(GO:0090037) |
| 0.0 | 8.4 | GO:0007264 | small GTPase mediated signal transduction(GO:0007264) |
| 0.0 | 0.1 | GO:0015886 | heme transport(GO:0015886) |
| 0.0 | 0.1 | GO:0006433 | prolyl-tRNA aminoacylation(GO:0006433) |
| 0.0 | 0.2 | GO:1901642 | nucleoside transmembrane transport(GO:1901642) |
| 0.0 | 0.0 | GO:0030213 | hyaluronan biosynthetic process(GO:0030213) |
| 0.0 | 0.1 | GO:0071711 | basement membrane organization(GO:0071711) |
| 0.0 | 0.1 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) sphingolipid mediated signaling pathway(GO:0090520) |
| 0.0 | 0.1 | GO:1900246 | positive regulation of RIG-I signaling pathway(GO:1900246) |
| 0.0 | 0.9 | GO:0000380 | alternative mRNA splicing, via spliceosome(GO:0000380) |
| 0.0 | 0.1 | GO:0060038 | striated muscle cell proliferation(GO:0014855) cardiac muscle tissue growth(GO:0055017) cardiac muscle cell proliferation(GO:0060038) |
| 0.0 | 0.1 | GO:0075044 | autophagy of host cells involved in interaction with symbiont(GO:0075044) autophagy involved in symbiotic interaction(GO:0075071) |
| 0.0 | 0.1 | GO:0030451 | regulation of complement activation, alternative pathway(GO:0030451) negative regulation of complement activation, alternative pathway(GO:0045957) |
| 0.0 | 0.1 | GO:0008286 | insulin receptor signaling pathway(GO:0008286) |
| 0.0 | 0.1 | GO:0021542 | dentate gyrus development(GO:0021542) |
| 0.0 | 0.1 | GO:2000659 | regulation of interleukin-1-mediated signaling pathway(GO:2000659) |
| 0.0 | 0.0 | GO:0090303 | positive regulation of wound healing(GO:0090303) |
| 0.0 | 0.2 | GO:0002430 | complement receptor mediated signaling pathway(GO:0002430) |
| 0.0 | 0.1 | GO:0090231 | regulation of spindle checkpoint(GO:0090231) |
| 0.0 | 0.1 | GO:0033145 | positive regulation of intracellular steroid hormone receptor signaling pathway(GO:0033145) |
| 0.0 | 0.0 | GO:0008334 | histone mRNA metabolic process(GO:0008334) |
| 0.0 | 0.1 | GO:0030259 | lipid glycosylation(GO:0030259) |
| 0.0 | 0.3 | GO:0050771 | negative regulation of axonogenesis(GO:0050771) |
| 0.0 | 0.1 | GO:0039702 | viral budding via host ESCRT complex(GO:0039702) |
| 0.0 | 0.0 | GO:0002316 | follicular B cell differentiation(GO:0002316) |
| 0.0 | 0.0 | GO:0042559 | tetrahydrobiopterin biosynthetic process(GO:0006729) pteridine-containing compound biosynthetic process(GO:0042559) tetrahydrobiopterin metabolic process(GO:0046146) |
| 0.0 | 0.1 | GO:0045104 | intermediate filament cytoskeleton organization(GO:0045104) |
| 0.0 | 0.2 | GO:0071276 | cellular response to cadmium ion(GO:0071276) |
| 0.0 | 0.1 | GO:0035588 | adenosine receptor signaling pathway(GO:0001973) G-protein coupled purinergic receptor signaling pathway(GO:0035588) |
| 0.0 | 0.0 | GO:0032094 | response to food(GO:0032094) |
| 0.0 | 0.1 | GO:0003301 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
| 0.0 | 1.5 | GO:0006413 | translational initiation(GO:0006413) |
| 0.0 | 0.1 | GO:0000060 | protein import into nucleus, translocation(GO:0000060) |
| 0.0 | 0.0 | GO:0021539 | subthalamus development(GO:0021539) |
| 0.0 | 0.1 | GO:0098751 | bone cell development(GO:0098751) |
| 0.0 | 0.0 | GO:0090669 | telomerase RNA stabilization(GO:0090669) |
| 0.0 | 0.1 | GO:0045086 | positive regulation of interleukin-2 biosynthetic process(GO:0045086) |
| 0.0 | 0.2 | GO:0006312 | mitotic recombination(GO:0006312) |
| 0.0 | 0.1 | GO:0006541 | glutamine metabolic process(GO:0006541) |
| 0.0 | 0.0 | GO:0071492 | cellular response to UV-A(GO:0071492) |
| 0.0 | 0.1 | GO:0016598 | protein arginylation(GO:0016598) |
| 0.0 | 0.3 | GO:0042744 | hydrogen peroxide catabolic process(GO:0042744) |
| 0.0 | 0.5 | GO:2001244 | positive regulation of intrinsic apoptotic signaling pathway(GO:2001244) |
| 0.0 | 0.1 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
| 0.0 | 0.0 | GO:0060026 | convergent extension(GO:0060026) |
| 0.0 | 0.0 | GO:0048262 | determination of dorsal/ventral asymmetry(GO:0048262) |
| 0.0 | 0.0 | GO:0070365 | hepatocyte differentiation(GO:0070365) |
| 0.0 | 0.0 | GO:1902956 | regulation of mitochondrial electron transport, NADH to ubiquinone(GO:1902956) negative regulation of mitochondrial electron transport, NADH to ubiquinone(GO:1902957) |
| 0.0 | 0.1 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
| 0.0 | 0.1 | GO:0021930 | cell proliferation in hindbrain(GO:0021534) cell proliferation in external granule layer(GO:0021924) cerebellar granule cell precursor proliferation(GO:0021930) |
| 0.0 | 0.0 | GO:0061298 | retina vasculature development in camera-type eye(GO:0061298) |
| 0.0 | 0.1 | GO:0061577 | calcium ion transmembrane transport via high voltage-gated calcium channel(GO:0061577) |
| 0.0 | 0.0 | GO:1900006 | positive regulation of dendrite development(GO:1900006) |
| 0.0 | 1.6 | GO:0042787 | protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0042787) |
| 0.0 | 0.6 | GO:0045071 | negative regulation of viral genome replication(GO:0045071) |
| 0.0 | 0.1 | GO:0001964 | startle response(GO:0001964) |
| 0.0 | 0.1 | GO:0006308 | DNA catabolic process(GO:0006308) |
| 0.0 | 0.1 | GO:0035095 | behavioral response to nicotine(GO:0035095) |
| 0.0 | 0.0 | GO:0023016 | signal transduction by trans-phosphorylation(GO:0023016) |
| 0.0 | 0.4 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
| 0.0 | 0.0 | GO:0050765 | negative regulation of phagocytosis(GO:0050765) |
| 0.0 | 0.0 | GO:0018027 | peptidyl-lysine dimethylation(GO:0018027) |
| 0.0 | 0.4 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
| 0.0 | 0.3 | GO:0002250 | adaptive immune response(GO:0002250) |
| 0.0 | 0.2 | GO:0006307 | DNA dealkylation involved in DNA repair(GO:0006307) |
| 0.0 | 0.2 | GO:0000245 | spliceosomal complex assembly(GO:0000245) |
| 0.0 | 0.2 | GO:1903830 | magnesium ion transmembrane transport(GO:1903830) |
| 0.0 | 0.1 | GO:0071578 | zinc II ion transmembrane import(GO:0071578) |
| 0.0 | 0.3 | GO:0006361 | transcription initiation from RNA polymerase I promoter(GO:0006361) |
| 0.0 | 0.0 | GO:0060638 | mesenchymal-epithelial cell signaling(GO:0060638) |
| 0.0 | 0.1 | GO:0051703 | social behavior(GO:0035176) intraspecies interaction between organisms(GO:0051703) |
| 0.0 | 0.1 | GO:0032354 | response to follicle-stimulating hormone(GO:0032354) |
| 0.0 | 0.4 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
| 0.0 | 0.1 | GO:0045022 | early endosome to late endosome transport(GO:0045022) |
| 0.0 | 0.0 | GO:0090503 | RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
| 0.0 | 0.0 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
| 0.0 | 0.1 | GO:0007512 | adult heart development(GO:0007512) |
| 0.0 | 0.0 | GO:0007253 | cytoplasmic sequestering of NF-kappaB(GO:0007253) |
| 0.0 | 0.1 | GO:0097120 | receptor localization to synapse(GO:0097120) |
| 0.0 | 0.0 | GO:0072156 | distal tubule morphogenesis(GO:0072156) |
| 0.0 | 0.2 | GO:0043567 | regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
| 0.0 | 0.2 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
| 0.0 | 0.0 | GO:0045838 | positive regulation of membrane potential(GO:0045838) |
| 0.0 | 0.0 | GO:0097359 | UDP-glucosylation(GO:0097359) |
Gene overrepresentation in cellular_component category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 1.5 | 6.0 | GO:0043259 | laminin-10 complex(GO:0043259) |
| 1.3 | 6.7 | GO:0032449 | CBM complex(GO:0032449) |
| 1.2 | 3.6 | GO:0031523 | Myb complex(GO:0031523) |
| 1.2 | 3.5 | GO:1990032 | parallel fiber(GO:1990032) |
| 1.1 | 5.4 | GO:0097149 | centralspindlin complex(GO:0097149) |
| 0.8 | 2.4 | GO:0016938 | kinesin I complex(GO:0016938) |
| 0.7 | 2.2 | GO:1990666 | PCSK9-LDLR complex(GO:1990666) |
| 0.7 | 2.1 | GO:0070762 | nuclear pore transmembrane ring(GO:0070762) |
| 0.7 | 4.7 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
| 0.7 | 2.7 | GO:0045160 | myosin I complex(GO:0045160) |
| 0.7 | 2.6 | GO:0071062 | alphav-beta3 integrin-vitronectin complex(GO:0071062) |
| 0.7 | 12.4 | GO:0005862 | muscle thin filament tropomyosin(GO:0005862) |
| 0.7 | 2.0 | GO:0034676 | integrin alpha6-beta4 complex(GO:0034676) |
| 0.6 | 1.9 | GO:0005900 | oncostatin-M receptor complex(GO:0005900) |
| 0.6 | 1.8 | GO:0005656 | nuclear pre-replicative complex(GO:0005656) pre-replicative complex(GO:0036387) |
| 0.6 | 1.8 | GO:0034667 | integrin alpha3-beta1 complex(GO:0034667) |
| 0.6 | 14.5 | GO:0043205 | microfibril(GO:0001527) fibril(GO:0043205) |
| 0.6 | 1.7 | GO:0097134 | cyclin E1-CDK2 complex(GO:0097134) |
| 0.6 | 1.7 | GO:0000939 | condensed chromosome inner kinetochore(GO:0000939) |
| 0.6 | 2.8 | GO:0020018 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
| 0.6 | 1.7 | GO:0005674 | transcription factor TFIIF complex(GO:0005674) |
| 0.5 | 1.1 | GO:0033186 | CAF-1 complex(GO:0033186) |
| 0.5 | 8.7 | GO:0008091 | spectrin(GO:0008091) |
| 0.5 | 2.5 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
| 0.5 | 2.0 | GO:1990796 | photoreceptor cell terminal bouton(GO:1990796) |
| 0.5 | 1.5 | GO:0070557 | PCNA-p21 complex(GO:0070557) |
| 0.5 | 1.9 | GO:0032437 | cuticular plate(GO:0032437) |
| 0.5 | 1.9 | GO:1990075 | periciliary membrane compartment(GO:1990075) |
| 0.5 | 2.4 | GO:0071797 | LUBAC complex(GO:0071797) |
| 0.5 | 1.4 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
| 0.5 | 2.3 | GO:0070876 | SOSS complex(GO:0070876) |
| 0.4 | 1.8 | GO:0033257 | Bcl3/NF-kappaB2 complex(GO:0033257) |
| 0.4 | 4.0 | GO:0098845 | postsynaptic endosome(GO:0098845) |
| 0.4 | 1.3 | GO:0032133 | chromosome passenger complex(GO:0032133) |
| 0.4 | 2.2 | GO:0061673 | mitotic spindle astral microtubule(GO:0061673) |
| 0.4 | 1.7 | GO:0031417 | NatC complex(GO:0031417) |
| 0.4 | 3.0 | GO:0097209 | epidermal lamellar body(GO:0097209) |
| 0.4 | 2.1 | GO:0042643 | actomyosin, actin portion(GO:0042643) |
| 0.4 | 3.0 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
| 0.4 | 5.8 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
| 0.4 | 0.4 | GO:0005899 | insulin receptor complex(GO:0005899) |
| 0.4 | 2.8 | GO:0043541 | UDP-N-acetylglucosamine transferase complex(GO:0043541) |
| 0.4 | 4.0 | GO:0000796 | condensin complex(GO:0000796) |
| 0.4 | 0.4 | GO:0034681 | integrin alpha11-beta1 complex(GO:0034681) |
| 0.4 | 1.1 | GO:0071065 | dense core granule membrane(GO:0032127) alpha9-beta1 integrin-vascular cell adhesion molecule-1 complex(GO:0071065) |
| 0.4 | 1.1 | GO:0044753 | amphisome(GO:0044753) |
| 0.4 | 8.7 | GO:0005922 | connexon complex(GO:0005922) |
| 0.4 | 4.3 | GO:0043203 | axon hillock(GO:0043203) |
| 0.4 | 2.8 | GO:0035976 | AP1 complex(GO:0035976) |
| 0.4 | 2.5 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
| 0.3 | 3.1 | GO:0005787 | signal peptidase complex(GO:0005787) |
| 0.3 | 5.5 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
| 0.3 | 1.4 | GO:0031436 | BRCA1-BARD1 complex(GO:0031436) |
| 0.3 | 4.4 | GO:0070938 | contractile ring(GO:0070938) |
| 0.3 | 1.4 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
| 0.3 | 1.0 | GO:0071821 | FANCM-MHF complex(GO:0071821) |
| 0.3 | 2.0 | GO:0070381 | endosome to plasma membrane transport vesicle(GO:0070381) |
| 0.3 | 1.0 | GO:0097447 | dendritic tree(GO:0097447) |
| 0.3 | 3.0 | GO:0030868 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
| 0.3 | 1.3 | GO:0000811 | GINS complex(GO:0000811) |
| 0.3 | 2.9 | GO:0031414 | N-terminal protein acetyltransferase complex(GO:0031414) |
| 0.3 | 1.6 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
| 0.3 | 0.9 | GO:0097059 | CNTFR-CLCF1 complex(GO:0097059) |
| 0.3 | 0.9 | GO:0030689 | Noc complex(GO:0030689) |
| 0.3 | 1.5 | GO:1990425 | ryanodine receptor complex(GO:1990425) |
| 0.3 | 9.9 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
| 0.3 | 3.8 | GO:0005577 | fibrinogen complex(GO:0005577) |
| 0.3 | 2.3 | GO:0070852 | cell body fiber(GO:0070852) |
| 0.3 | 0.9 | GO:0044609 | DBIRD complex(GO:0044609) |
| 0.3 | 0.3 | GO:0000110 | nucleotide-excision repair factor 1 complex(GO:0000110) |
| 0.3 | 2.3 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
| 0.3 | 2.8 | GO:0042587 | glycogen granule(GO:0042587) |
| 0.3 | 0.5 | GO:0005683 | U7 snRNP(GO:0005683) |
| 0.3 | 2.2 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
| 0.3 | 1.3 | GO:0009368 | endopeptidase Clp complex(GO:0009368) |
| 0.3 | 1.0 | GO:0097443 | sorting endosome(GO:0097443) |
| 0.3 | 2.1 | GO:0005587 | collagen type IV trimer(GO:0005587) |
| 0.3 | 0.3 | GO:0072563 | endothelial microparticle(GO:0072563) |
| 0.3 | 6.9 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
| 0.3 | 1.5 | GO:0036056 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
| 0.2 | 5.0 | GO:0030056 | hemidesmosome(GO:0030056) |
| 0.2 | 2.5 | GO:0008541 | proteasome regulatory particle, lid subcomplex(GO:0008541) |
| 0.2 | 1.2 | GO:1903349 | omegasome membrane(GO:1903349) |
| 0.2 | 2.0 | GO:0000120 | RNA polymerase I transcription factor complex(GO:0000120) |
| 0.2 | 1.0 | GO:0030934 | anchoring collagen complex(GO:0030934) |
| 0.2 | 0.5 | GO:0045202 | synapse(GO:0045202) |
| 0.2 | 3.4 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
| 0.2 | 0.7 | GO:0035859 | Seh1-associated complex(GO:0035859) |
| 0.2 | 2.9 | GO:0043219 | lateral loop(GO:0043219) |
| 0.2 | 5.7 | GO:0005614 | interstitial matrix(GO:0005614) |
| 0.2 | 0.9 | GO:0097442 | CA3 pyramidal cell dendrite(GO:0097442) |
| 0.2 | 1.2 | GO:0031905 | early endosome lumen(GO:0031905) |
| 0.2 | 0.9 | GO:0032280 | symmetric synapse(GO:0032280) |
| 0.2 | 0.2 | GO:0042721 | mitochondrial inner membrane protein insertion complex(GO:0042721) |
| 0.2 | 0.9 | GO:0071595 | Nem1-Spo7 phosphatase complex(GO:0071595) |
| 0.2 | 1.4 | GO:0030678 | mitochondrial ribonuclease P complex(GO:0030678) |
| 0.2 | 2.8 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
| 0.2 | 0.5 | GO:0071437 | invadopodium(GO:0071437) |
| 0.2 | 1.6 | GO:0042825 | TAP complex(GO:0042825) |
| 0.2 | 2.0 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
| 0.2 | 1.8 | GO:0000931 | gamma-tubulin large complex(GO:0000931) gamma-tubulin ring complex(GO:0008274) |
| 0.2 | 0.4 | GO:0097125 | cyclin B1-CDK1 complex(GO:0097125) |
| 0.2 | 8.2 | GO:0005865 | striated muscle thin filament(GO:0005865) |
| 0.2 | 0.7 | GO:0044614 | nuclear pore cytoplasmic filaments(GO:0044614) |
| 0.2 | 0.7 | GO:0019008 | molybdopterin synthase complex(GO:0019008) |
| 0.2 | 0.9 | GO:0000839 | Hrd1p ubiquitin ligase ERAD-L complex(GO:0000839) |
| 0.2 | 2.2 | GO:0008278 | cohesin complex(GO:0008278) |
| 0.2 | 2.7 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
| 0.2 | 0.6 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
| 0.2 | 1.2 | GO:0070022 | transforming growth factor beta receptor homodimeric complex(GO:0070022) |
| 0.2 | 2.9 | GO:0005921 | gap junction(GO:0005921) |
| 0.2 | 1.2 | GO:0012507 | ER to Golgi transport vesicle membrane(GO:0012507) |
| 0.2 | 0.6 | GO:0033185 | dolichol-phosphate-mannose synthase complex(GO:0033185) |
| 0.2 | 1.0 | GO:0098843 | postsynaptic endocytic zone(GO:0098843) |
| 0.2 | 1.0 | GO:0000502 | proteasome complex(GO:0000502) |
| 0.2 | 3.1 | GO:0042555 | MCM complex(GO:0042555) |
| 0.2 | 6.4 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
| 0.2 | 0.6 | GO:0000126 | transcription factor TFIIIB complex(GO:0000126) |
| 0.2 | 2.1 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
| 0.2 | 0.6 | GO:0036194 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
| 0.2 | 1.0 | GO:0016942 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) |
| 0.2 | 0.9 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
| 0.2 | 0.6 | GO:1990298 | mitotic checkpoint complex(GO:0033597) bub1-bub3 complex(GO:1990298) |
| 0.2 | 1.1 | GO:0045323 | interleukin-1 receptor complex(GO:0045323) |
| 0.2 | 6.2 | GO:0030057 | desmosome(GO:0030057) |
| 0.2 | 0.5 | GO:0002945 | cyclin K-CDK13 complex(GO:0002945) |
| 0.2 | 0.4 | GO:0031310 | integral component of vacuolar membrane(GO:0031166) intrinsic component of vacuolar membrane(GO:0031310) |
| 0.2 | 0.7 | GO:0070436 | Grb2-EGFR complex(GO:0070436) |
| 0.2 | 0.7 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
| 0.2 | 1.4 | GO:0000127 | transcription factor TFIIIC complex(GO:0000127) |
| 0.2 | 0.5 | GO:0033565 | ESCRT-0 complex(GO:0033565) |
| 0.2 | 0.5 | GO:0097489 | multivesicular body, internal vesicle lumen(GO:0097489) |
| 0.2 | 0.7 | GO:0071149 | TEAD-2-YAP complex(GO:0071149) |
| 0.2 | 2.6 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
| 0.2 | 0.3 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
| 0.2 | 1.9 | GO:0031519 | PcG protein complex(GO:0031519) |
| 0.2 | 0.9 | GO:0044352 | pinosome(GO:0044352) macropinosome(GO:0044354) |
| 0.2 | 0.7 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
| 0.2 | 1.5 | GO:0030897 | HOPS complex(GO:0030897) |
| 0.2 | 1.7 | GO:0000347 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
| 0.2 | 5.8 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
| 0.2 | 0.2 | GO:0042405 | nuclear inclusion body(GO:0042405) |
| 0.2 | 1.2 | GO:0031298 | replication fork protection complex(GO:0031298) |
| 0.2 | 0.3 | GO:0044393 | microspike(GO:0044393) |
| 0.2 | 0.3 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
| 0.2 | 1.3 | GO:0032059 | bleb(GO:0032059) |
| 0.2 | 0.8 | GO:0035370 | UBC13-UEV1A complex(GO:0035370) |
| 0.2 | 0.9 | GO:0010008 | endosome membrane(GO:0010008) endosomal part(GO:0044440) |
| 0.2 | 0.5 | GO:1990597 | AIP1-IRE1 complex(GO:1990597) |
| 0.2 | 2.8 | GO:0034709 | methylosome(GO:0034709) |
| 0.2 | 1.1 | GO:0070531 | BRCA1-A complex(GO:0070531) |
| 0.2 | 2.0 | GO:0005769 | early endosome(GO:0005769) |
| 0.2 | 0.5 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
| 0.2 | 1.8 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
| 0.2 | 1.8 | GO:0005915 | zonula adherens(GO:0005915) |
| 0.2 | 0.8 | GO:0001405 | presequence translocase-associated import motor(GO:0001405) |
| 0.1 | 3.0 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
| 0.1 | 0.4 | GO:0070435 | Shc-EGFR complex(GO:0070435) |
| 0.1 | 5.0 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
| 0.1 | 6.0 | GO:0031258 | lamellipodium membrane(GO:0031258) |
| 0.1 | 0.9 | GO:0005663 | DNA replication factor C complex(GO:0005663) |
| 0.1 | 0.7 | GO:0071144 | SMAD2-SMAD3 protein complex(GO:0071144) |
| 0.1 | 0.3 | GO:0097135 | cyclin E2-CDK2 complex(GO:0097135) |
| 0.1 | 16.1 | GO:0031093 | platelet alpha granule lumen(GO:0031093) |
| 0.1 | 2.9 | GO:0031597 | cytosolic proteasome complex(GO:0031597) |
| 0.1 | 4.5 | GO:1990752 | microtubule end(GO:1990752) |
| 0.1 | 1.7 | GO:0033093 | Weibel-Palade body(GO:0033093) |
| 0.1 | 14.8 | GO:0005905 | clathrin-coated pit(GO:0005905) |
| 0.1 | 2.1 | GO:0045180 | basal cortex(GO:0045180) |
| 0.1 | 0.4 | GO:0032807 | DNA ligase IV complex(GO:0032807) |
| 0.1 | 3.3 | GO:0097440 | apical dendrite(GO:0097440) |
| 0.1 | 0.6 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
| 0.1 | 0.7 | GO:0071438 | invadopodium membrane(GO:0071438) |
| 0.1 | 4.2 | GO:0005640 | nuclear outer membrane(GO:0005640) |
| 0.1 | 0.4 | GO:0042565 | RNA nuclear export complex(GO:0042565) |
| 0.1 | 0.4 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
| 0.1 | 0.5 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
| 0.1 | 0.3 | GO:0016589 | NURF complex(GO:0016589) |
| 0.1 | 0.4 | GO:0097181 | protein C inhibitor-TMPRSS7 complex(GO:0036024) protein C inhibitor-TMPRSS11E complex(GO:0036025) protein C inhibitor-PLAT complex(GO:0036026) protein C inhibitor-PLAU complex(GO:0036027) protein C inhibitor-thrombin complex(GO:0036028) protein C inhibitor-KLK3 complex(GO:0036029) protein C inhibitor-plasma kallikrein complex(GO:0036030) serine protease inhibitor complex(GO:0097180) protein C inhibitor-coagulation factor V complex(GO:0097181) protein C inhibitor-coagulation factor Xa complex(GO:0097182) protein C inhibitor-coagulation factor XI complex(GO:0097183) |
| 0.1 | 0.8 | GO:0097129 | cyclin D2-CDK4 complex(GO:0097129) |
| 0.1 | 1.2 | GO:0001891 | phagocytic cup(GO:0001891) |
| 0.1 | 1.4 | GO:0045252 | oxoglutarate dehydrogenase complex(GO:0045252) |
| 0.1 | 1.0 | GO:0016272 | prefoldin complex(GO:0016272) |
| 0.1 | 0.8 | GO:0090661 | box H/ACA scaRNP complex(GO:0072589) box H/ACA telomerase RNP complex(GO:0090661) |
| 0.1 | 0.6 | GO:0008275 | gamma-tubulin small complex(GO:0008275) |
| 0.1 | 1.4 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) |
| 0.1 | 8.9 | GO:0000315 | organellar large ribosomal subunit(GO:0000315) mitochondrial large ribosomal subunit(GO:0005762) |
| 0.1 | 1.7 | GO:0072686 | mitotic spindle(GO:0072686) |
| 0.1 | 0.2 | GO:0098575 | lumenal side of lysosomal membrane(GO:0098575) |
| 0.1 | 1.1 | GO:0005638 | lamin filament(GO:0005638) |
| 0.1 | 0.8 | GO:0019815 | B cell receptor complex(GO:0019815) |
| 0.1 | 1.4 | GO:0000800 | lateral element(GO:0000800) |
| 0.1 | 1.4 | GO:0016600 | flotillin complex(GO:0016600) |
| 0.1 | 1.4 | GO:0031616 | spindle pole centrosome(GO:0031616) |
| 0.1 | 0.4 | GO:1990635 | proximal dendrite(GO:1990635) |
| 0.1 | 2.0 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
| 0.1 | 2.1 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
| 0.1 | 0.5 | GO:0032144 | 4-aminobutyrate transaminase complex(GO:0032144) |
| 0.1 | 0.3 | GO:0005685 | U1 snRNP(GO:0005685) |
| 0.1 | 0.3 | GO:0033391 | chromatoid body(GO:0033391) |
| 0.1 | 0.8 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
| 0.1 | 0.5 | GO:0031085 | BLOC-3 complex(GO:0031085) |
| 0.1 | 0.1 | GO:0048475 | membrane coat(GO:0030117) coated membrane(GO:0048475) |
| 0.1 | 8.9 | GO:0030864 | cortical actin cytoskeleton(GO:0030864) |
| 0.1 | 0.6 | GO:0005770 | late endosome(GO:0005770) |
| 0.1 | 0.1 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
| 0.1 | 0.4 | GO:0097013 | phagocytic vesicle lumen(GO:0097013) |
| 0.1 | 2.3 | GO:0030127 | COPII vesicle coat(GO:0030127) |
| 0.1 | 0.4 | GO:0043293 | apoptosome(GO:0043293) |
| 0.1 | 0.4 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
| 0.1 | 1.1 | GO:0000243 | commitment complex(GO:0000243) |
| 0.1 | 9.8 | GO:0001725 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
| 0.1 | 0.6 | GO:0061700 | GATOR2 complex(GO:0061700) |
| 0.1 | 0.2 | GO:1990393 | 3M complex(GO:1990393) |
| 0.1 | 9.6 | GO:0005811 | lipid particle(GO:0005811) |
| 0.1 | 0.4 | GO:0031251 | PAN complex(GO:0031251) |
| 0.1 | 1.6 | GO:0000815 | ESCRT III complex(GO:0000815) |
| 0.1 | 0.3 | GO:0000178 | exosome (RNase complex)(GO:0000178) |
| 0.1 | 4.0 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
| 0.1 | 7.3 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
| 0.1 | 0.4 | GO:0005712 | chiasma(GO:0005712) |
| 0.1 | 3.9 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
| 0.1 | 0.5 | GO:0017102 | methionyl glutamyl tRNA synthetase complex(GO:0017102) |
| 0.1 | 1.5 | GO:0034518 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
| 0.1 | 1.2 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
| 0.1 | 3.2 | GO:0008287 | protein serine/threonine phosphatase complex(GO:0008287) phosphatase complex(GO:1903293) |
| 0.1 | 1.1 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
| 0.1 | 1.2 | GO:0032797 | SMN complex(GO:0032797) |
| 0.1 | 0.5 | GO:1990726 | Lsm1-7-Pat1 complex(GO:1990726) |
| 0.1 | 0.3 | GO:0042720 | mitochondrial inner membrane peptidase complex(GO:0042720) |
| 0.1 | 2.2 | GO:0031932 | TORC2 complex(GO:0031932) |
| 0.1 | 2.2 | GO:0030686 | 90S preribosome(GO:0030686) |
| 0.1 | 2.9 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
| 0.1 | 0.5 | GO:0030906 | retromer, cargo-selective complex(GO:0030906) |
| 0.1 | 3.0 | GO:0005763 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
| 0.1 | 2.6 | GO:0031941 | filamentous actin(GO:0031941) |
| 0.1 | 1.8 | GO:0031265 | CD95 death-inducing signaling complex(GO:0031265) |
| 0.1 | 0.5 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
| 0.1 | 0.7 | GO:0071986 | Ragulator complex(GO:0071986) |
| 0.1 | 1.9 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
| 0.1 | 1.2 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
| 0.1 | 0.4 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
| 0.1 | 4.8 | GO:0009295 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
| 0.1 | 1.0 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
| 0.1 | 0.2 | GO:0045177 | apical part of cell(GO:0045177) |
| 0.1 | 0.3 | GO:0098855 | HCN channel complex(GO:0098855) |
| 0.1 | 0.5 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
| 0.1 | 0.4 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
| 0.1 | 7.2 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
| 0.1 | 0.8 | GO:0061202 | clathrin-sculpted gamma-aminobutyric acid transport vesicle(GO:0061200) clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane(GO:0061202) |
| 0.1 | 49.0 | GO:0005925 | focal adhesion(GO:0005925) |
| 0.1 | 0.4 | GO:1990730 | VCP-NSFL1C complex(GO:1990730) |
| 0.1 | 0.4 | GO:0097422 | tubular endosome(GO:0097422) |
| 0.1 | 0.6 | GO:0005610 | laminin-5 complex(GO:0005610) |
| 0.1 | 0.4 | GO:0097342 | ripoptosome(GO:0097342) |
| 0.1 | 1.2 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
| 0.1 | 0.6 | GO:0035748 | myelin sheath abaxonal region(GO:0035748) |
| 0.1 | 0.3 | GO:0045240 | dihydrolipoyl dehydrogenase complex(GO:0045240) |
| 0.1 | 0.6 | GO:0051286 | cell tip(GO:0051286) |
| 0.1 | 2.2 | GO:0016581 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) |
| 0.1 | 0.5 | GO:0032433 | filopodium tip(GO:0032433) |
| 0.1 | 0.4 | GO:0032021 | NELF complex(GO:0032021) |
| 0.1 | 0.3 | GO:0036398 | TCR signalosome(GO:0036398) |
| 0.1 | 0.7 | GO:0030426 | growth cone(GO:0030426) |
| 0.1 | 1.7 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
| 0.1 | 1.0 | GO:0005642 | annulate lamellae(GO:0005642) |
| 0.1 | 8.3 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
| 0.1 | 0.7 | GO:0005883 | neurofilament(GO:0005883) |
| 0.1 | 0.1 | GO:0038039 | G-protein coupled receptor heterodimeric complex(GO:0038039) |
| 0.1 | 0.6 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
| 0.1 | 1.1 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
| 0.1 | 3.3 | GO:0005876 | spindle microtubule(GO:0005876) |
| 0.1 | 0.5 | GO:0036020 | endolysosome membrane(GO:0036020) |
| 0.1 | 0.3 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
| 0.1 | 0.2 | GO:1990031 | pinceau fiber(GO:1990031) |
| 0.1 | 0.9 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
| 0.1 | 1.3 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
| 0.1 | 0.6 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
| 0.1 | 0.6 | GO:0030669 | clathrin-coated endocytic vesicle membrane(GO:0030669) |
| 0.1 | 0.4 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
| 0.1 | 0.7 | GO:0044194 | cytolytic granule(GO:0044194) |
| 0.1 | 1.3 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
| 0.1 | 1.7 | GO:0001741 | XY body(GO:0001741) |
| 0.1 | 1.1 | GO:0098647 | collagen type VI trimer(GO:0005589) collagen beaded filament(GO:0098647) |
| 0.1 | 0.2 | GO:0055087 | Ski complex(GO:0055087) |
| 0.1 | 0.3 | GO:0019031 | viral envelope(GO:0019031) viral membrane(GO:0036338) |
| 0.1 | 0.4 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
| 0.1 | 0.7 | GO:1990909 | Wnt signalosome(GO:1990909) |
| 0.1 | 7.2 | GO:0031901 | early endosome membrane(GO:0031901) |
| 0.1 | 10.6 | GO:0030027 | lamellipodium(GO:0030027) |
| 0.1 | 0.7 | GO:0000145 | exocyst(GO:0000145) |
| 0.1 | 0.2 | GO:0072517 | viral factory(GO:0039713) cytoplasmic viral factory(GO:0039714) host cell viral assembly compartment(GO:0072517) |
| 0.1 | 3.8 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
| 0.1 | 2.7 | GO:0001533 | cornified envelope(GO:0001533) |
| 0.1 | 1.7 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
| 0.1 | 0.6 | GO:0005869 | dynactin complex(GO:0005869) |
| 0.1 | 0.6 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
| 0.1 | 1.2 | GO:0005686 | U2 snRNP(GO:0005686) |
| 0.1 | 2.6 | GO:0008180 | COP9 signalosome(GO:0008180) |
| 0.1 | 0.4 | GO:0035061 | interchromatin granule(GO:0035061) |
| 0.1 | 7.6 | GO:0070821 | tertiary granule membrane(GO:0070821) |
| 0.1 | 0.3 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
| 0.1 | 2.4 | GO:0000421 | autophagosome membrane(GO:0000421) |
| 0.1 | 0.3 | GO:0042382 | paraspeckles(GO:0042382) |
| 0.1 | 0.4 | GO:0043198 | dendritic shaft(GO:0043198) |
| 0.1 | 0.5 | GO:0070847 | core mediator complex(GO:0070847) |
| 0.1 | 7.3 | GO:1904813 | ficolin-1-rich granule(GO:0101002) ficolin-1-rich granule lumen(GO:1904813) |
| 0.1 | 0.1 | GO:1990023 | mitotic spindle midzone(GO:1990023) |
| 0.1 | 0.2 | GO:0071148 | TEAD-1-YAP complex(GO:0071148) |
| 0.1 | 0.2 | GO:0070765 | gamma-secretase complex(GO:0070765) |
| 0.1 | 1.1 | GO:0030008 | TRAPP complex(GO:0030008) |
| 0.1 | 2.9 | GO:0005884 | actin filament(GO:0005884) |
| 0.1 | 3.3 | GO:0015934 | large ribosomal subunit(GO:0015934) |
| 0.1 | 0.3 | GO:0071817 | MMXD complex(GO:0071817) |
| 0.1 | 3.6 | GO:0031526 | brush border membrane(GO:0031526) |
| 0.1 | 0.1 | GO:0017119 | Golgi transport complex(GO:0017119) |
| 0.1 | 0.1 | GO:0045272 | plasma membrane respiratory chain complex I(GO:0045272) plasma membrane respiratory chain(GO:0070470) |
| 0.1 | 0.8 | GO:0097431 | mitotic spindle pole(GO:0097431) |
| 0.1 | 0.3 | GO:0001739 | sex chromatin(GO:0001739) |
| 0.1 | 0.6 | GO:0042629 | mast cell granule(GO:0042629) |
| 0.1 | 0.8 | GO:0042627 | chylomicron(GO:0042627) |
| 0.1 | 0.2 | GO:0005819 | spindle(GO:0005819) |
| 0.1 | 0.4 | GO:0005761 | organellar ribosome(GO:0000313) mitochondrial ribosome(GO:0005761) |
| 0.1 | 0.1 | GO:0002139 | stereocilia coupling link(GO:0002139) |
| 0.1 | 0.2 | GO:0033011 | perinuclear theca(GO:0033011) |
| 0.1 | 10.8 | GO:0044798 | nuclear transcription factor complex(GO:0044798) |
| 0.1 | 0.7 | GO:0002178 | palmitoyltransferase complex(GO:0002178) |
| 0.1 | 0.2 | GO:1990923 | PET complex(GO:1990923) |
| 0.1 | 4.0 | GO:1904724 | tertiary granule lumen(GO:1904724) |
| 0.1 | 0.1 | GO:0044094 | host cell nucleus(GO:0042025) host cell nuclear part(GO:0044094) |
| 0.1 | 0.2 | GO:0071020 | post-spliceosomal complex(GO:0071020) |
| 0.1 | 0.4 | GO:0043196 | varicosity(GO:0043196) |
| 0.1 | 2.2 | GO:0031201 | SNARE complex(GO:0031201) |
| 0.1 | 63.4 | GO:0005730 | nucleolus(GO:0005730) |
| 0.1 | 0.4 | GO:0097225 | sperm midpiece(GO:0097225) |
| 0.1 | 2.1 | GO:0030673 | axolemma(GO:0030673) |
| 0.1 | 2.3 | GO:0035578 | azurophil granule lumen(GO:0035578) |
| 0.1 | 0.2 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
| 0.1 | 0.1 | GO:0031379 | RNA-directed RNA polymerase complex(GO:0031379) |
| 0.1 | 0.5 | GO:0033202 | Ino80 complex(GO:0031011) DNA helicase complex(GO:0033202) |
| 0.1 | 6.8 | GO:0001726 | ruffle(GO:0001726) |
| 0.1 | 0.2 | GO:0032426 | stereocilium tip(GO:0032426) |
| 0.1 | 0.7 | GO:0032039 | integrator complex(GO:0032039) |
| 0.1 | 0.3 | GO:0000275 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) proton-transporting ATP synthase complex, catalytic core F(1)(GO:0045261) |
| 0.1 | 0.1 | GO:0031510 | SUMO activating enzyme complex(GO:0031510) |
| 0.1 | 4.9 | GO:0060170 | ciliary membrane(GO:0060170) |
| 0.1 | 0.2 | GO:0018444 | translation release factor complex(GO:0018444) |
| 0.1 | 2.3 | GO:0045211 | postsynaptic membrane(GO:0045211) |
| 0.1 | 0.1 | GO:0016342 | catenin complex(GO:0016342) |
| 0.1 | 3.3 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
| 0.1 | 3.1 | GO:0031907 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
| 0.1 | 0.2 | GO:0031313 | extrinsic component of endosome membrane(GO:0031313) |
| 0.1 | 1.0 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
| 0.1 | 0.3 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
| 0.1 | 0.4 | GO:0030904 | retromer complex(GO:0030904) |
| 0.1 | 0.1 | GO:0030120 | vesicle coat(GO:0030120) |
| 0.1 | 0.3 | GO:0098559 | cytoplasmic side of early endosome membrane(GO:0098559) |
| 0.1 | 2.2 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
| 0.1 | 0.6 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
| 0.0 | 0.2 | GO:0071203 | WASH complex(GO:0071203) |
| 0.0 | 0.1 | GO:0097449 | astrocyte projection(GO:0097449) |
| 0.0 | 1.0 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
| 0.0 | 0.2 | GO:1990246 | uniplex complex(GO:1990246) |
| 0.0 | 0.4 | GO:0005719 | nuclear euchromatin(GO:0005719) |
| 0.0 | 0.3 | GO:0032585 | multivesicular body membrane(GO:0032585) |
| 0.0 | 6.9 | GO:0030176 | integral component of endoplasmic reticulum membrane(GO:0030176) |
| 0.0 | 0.4 | GO:0030662 | coated vesicle membrane(GO:0030662) |
| 0.0 | 0.4 | GO:0030136 | clathrin-coated vesicle(GO:0030136) |
| 0.0 | 9.0 | GO:0019867 | outer membrane(GO:0019867) |
| 0.0 | 0.3 | GO:0071439 | clathrin complex(GO:0071439) |
| 0.0 | 0.1 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
| 0.0 | 0.3 | GO:0035032 | phosphatidylinositol 3-kinase complex, class III(GO:0035032) |
| 0.0 | 0.9 | GO:0030867 | rough endoplasmic reticulum membrane(GO:0030867) |
| 0.0 | 2.2 | GO:0005902 | microvillus(GO:0005902) |
| 0.0 | 0.4 | GO:0005903 | brush border(GO:0005903) |
| 0.0 | 0.2 | GO:0005594 | collagen type IX trimer(GO:0005594) |
| 0.0 | 0.4 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
| 0.0 | 1.7 | GO:0045178 | basal part of cell(GO:0045178) |
| 0.0 | 4.2 | GO:0030018 | Z disc(GO:0030018) |
| 0.0 | 0.1 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
| 0.0 | 0.3 | GO:0071546 | pi-body(GO:0071546) |
| 0.0 | 7.8 | GO:0098857 | membrane microdomain(GO:0098857) |
| 0.0 | 0.5 | GO:0031089 | platelet dense granule lumen(GO:0031089) |
| 0.0 | 0.2 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
| 0.0 | 0.2 | GO:0005600 | collagen type XIII trimer(GO:0005600) transmembrane collagen trimer(GO:0030936) |
| 0.0 | 0.8 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
| 0.0 | 0.2 | GO:0060077 | inhibitory synapse(GO:0060077) |
| 0.0 | 0.5 | GO:0005583 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
| 0.0 | 0.2 | GO:0036019 | endolysosome(GO:0036019) |
| 0.0 | 0.3 | GO:0030314 | junctional membrane complex(GO:0030314) |
| 0.0 | 0.1 | GO:0000308 | cytoplasmic cyclin-dependent protein kinase holoenzyme complex(GO:0000308) |
| 0.0 | 0.1 | GO:0070695 | FHF complex(GO:0070695) |
| 0.0 | 0.2 | GO:0000812 | Swr1 complex(GO:0000812) |
| 0.0 | 0.2 | GO:0098839 | postsynaptic density membrane(GO:0098839) |
| 0.0 | 0.6 | GO:0031083 | BLOC-1 complex(GO:0031083) |
| 0.0 | 0.3 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
| 0.0 | 0.7 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
| 0.0 | 1.0 | GO:0048770 | melanosome(GO:0042470) pigment granule(GO:0048770) |
| 0.0 | 0.1 | GO:0033263 | CORVET complex(GO:0033263) |
| 0.0 | 2.0 | GO:0030666 | endocytic vesicle membrane(GO:0030666) |
| 0.0 | 0.2 | GO:0009328 | phenylalanine-tRNA ligase complex(GO:0009328) |
| 0.0 | 1.5 | GO:0043657 | host(GO:0018995) host cell(GO:0043657) |
| 0.0 | 0.7 | GO:0000795 | synaptonemal complex(GO:0000795) |
| 0.0 | 0.3 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
| 0.0 | 0.3 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
| 0.0 | 1.2 | GO:0031902 | late endosome membrane(GO:0031902) |
| 0.0 | 1.8 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
| 0.0 | 0.3 | GO:0033018 | sarcoplasmic reticulum lumen(GO:0033018) |
| 0.0 | 0.2 | GO:0000221 | vacuolar proton-transporting V-type ATPase, V1 domain(GO:0000221) |
| 0.0 | 0.6 | GO:0016460 | myosin II complex(GO:0016460) |
| 0.0 | 1.9 | GO:0005604 | basement membrane(GO:0005604) |
| 0.0 | 0.1 | GO:0032173 | septin ring(GO:0005940) septin collar(GO:0032173) |
| 0.0 | 0.5 | GO:0071564 | npBAF complex(GO:0071564) |
| 0.0 | 0.1 | GO:0072558 | NLRP1 inflammasome complex(GO:0072558) |
| 0.0 | 0.1 | GO:0031314 | extrinsic component of mitochondrial inner membrane(GO:0031314) |
| 0.0 | 0.3 | GO:0031461 | cullin-RING ubiquitin ligase complex(GO:0031461) |
| 0.0 | 0.1 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
| 0.0 | 0.2 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
| 0.0 | 0.6 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
| 0.0 | 10.2 | GO:0005759 | mitochondrial matrix(GO:0005759) |
| 0.0 | 0.2 | GO:0030424 | axon(GO:0030424) |
| 0.0 | 0.2 | GO:0032584 | growth cone membrane(GO:0032584) |
| 0.0 | 1.5 | GO:0000779 | condensed chromosome, centromeric region(GO:0000779) |
| 0.0 | 1.9 | GO:0030658 | transport vesicle membrane(GO:0030658) |
| 0.0 | 2.0 | GO:0045095 | keratin filament(GO:0045095) |
| 0.0 | 0.2 | GO:0043194 | axon initial segment(GO:0043194) |
| 0.0 | 0.0 | GO:0000153 | cytoplasmic ubiquitin ligase complex(GO:0000153) |
| 0.0 | 0.2 | GO:0016461 | unconventional myosin complex(GO:0016461) |
| 0.0 | 0.2 | GO:0048786 | presynaptic active zone(GO:0048786) |
| 0.0 | 17.4 | GO:0009986 | cell surface(GO:0009986) |
| 0.0 | 0.1 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
| 0.0 | 1.1 | GO:0005840 | ribosome(GO:0005840) |
| 0.0 | 0.2 | GO:0044232 | organelle membrane contact site(GO:0044232) |
| 0.0 | 0.2 | GO:0097486 | multivesicular body lumen(GO:0097486) |
| 0.0 | 1.2 | GO:0000922 | spindle pole(GO:0000922) |
| 0.0 | 0.1 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
| 0.0 | 0.9 | GO:0005773 | vacuole(GO:0005773) |
| 0.0 | 1.2 | GO:0042734 | presynaptic membrane(GO:0042734) |
| 0.0 | 0.0 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
| 0.0 | 0.1 | GO:0030870 | Mre11 complex(GO:0030870) |
| 0.0 | 0.3 | GO:0070822 | Sin3-type complex(GO:0070822) |
| 0.0 | 0.1 | GO:1902560 | GMP reductase complex(GO:1902560) |
| 0.0 | 0.1 | GO:0060076 | excitatory synapse(GO:0060076) |
| 0.0 | 0.1 | GO:0097550 | transcriptional preinitiation complex(GO:0097550) |
| 0.0 | 0.2 | GO:0005791 | rough endoplasmic reticulum(GO:0005791) |
| 0.0 | 0.1 | GO:0046930 | pore complex(GO:0046930) |
| 0.0 | 0.1 | GO:0031430 | M band(GO:0031430) |
| 0.0 | 0.1 | GO:0030054 | cell junction(GO:0030054) |
| 0.0 | 0.3 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
| 0.0 | 0.3 | GO:0000785 | chromatin(GO:0000785) |
| 0.0 | 0.1 | GO:0032311 | angiogenin-PRI complex(GO:0032311) |
| 0.0 | 4.4 | GO:0016607 | nuclear speck(GO:0016607) |
| 0.0 | 2.9 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
| 0.0 | 0.2 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
| 0.0 | 0.1 | GO:0005750 | mitochondrial respiratory chain complex III(GO:0005750) respiratory chain complex III(GO:0045275) |
| 0.0 | 0.1 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
| 0.0 | 0.1 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
Gene overrepresentation in molecular_function category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 3.2 | 9.6 | GO:0050421 | cystathionine beta-synthase activity(GO:0004122) oxidoreductase activity, acting on other nitrogenous compounds as donors, cytochrome as acceptor(GO:0016662) nitrite reductase (NO-forming) activity(GO:0050421) carbon monoxide binding(GO:0070025) nitrite reductase activity(GO:0098809) |
| 1.5 | 5.8 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
| 1.4 | 6.9 | GO:0004850 | uridine phosphorylase activity(GO:0004850) |
| 1.2 | 7.1 | GO:0017050 | sphinganine kinase activity(GO:0008481) D-erythro-sphingosine kinase activity(GO:0017050) |
| 1.0 | 1.0 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
| 0.9 | 4.7 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
| 0.8 | 2.5 | GO:0047696 | beta-adrenergic receptor kinase activity(GO:0047696) |
| 0.8 | 2.5 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) |
| 0.8 | 4.8 | GO:0008269 | JAK pathway signal transduction adaptor activity(GO:0008269) |
| 0.8 | 3.1 | GO:0003938 | IMP dehydrogenase activity(GO:0003938) |
| 0.8 | 2.3 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
| 0.8 | 3.1 | GO:0050509 | N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase activity(GO:0050509) |
| 0.7 | 2.2 | GO:0072510 | ferric iron transmembrane transporter activity(GO:0015091) trivalent inorganic cation transmembrane transporter activity(GO:0072510) |
| 0.7 | 2.9 | GO:0016784 | 3-mercaptopyruvate sulfurtransferase activity(GO:0016784) |
| 0.7 | 5.0 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
| 0.7 | 2.8 | GO:0008431 | vitamin E binding(GO:0008431) |
| 0.7 | 7.0 | GO:0042731 | PH domain binding(GO:0042731) |
| 0.7 | 11.7 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
| 0.7 | 4.1 | GO:0045569 | TRAIL binding(GO:0045569) |
| 0.7 | 2.0 | GO:0008476 | protein-tyrosine sulfotransferase activity(GO:0008476) |
| 0.7 | 2.0 | GO:0033823 | procollagen-lysine 5-dioxygenase activity(GO:0008475) procollagen glucosyltransferase activity(GO:0033823) |
| 0.7 | 3.3 | GO:0070644 | vitamin D response element binding(GO:0070644) |
| 0.7 | 2.0 | GO:0015130 | mevalonate transmembrane transporter activity(GO:0015130) |
| 0.7 | 2.6 | GO:0004102 | choline O-acetyltransferase activity(GO:0004102) |
| 0.7 | 5.9 | GO:0086083 | cell adhesive protein binding involved in bundle of His cell-Purkinje myocyte communication(GO:0086083) |
| 0.6 | 3.9 | GO:0043515 | kinetochore binding(GO:0043515) |
| 0.6 | 6.4 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
| 0.6 | 2.5 | GO:0004461 | lactose synthase activity(GO:0004461) |
| 0.6 | 7.6 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
| 0.6 | 2.5 | GO:0052798 | beta-galactoside alpha-2,3-sialyltransferase activity(GO:0052798) |
| 0.6 | 1.9 | GO:0070052 | collagen V binding(GO:0070052) |
| 0.6 | 2.5 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
| 0.6 | 0.6 | GO:0008242 | omega peptidase activity(GO:0008242) |
| 0.6 | 3.1 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
| 0.6 | 5.4 | GO:0009922 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
| 0.6 | 1.8 | GO:0008413 | 8-oxo-7,8-dihydroguanosine triphosphate pyrophosphatase activity(GO:0008413) 8-oxo-7,8-dihydrodeoxyguanosine triphosphate pyrophosphatase activity(GO:0035539) |
| 0.6 | 3.0 | GO:0050436 | microfibril binding(GO:0050436) |
| 0.6 | 4.7 | GO:0004064 | arylesterase activity(GO:0004064) |
| 0.6 | 4.5 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
| 0.6 | 1.7 | GO:0016418 | S-acetyltransferase activity(GO:0016418) |
| 0.5 | 2.2 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
| 0.5 | 1.6 | GO:0050252 | retinol O-fatty-acyltransferase activity(GO:0050252) |
| 0.5 | 1.1 | GO:0070815 | peptidyl-lysine 5-dioxygenase activity(GO:0070815) |
| 0.5 | 5.9 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
| 0.5 | 1.6 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
| 0.5 | 2.6 | GO:0008934 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
| 0.5 | 2.5 | GO:0061731 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
| 0.5 | 3.1 | GO:0023030 | MHC class Ib protein complex binding(GO:0023025) MHC class Ib protein binding, via antigen binding groove(GO:0023030) |
| 0.5 | 1.5 | GO:0052895 | norspermine:oxygen oxidoreductase activity(GO:0052894) N1-acetylspermine:oxygen oxidoreductase (N1-acetylspermidine-forming) activity(GO:0052895) |
| 0.5 | 1.5 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
| 0.5 | 5.1 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
| 0.5 | 2.4 | GO:0045134 | uridine-diphosphatase activity(GO:0045134) |
| 0.5 | 2.4 | GO:0046899 | nucleoside triphosphate adenylate kinase activity(GO:0046899) |
| 0.5 | 1.4 | GO:0019981 | interleukin-6 receptor activity(GO:0004915) interleukin-6 binding(GO:0019981) |
| 0.5 | 1.9 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
| 0.5 | 1.4 | GO:0000992 | polymerase III regulatory region sequence-specific DNA binding(GO:0000992) RNA polymerase III type 1 promoter sequence-specific DNA binding(GO:0001002) RNA polymerase III type 2 promoter sequence-specific DNA binding(GO:0001003) |
| 0.5 | 4.2 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
| 0.5 | 2.3 | GO:0004906 | interferon-gamma receptor activity(GO:0004906) |
| 0.5 | 0.9 | GO:0002060 | purine nucleobase binding(GO:0002060) |
| 0.5 | 3.7 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
| 0.5 | 3.6 | GO:0005329 | dopamine transmembrane transporter activity(GO:0005329) |
| 0.5 | 4.1 | GO:0032051 | clathrin light chain binding(GO:0032051) |
| 0.5 | 5.0 | GO:0097157 | pre-mRNA intronic binding(GO:0097157) |
| 0.4 | 1.8 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
| 0.4 | 1.8 | GO:0003865 | 3-oxo-5-alpha-steroid 4-dehydrogenase activity(GO:0003865) steroid dehydrogenase activity, acting on the CH-CH group of donors(GO:0033765) cholestenone 5-alpha-reductase activity(GO:0047751) |
| 0.4 | 6.1 | GO:0047134 | protein-disulfide reductase activity(GO:0047134) |
| 0.4 | 2.6 | GO:0051032 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
| 0.4 | 1.3 | GO:0035403 | histone kinase activity (H3-T6 specific)(GO:0035403) |
| 0.4 | 1.3 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
| 0.4 | 5.9 | GO:0048185 | activin binding(GO:0048185) |
| 0.4 | 1.2 | GO:0050816 | phosphothreonine binding(GO:0050816) |
| 0.4 | 1.2 | GO:0050211 | procollagen galactosyltransferase activity(GO:0050211) |
| 0.4 | 1.6 | GO:0035650 | AP-1 adaptor complex binding(GO:0035650) |
| 0.4 | 1.2 | GO:0004938 | alpha2-adrenergic receptor activity(GO:0004938) |
| 0.4 | 5.7 | GO:0035256 | G-protein coupled glutamate receptor binding(GO:0035256) |
| 0.4 | 1.2 | GO:0003839 | gamma-glutamylcyclotransferase activity(GO:0003839) |
| 0.4 | 6.8 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
| 0.4 | 1.6 | GO:0034988 | Fc-gamma receptor I complex binding(GO:0034988) |
| 0.4 | 1.9 | GO:0010521 | telomerase inhibitor activity(GO:0010521) |
| 0.4 | 1.2 | GO:0098770 | FBXO family protein binding(GO:0098770) |
| 0.4 | 1.5 | GO:0010348 | lithium:proton antiporter activity(GO:0010348) |
| 0.4 | 3.8 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
| 0.4 | 3.8 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
| 0.4 | 1.1 | GO:0004797 | thymidine kinase activity(GO:0004797) |
| 0.4 | 3.3 | GO:0019238 | cyclohydrolase activity(GO:0019238) |
| 0.4 | 1.8 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
| 0.4 | 1.5 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
| 0.4 | 2.6 | GO:0015315 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
| 0.4 | 7.6 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
| 0.4 | 1.8 | GO:0047493 | sphingomyelin synthase activity(GO:0033188) ceramide cholinephosphotransferase activity(GO:0047493) |
| 0.4 | 1.1 | GO:0017095 | heparan sulfate 6-O-sulfotransferase activity(GO:0017095) |
| 0.4 | 1.4 | GO:0005457 | GDP-fucose transmembrane transporter activity(GO:0005457) purine nucleotide-sugar transmembrane transporter activity(GO:0036080) |
| 0.3 | 1.0 | GO:0070984 | SET domain binding(GO:0070984) |
| 0.3 | 1.4 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
| 0.3 | 3.4 | GO:0019211 | phosphatase activator activity(GO:0019211) |
| 0.3 | 1.3 | GO:0004074 | biliverdin reductase activity(GO:0004074) |
| 0.3 | 5.2 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
| 0.3 | 0.7 | GO:0070643 | vitamin D3 25-hydroxylase activity(GO:0030343) vitamin D 25-hydroxylase activity(GO:0070643) |
| 0.3 | 2.9 | GO:0034235 | GPI anchor binding(GO:0034235) |
| 0.3 | 1.6 | GO:0005219 | ryanodine-sensitive calcium-release channel activity(GO:0005219) |
| 0.3 | 0.6 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
| 0.3 | 1.6 | GO:0080019 | fatty-acyl-CoA reductase (alcohol-forming) activity(GO:0080019) |
| 0.3 | 4.6 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
| 0.3 | 3.7 | GO:0038132 | neuregulin binding(GO:0038132) |
| 0.3 | 0.3 | GO:0005277 | acetylcholine transmembrane transporter activity(GO:0005277) acetate ester transmembrane transporter activity(GO:1901375) |
| 0.3 | 1.2 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
| 0.3 | 1.2 | GO:0034602 | oxoglutarate dehydrogenase (NAD+) activity(GO:0034602) |
| 0.3 | 0.9 | GO:0052856 | NADHX epimerase activity(GO:0052856) NADPHX epimerase activity(GO:0052857) |
| 0.3 | 1.8 | GO:0052656 | branched-chain-amino-acid transaminase activity(GO:0004084) L-leucine transaminase activity(GO:0052654) L-valine transaminase activity(GO:0052655) L-isoleucine transaminase activity(GO:0052656) |
| 0.3 | 1.5 | GO:0032810 | sterol response element binding(GO:0032810) |
| 0.3 | 1.5 | GO:0070905 | serine binding(GO:0070905) |
| 0.3 | 1.5 | GO:0004991 | parathyroid hormone receptor activity(GO:0004991) |
| 0.3 | 4.3 | GO:0055106 | ubiquitin-protein transferase regulator activity(GO:0055106) |
| 0.3 | 3.2 | GO:0004849 | uridine kinase activity(GO:0004849) |
| 0.3 | 7.1 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
| 0.3 | 5.1 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
| 0.3 | 4.0 | GO:0004723 | calcium-dependent protein serine/threonine phosphatase activity(GO:0004723) |
| 0.3 | 0.8 | GO:0004392 | heme oxygenase (decyclizing) activity(GO:0004392) |
| 0.3 | 3.1 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
| 0.3 | 0.8 | GO:0055077 | gap junction hemi-channel activity(GO:0055077) |
| 0.3 | 1.4 | GO:0004489 | methylenetetrahydrofolate reductase (NAD(P)H) activity(GO:0004489) |
| 0.3 | 0.3 | GO:0008192 | RNA guanylyltransferase activity(GO:0008192) |
| 0.3 | 0.8 | GO:0004157 | dihydropyrimidinase activity(GO:0004157) |
| 0.3 | 1.1 | GO:0003985 | acetyl-CoA C-acetyltransferase activity(GO:0003985) |
| 0.3 | 1.1 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
| 0.3 | 2.5 | GO:1901611 | phosphatidylglycerol binding(GO:1901611) cardiolipin binding(GO:1901612) |
| 0.3 | 3.0 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
| 0.3 | 0.8 | GO:0003883 | CTP synthase activity(GO:0003883) |
| 0.3 | 5.4 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
| 0.3 | 1.1 | GO:1990190 | peptide-glutamate-N-acetyltransferase activity(GO:1990190) |
| 0.3 | 6.8 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
| 0.3 | 1.1 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
| 0.3 | 2.4 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
| 0.3 | 1.3 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
| 0.3 | 5.6 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
| 0.3 | 1.6 | GO:0023029 | MHC class Ib protein binding(GO:0023029) |
| 0.3 | 1.6 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
| 0.3 | 1.6 | GO:0042835 | BRE binding(GO:0042835) |
| 0.3 | 0.8 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
| 0.3 | 0.8 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
| 0.3 | 1.6 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
| 0.3 | 0.5 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
| 0.3 | 0.8 | GO:0098808 | mRNA cap binding(GO:0098808) |
| 0.3 | 0.8 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
| 0.3 | 1.8 | GO:0004645 | phosphorylase activity(GO:0004645) |
| 0.3 | 6.9 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
| 0.3 | 4.3 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
| 0.3 | 3.3 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
| 0.3 | 1.3 | GO:0004830 | tryptophan-tRNA ligase activity(GO:0004830) |
| 0.2 | 2.2 | GO:0048495 | Roundabout binding(GO:0048495) |
| 0.2 | 4.2 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
| 0.2 | 0.7 | GO:0050659 | N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity(GO:0050659) |
| 0.2 | 1.2 | GO:0032217 | riboflavin transporter activity(GO:0032217) |
| 0.2 | 2.7 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
| 0.2 | 0.7 | GO:0004828 | serine-tRNA ligase activity(GO:0004828) |
| 0.2 | 1.4 | GO:0098639 | collagen binding involved in cell-matrix adhesion(GO:0098639) |
| 0.2 | 1.2 | GO:0005152 | interleukin-1 receptor antagonist activity(GO:0005152) |
| 0.2 | 2.3 | GO:0071253 | connexin binding(GO:0071253) |
| 0.2 | 0.7 | GO:0030377 | urokinase plasminogen activator receptor activity(GO:0030377) |
| 0.2 | 0.7 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
| 0.2 | 0.2 | GO:0005150 | interleukin-1, Type I receptor binding(GO:0005150) |
| 0.2 | 0.9 | GO:0015563 | uptake transmembrane transporter activity(GO:0015563) |
| 0.2 | 0.5 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
| 0.2 | 1.4 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
| 0.2 | 0.7 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
| 0.2 | 0.7 | GO:0010698 | acetyltransferase activator activity(GO:0010698) |
| 0.2 | 1.6 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
| 0.2 | 1.6 | GO:0030620 | U2 snRNA binding(GO:0030620) |
| 0.2 | 0.7 | GO:0017130 | poly(C) RNA binding(GO:0017130) |
| 0.2 | 2.4 | GO:0030274 | LIM domain binding(GO:0030274) |
| 0.2 | 0.7 | GO:0004817 | cysteine-tRNA ligase activity(GO:0004817) |
| 0.2 | 4.7 | GO:0070628 | proteasome binding(GO:0070628) |
| 0.2 | 3.1 | GO:0005243 | gap junction channel activity(GO:0005243) |
| 0.2 | 0.9 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
| 0.2 | 1.3 | GO:0016303 | 1-phosphatidylinositol-3-kinase activity(GO:0016303) |
| 0.2 | 0.6 | GO:1904455 | ubiquitin-specific protease activity involved in negative regulation of ERAD pathway(GO:1904455) |
| 0.2 | 0.6 | GO:0016406 | carnitine O-acyltransferase activity(GO:0016406) |
| 0.2 | 2.3 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) phospholipase C activity(GO:0004629) |
| 0.2 | 0.4 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
| 0.2 | 1.3 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
| 0.2 | 0.8 | GO:0071209 | U7 snRNA binding(GO:0071209) |
| 0.2 | 2.9 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
| 0.2 | 1.0 | GO:0043120 | tumor necrosis factor binding(GO:0043120) |
| 0.2 | 7.3 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
| 0.2 | 2.2 | GO:0017169 | CDP-alcohol phosphatidyltransferase activity(GO:0017169) |
| 0.2 | 0.6 | GO:0050254 | rhodopsin kinase activity(GO:0050254) |
| 0.2 | 0.6 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
| 0.2 | 0.8 | GO:0035473 | lipase binding(GO:0035473) |
| 0.2 | 0.6 | GO:0004913 | interleukin-4 receptor activity(GO:0004913) |
| 0.2 | 1.2 | GO:0035184 | histone threonine kinase activity(GO:0035184) |
| 0.2 | 0.6 | GO:0061752 | telomeric repeat-containing RNA binding(GO:0061752) |
| 0.2 | 1.2 | GO:0008443 | phosphofructokinase activity(GO:0008443) |
| 0.2 | 1.8 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
| 0.2 | 3.6 | GO:0016274 | arginine N-methyltransferase activity(GO:0016273) protein-arginine N-methyltransferase activity(GO:0016274) |
| 0.2 | 6.1 | GO:0030159 | receptor signaling complex scaffold activity(GO:0030159) |
| 0.2 | 0.8 | GO:0050265 | RNA uridylyltransferase activity(GO:0050265) |
| 0.2 | 1.6 | GO:0004465 | lipoprotein lipase activity(GO:0004465) |
| 0.2 | 0.8 | GO:0003978 | UDP-N-acetylglucosamine 4-epimerase activity(GO:0003974) UDP-glucose 4-epimerase activity(GO:0003978) |
| 0.2 | 0.6 | GO:0004574 | oligo-1,6-glucosidase activity(GO:0004574) |
| 0.2 | 4.3 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
| 0.2 | 10.9 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
| 0.2 | 0.6 | GO:0046921 | glycoprotein 6-alpha-L-fucosyltransferase activity(GO:0008424) alpha-(1->6)-fucosyltransferase activity(GO:0046921) |
| 0.2 | 2.3 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
| 0.2 | 1.0 | GO:0016900 | oxidoreductase activity, acting on the CH-OH group of donors, disulfide as acceptor(GO:0016900) vitamin-K-epoxide reductase (warfarin-sensitive) activity(GO:0047057) |
| 0.2 | 2.3 | GO:0050542 | icosanoid binding(GO:0050542) fatty acid derivative binding(GO:1901567) |
| 0.2 | 0.6 | GO:0001026 | TFIIIB-type transcription factor activity(GO:0001026) |
| 0.2 | 0.8 | GO:0003989 | acetyl-CoA carboxylase activity(GO:0003989) |
| 0.2 | 1.3 | GO:0001517 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) |
| 0.2 | 0.8 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
| 0.2 | 2.7 | GO:0031014 | troponin T binding(GO:0031014) |
| 0.2 | 0.6 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
| 0.2 | 1.1 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) |
| 0.2 | 4.4 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
| 0.2 | 0.6 | GO:0061599 | molybdopterin adenylyltransferase activity(GO:0061598) molybdopterin molybdotransferase activity(GO:0061599) |
| 0.2 | 0.8 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
| 0.2 | 0.9 | GO:0070576 | vitamin D 24-hydroxylase activity(GO:0070576) |
| 0.2 | 1.9 | GO:0051787 | misfolded protein binding(GO:0051787) |
| 0.2 | 0.6 | GO:0030984 | kininogen binding(GO:0030984) |
| 0.2 | 0.6 | GO:0008457 | beta-galactosyl-N-acetylglucosaminylgalactosylglucosyl-ceramide beta-1,3-acetylglucosaminyltransferase activity(GO:0008457) lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase activity(GO:0047256) |
| 0.2 | 0.4 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
| 0.2 | 0.6 | GO:0000994 | RNA polymerase III core binding(GO:0000994) |
| 0.2 | 3.7 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
| 0.2 | 4.4 | GO:0017166 | vinculin binding(GO:0017166) |
| 0.2 | 1.1 | GO:0005047 | signal recognition particle binding(GO:0005047) |
| 0.2 | 3.1 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
| 0.2 | 0.5 | GO:0070735 | protein-glycine ligase activity(GO:0070735) |
| 0.2 | 0.4 | GO:1903135 | cupric ion binding(GO:1903135) |
| 0.2 | 0.5 | GO:0004766 | spermidine synthase activity(GO:0004766) |
| 0.2 | 9.7 | GO:0061650 | ubiquitin-like protein conjugating enzyme activity(GO:0061650) |
| 0.2 | 4.3 | GO:0045028 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
| 0.2 | 0.4 | GO:1901474 | azole transmembrane transporter activity(GO:1901474) |
| 0.2 | 0.2 | GO:0048256 | flap endonuclease activity(GO:0048256) |
| 0.2 | 0.7 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
| 0.2 | 7.6 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
| 0.2 | 0.5 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
| 0.2 | 0.7 | GO:0043274 | phospholipase binding(GO:0043274) |
| 0.2 | 0.7 | GO:0004132 | dCMP deaminase activity(GO:0004132) |
| 0.2 | 1.2 | GO:0016717 | oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water(GO:0016717) |
| 0.2 | 0.5 | GO:0016435 | rRNA (guanine) methyltransferase activity(GO:0016435) |
| 0.2 | 1.2 | GO:0042910 | xenobiotic transporter activity(GO:0042910) |
| 0.2 | 0.7 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
| 0.2 | 0.5 | GO:0071885 | N-terminal protein N-methyltransferase activity(GO:0071885) |
| 0.2 | 0.2 | GO:0036435 | K48-linked polyubiquitin binding(GO:0036435) |
| 0.2 | 1.4 | GO:0030621 | U4 snRNA binding(GO:0030621) |
| 0.2 | 0.3 | GO:0000822 | inositol hexakisphosphate binding(GO:0000822) |
| 0.2 | 3.7 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
| 0.2 | 0.5 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
| 0.2 | 0.8 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
| 0.2 | 2.3 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
| 0.2 | 1.0 | GO:0070139 | ubiquitin-like protein-specific endopeptidase activity(GO:0070137) SUMO-specific endopeptidase activity(GO:0070139) |
| 0.2 | 0.5 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
| 0.2 | 1.7 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
| 0.2 | 0.7 | GO:0044715 | 8-oxo-dGDP phosphatase activity(GO:0044715) |
| 0.2 | 3.1 | GO:0004707 | MAP kinase activity(GO:0004707) |
| 0.2 | 2.4 | GO:0016888 | endodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016888) |
| 0.2 | 1.0 | GO:0015307 | drug:proton antiporter activity(GO:0015307) |
| 0.2 | 2.4 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
| 0.2 | 0.6 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
| 0.2 | 1.1 | GO:1990254 | keratin filament binding(GO:1990254) |
| 0.2 | 1.0 | GO:0016823 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
| 0.2 | 1.0 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
| 0.2 | 1.3 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
| 0.2 | 0.6 | GO:0008426 | protein kinase C inhibitor activity(GO:0008426) |
| 0.2 | 2.7 | GO:0033549 | MAP kinase phosphatase activity(GO:0033549) |
| 0.2 | 15.4 | GO:0008307 | structural constituent of muscle(GO:0008307) |
| 0.2 | 1.7 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
| 0.2 | 3.9 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
| 0.2 | 0.6 | GO:0005046 | KDEL sequence binding(GO:0005046) |
| 0.2 | 0.6 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
| 0.2 | 4.1 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
| 0.2 | 1.4 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
| 0.2 | 0.5 | GO:0050072 | m7G(5')pppN diphosphatase activity(GO:0050072) |
| 0.2 | 1.1 | GO:0016416 | O-palmitoyltransferase activity(GO:0016416) |
| 0.2 | 0.5 | GO:0008518 | reduced folate carrier activity(GO:0008518) |
| 0.2 | 1.2 | GO:0015450 | P-P-bond-hydrolysis-driven protein transmembrane transporter activity(GO:0015450) |
| 0.2 | 0.5 | GO:0038131 | neuregulin receptor activity(GO:0038131) |
| 0.2 | 0.9 | GO:0015142 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
| 0.2 | 0.6 | GO:0015333 | peptide:proton symporter activity(GO:0015333) proton-dependent peptide secondary active transmembrane transporter activity(GO:0022897) |
| 0.2 | 48.1 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
| 0.2 | 0.8 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
| 0.2 | 0.5 | GO:0034739 | histone deacetylase activity (H4-K16 specific)(GO:0034739) |
| 0.2 | 2.4 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
| 0.2 | 0.3 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
| 0.1 | 3.0 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
| 0.1 | 0.3 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
| 0.1 | 3.1 | GO:0050750 | low-density lipoprotein particle receptor binding(GO:0050750) |
| 0.1 | 0.1 | GO:0003997 | acyl-CoA oxidase activity(GO:0003997) |
| 0.1 | 1.8 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
| 0.1 | 0.4 | GO:0010385 | double-stranded methylated DNA binding(GO:0010385) |
| 0.1 | 0.7 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
| 0.1 | 0.4 | GO:0004819 | glutamine-tRNA ligase activity(GO:0004819) |
| 0.1 | 1.3 | GO:0035197 | siRNA binding(GO:0035197) |
| 0.1 | 0.9 | GO:0052828 | phosphatidylinositol-3,4-bisphosphate 4-phosphatase activity(GO:0016316) inositol-1,3,4-trisphosphate 4-phosphatase activity(GO:0017161) inositol-3,4-bisphosphate 4-phosphatase activity(GO:0052828) |
| 0.1 | 3.4 | GO:0038191 | neuropilin binding(GO:0038191) |
| 0.1 | 0.1 | GO:0070097 | delta-catenin binding(GO:0070097) |
| 0.1 | 0.9 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
| 0.1 | 1.3 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
| 0.1 | 0.4 | GO:0004796 | thromboxane-A synthase activity(GO:0004796) 12-hydroxyheptadecatrienoic acid synthase activity(GO:0036134) |
| 0.1 | 0.6 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
| 0.1 | 1.6 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
| 0.1 | 0.7 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
| 0.1 | 2.6 | GO:0005522 | profilin binding(GO:0005522) |
| 0.1 | 0.6 | GO:0098518 | polynucleotide phosphatase activity(GO:0098518) |
| 0.1 | 1.0 | GO:0019798 | procollagen-proline 4-dioxygenase activity(GO:0004656) procollagen-proline dioxygenase activity(GO:0019798) |
| 0.1 | 1.1 | GO:0034596 | phosphatidylinositol phosphate 4-phosphatase activity(GO:0034596) |
| 0.1 | 2.8 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
| 0.1 | 1.1 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
| 0.1 | 1.4 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
| 0.1 | 1.4 | GO:0043142 | single-stranded DNA-dependent ATPase activity(GO:0043142) |
| 0.1 | 0.4 | GO:0051139 | metal ion:proton antiporter activity(GO:0051139) |
| 0.1 | 0.1 | GO:0038049 | transcription factor activity, ligand-activated RNA polymerase II transcription factor binding(GO:0038049) |
| 0.1 | 0.7 | GO:0046790 | virion binding(GO:0046790) |
| 0.1 | 1.5 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
| 0.1 | 0.5 | GO:0050262 | ribosylnicotinamide kinase activity(GO:0050262) ribosylnicotinate kinase activity(GO:0061769) |
| 0.1 | 2.0 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
| 0.1 | 0.4 | GO:0090631 | pre-miRNA transporter activity(GO:0090631) |
| 0.1 | 0.1 | GO:0004137 | deoxycytidine kinase activity(GO:0004137) |
| 0.1 | 0.3 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
| 0.1 | 0.4 | GO:0070051 | fibrinogen binding(GO:0070051) |
| 0.1 | 0.7 | GO:0016314 | phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity(GO:0016314) |
| 0.1 | 0.3 | GO:0035662 | Toll-like receptor 4 binding(GO:0035662) |
| 0.1 | 3.2 | GO:0070530 | K63-linked polyubiquitin binding(GO:0070530) |
| 0.1 | 0.3 | GO:0008969 | phosphohistidine phosphatase activity(GO:0008969) |
| 0.1 | 0.4 | GO:0031996 | thioesterase binding(GO:0031996) |
| 0.1 | 3.2 | GO:0016918 | retinal binding(GO:0016918) |
| 0.1 | 0.3 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
| 0.1 | 0.9 | GO:0015266 | protein channel activity(GO:0015266) |
| 0.1 | 0.8 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) |
| 0.1 | 0.3 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
| 0.1 | 0.4 | GO:0045127 | N-acetylglucosamine kinase activity(GO:0045127) |
| 0.1 | 0.4 | GO:0000384 | first spliceosomal transesterification activity(GO:0000384) |
| 0.1 | 7.3 | GO:0050699 | WW domain binding(GO:0050699) |
| 0.1 | 0.6 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
| 0.1 | 4.7 | GO:0001671 | ATPase activator activity(GO:0001671) |
| 0.1 | 2.0 | GO:0002162 | dystroglycan binding(GO:0002162) |
| 0.1 | 0.4 | GO:0031403 | pyridoxal kinase activity(GO:0008478) lithium ion binding(GO:0031403) |
| 0.1 | 0.9 | GO:0051880 | G-quadruplex DNA binding(GO:0051880) |
| 0.1 | 2.9 | GO:0017127 | cholesterol transporter activity(GO:0017127) |
| 0.1 | 1.3 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
| 0.1 | 1.6 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
| 0.1 | 0.3 | GO:0009041 | uridylate kinase activity(GO:0009041) |
| 0.1 | 1.6 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
| 0.1 | 1.3 | GO:0034452 | dynactin binding(GO:0034452) |
| 0.1 | 5.3 | GO:0003785 | actin monomer binding(GO:0003785) |
| 0.1 | 4.1 | GO:0051721 | protein phosphatase 2A binding(GO:0051721) |
| 0.1 | 0.2 | GO:0061628 | H3K27me3 modified histone binding(GO:0061628) |
| 0.1 | 0.7 | GO:0046870 | cadmium ion binding(GO:0046870) |
| 0.1 | 1.2 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
| 0.1 | 1.0 | GO:0030613 | oxidoreductase activity, acting on phosphorus or arsenic in donors(GO:0030613) oxidoreductase activity, acting on phosphorus or arsenic in donors, disulfide as acceptor(GO:0030614) |
| 0.1 | 0.6 | GO:0005315 | inorganic phosphate transmembrane transporter activity(GO:0005315) |
| 0.1 | 18.4 | GO:0002020 | protease binding(GO:0002020) |
| 0.1 | 0.5 | GO:0016936 | galactoside binding(GO:0016936) |
| 0.1 | 0.2 | GO:0016639 | oxidoreductase activity, acting on the CH-NH2 group of donors, NAD or NADP as acceptor(GO:0016639) |
| 0.1 | 0.8 | GO:1904929 | coreceptor activity involved in Wnt signaling pathway, planar cell polarity pathway(GO:1904929) |
| 0.1 | 1.7 | GO:0004697 | protein kinase C activity(GO:0004697) |
| 0.1 | 3.7 | GO:0017091 | AU-rich element binding(GO:0017091) |
| 0.1 | 1.2 | GO:0031210 | phosphatidylcholine binding(GO:0031210) |
| 0.1 | 0.4 | GO:0004663 | Rab geranylgeranyltransferase activity(GO:0004663) |
| 0.1 | 0.8 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
| 0.1 | 0.4 | GO:0047223 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity(GO:0047223) |
| 0.1 | 0.7 | GO:0042015 | interleukin-20 binding(GO:0042015) |
| 0.1 | 0.6 | GO:0004105 | choline-phosphate cytidylyltransferase activity(GO:0004105) |
| 0.1 | 0.7 | GO:0004167 | dopachrome isomerase activity(GO:0004167) |
| 0.1 | 0.6 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
| 0.1 | 3.2 | GO:0016628 | oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor(GO:0016628) |
| 0.1 | 0.3 | GO:0004962 | endothelin receptor activity(GO:0004962) |
| 0.1 | 4.1 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
| 0.1 | 0.5 | GO:0003867 | 4-aminobutyrate transaminase activity(GO:0003867) succinate-semialdehyde dehydrogenase binding(GO:0032145) (S)-3-amino-2-methylpropionate transaminase activity(GO:0047298) |
| 0.1 | 1.0 | GO:0030023 | extracellular matrix constituent conferring elasticity(GO:0030023) |
| 0.1 | 0.3 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
| 0.1 | 0.6 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
| 0.1 | 0.7 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
| 0.1 | 0.3 | GO:0015616 | DNA translocase activity(GO:0015616) |
| 0.1 | 0.9 | GO:0016427 | tRNA (cytosine) methyltransferase activity(GO:0016427) |
| 0.1 | 4.3 | GO:0036002 | pre-mRNA binding(GO:0036002) |
| 0.1 | 2.0 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) serine-type exopeptidase activity(GO:0070008) |
| 0.1 | 0.6 | GO:0035174 | histone serine kinase activity(GO:0035174) |
| 0.1 | 0.9 | GO:0017070 | U6 snRNA binding(GO:0017070) |
| 0.1 | 12.5 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
| 0.1 | 2.2 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
| 0.1 | 1.1 | GO:0051378 | amine binding(GO:0043176) serotonin binding(GO:0051378) |
| 0.1 | 1.7 | GO:0046527 | glucosyltransferase activity(GO:0046527) |
| 0.1 | 0.2 | GO:0005169 | neurotrophin TRKB receptor binding(GO:0005169) |
| 0.1 | 0.4 | GO:0008745 | N-acetylmuramoyl-L-alanine amidase activity(GO:0008745) |
| 0.1 | 1.9 | GO:0003924 | GTPase activity(GO:0003924) |
| 0.1 | 0.3 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
| 0.1 | 1.0 | GO:0004784 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
| 0.1 | 0.6 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
| 0.1 | 0.3 | GO:0034038 | deoxyhypusine synthase activity(GO:0034038) |
| 0.1 | 4.4 | GO:0043022 | ribosome binding(GO:0043022) |
| 0.1 | 0.3 | GO:0004170 | dUTP diphosphatase activity(GO:0004170) |
| 0.1 | 0.4 | GO:0019213 | deacetylase activity(GO:0019213) |
| 0.1 | 0.7 | GO:0097643 | amylin receptor activity(GO:0097643) |
| 0.1 | 0.3 | GO:0004821 | histidine-tRNA ligase activity(GO:0004821) |
| 0.1 | 1.1 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
| 0.1 | 0.2 | GO:0015275 | stretch-activated, cation-selective, calcium channel activity(GO:0015275) |
| 0.1 | 0.7 | GO:0042609 | CD4 receptor binding(GO:0042609) |
| 0.1 | 0.3 | GO:0001181 | transcription factor activity, core RNA polymerase I binding(GO:0001181) |
| 0.1 | 0.9 | GO:0005381 | iron ion transmembrane transporter activity(GO:0005381) |
| 0.1 | 2.1 | GO:0031005 | filamin binding(GO:0031005) |
| 0.1 | 0.3 | GO:0004119 | cGMP-inhibited cyclic-nucleotide phosphodiesterase activity(GO:0004119) |
| 0.1 | 0.3 | GO:0001010 | transcription factor activity, sequence-specific DNA binding transcription factor recruiting(GO:0001010) |
| 0.1 | 0.3 | GO:0047374 | methylumbelliferyl-acetate deacetylase activity(GO:0047374) |
| 0.1 | 1.3 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
| 0.1 | 1.1 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
| 0.1 | 3.0 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
| 0.1 | 0.7 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
| 0.1 | 0.5 | GO:0016312 | inositol bisphosphate phosphatase activity(GO:0016312) |
| 0.1 | 1.9 | GO:0050786 | RAGE receptor binding(GO:0050786) |
| 0.1 | 3.9 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
| 0.1 | 0.6 | GO:0002114 | interleukin-33 receptor activity(GO:0002114) |
| 0.1 | 0.1 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
| 0.1 | 0.3 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
| 0.1 | 0.7 | GO:0003960 | NADPH:quinone reductase activity(GO:0003960) |
| 0.1 | 1.1 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
| 0.1 | 0.5 | GO:0008113 | peptide-methionine (S)-S-oxide reductase activity(GO:0008113) |
| 0.1 | 0.8 | GO:0016742 | hydroxymethyl-, formyl- and related transferase activity(GO:0016742) |
| 0.1 | 0.1 | GO:0052642 | lysophosphatidic acid phosphatase activity(GO:0052642) |
| 0.1 | 3.1 | GO:0016866 | intramolecular transferase activity(GO:0016866) |
| 0.1 | 0.4 | GO:0016748 | succinyltransferase activity(GO:0016748) |
| 0.1 | 1.0 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
| 0.1 | 0.8 | GO:0016842 | amidine-lyase activity(GO:0016842) |
| 0.1 | 0.7 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
| 0.1 | 0.3 | GO:0004822 | isoleucine-tRNA ligase activity(GO:0004822) |
| 0.1 | 0.3 | GO:0070546 | L-aspartate:2-oxoglutarate aminotransferase activity(GO:0004069) L-phenylalanine aminotransferase activity(GO:0070546) L-phenylalanine:2-oxoglutarate aminotransferase activity(GO:0080130) |
| 0.1 | 0.3 | GO:0004608 | phosphatidyl-N-methylethanolamine N-methyltransferase activity(GO:0000773) phosphatidylethanolamine N-methyltransferase activity(GO:0004608) phosphatidyl-N-dimethylethanolamine N-methyltransferase activity(GO:0080101) |
| 0.1 | 0.1 | GO:0005326 | neurotransmitter transporter activity(GO:0005326) |
| 0.1 | 1.3 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
| 0.1 | 0.4 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
| 0.1 | 0.4 | GO:0035173 | histone kinase activity(GO:0035173) |
| 0.1 | 4.0 | GO:0008536 | Ran GTPase binding(GO:0008536) |
| 0.1 | 1.1 | GO:0022833 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
| 0.1 | 0.7 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
| 0.1 | 1.6 | GO:0000339 | RNA cap binding(GO:0000339) |
| 0.1 | 1.3 | GO:0003688 | DNA replication origin binding(GO:0003688) |
| 0.1 | 13.1 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
| 0.1 | 0.9 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
| 0.1 | 3.8 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
| 0.1 | 0.7 | GO:0015288 | porin activity(GO:0015288) |
| 0.1 | 0.4 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
| 0.1 | 2.5 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
| 0.1 | 1.7 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
| 0.1 | 0.1 | GO:0030272 | cyclo-ligase activity(GO:0016882) 5-formyltetrahydrofolate cyclo-ligase activity(GO:0030272) |
| 0.1 | 0.8 | GO:0045159 | myosin II binding(GO:0045159) |
| 0.1 | 0.4 | GO:0016230 | sphingomyelin phosphodiesterase activator activity(GO:0016230) |
| 0.1 | 0.5 | GO:0004075 | biotin carboxylase activity(GO:0004075) |
| 0.1 | 0.7 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
| 0.1 | 0.2 | GO:0031852 | mu-type opioid receptor binding(GO:0031852) |
| 0.1 | 0.6 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
| 0.1 | 0.4 | GO:0050119 | N-acetylglucosamine deacetylase activity(GO:0050119) |
| 0.1 | 0.1 | GO:1904047 | S-adenosyl-L-methionine binding(GO:1904047) |
| 0.1 | 2.5 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
| 0.1 | 3.1 | GO:0016709 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen(GO:0016709) |
| 0.1 | 1.4 | GO:0000146 | microfilament motor activity(GO:0000146) |
| 0.1 | 1.2 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
| 0.1 | 0.3 | GO:0070283 | lipoate synthase activity(GO:0016992) radical SAM enzyme activity(GO:0070283) |
| 0.1 | 0.9 | GO:0008297 | single-stranded DNA exodeoxyribonuclease activity(GO:0008297) |
| 0.1 | 0.4 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
| 0.1 | 7.1 | GO:0001618 | virus receptor activity(GO:0001618) |
| 0.1 | 0.5 | GO:0019215 | intermediate filament binding(GO:0019215) |
| 0.1 | 7.5 | GO:0008565 | protein transporter activity(GO:0008565) |
| 0.1 | 0.7 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
| 0.1 | 0.3 | GO:0005174 | CD40 receptor binding(GO:0005174) |
| 0.1 | 1.8 | GO:0097602 | cullin family protein binding(GO:0097602) |
| 0.1 | 8.6 | GO:0017124 | SH3 domain binding(GO:0017124) |
| 0.1 | 0.1 | GO:0001222 | transcription corepressor binding(GO:0001222) |
| 0.1 | 0.5 | GO:0016802 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
| 0.1 | 1.3 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
| 0.1 | 0.3 | GO:0004832 | valine-tRNA ligase activity(GO:0004832) |
| 0.1 | 0.3 | GO:0003963 | RNA-3'-phosphate cyclase activity(GO:0003963) |
| 0.1 | 1.3 | GO:0015299 | solute:proton antiporter activity(GO:0015299) |
| 0.1 | 2.1 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
| 0.1 | 1.6 | GO:0043495 | protein anchor(GO:0043495) |
| 0.1 | 1.1 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
| 0.1 | 0.4 | GO:0008079 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
| 0.1 | 3.0 | GO:0005080 | protein kinase C binding(GO:0005080) |
| 0.1 | 0.2 | GO:0005052 | peroxisome matrix targeting signal-1 binding(GO:0005052) |
| 0.1 | 1.6 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
| 0.1 | 0.2 | GO:0015230 | FAD transmembrane transporter activity(GO:0015230) |
| 0.1 | 0.9 | GO:0022820 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
| 0.1 | 0.4 | GO:0004359 | glutaminase activity(GO:0004359) |
| 0.1 | 0.6 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
| 0.1 | 0.9 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
| 0.1 | 1.2 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
| 0.1 | 0.2 | GO:0008281 | sulfonylurea receptor activity(GO:0008281) |
| 0.1 | 1.2 | GO:0016646 | oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor(GO:0016646) |
| 0.1 | 1.3 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
| 0.1 | 6.2 | GO:0017048 | Rho GTPase binding(GO:0017048) |
| 0.1 | 1.7 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
| 0.1 | 0.2 | GO:0004385 | guanylate kinase activity(GO:0004385) |
| 0.1 | 1.1 | GO:0005249 | voltage-gated potassium channel activity(GO:0005249) |
| 0.1 | 0.3 | GO:0004809 | tRNA (guanine-N2-)-methyltransferase activity(GO:0004809) |
| 0.1 | 5.1 | GO:0019003 | GDP binding(GO:0019003) |
| 0.1 | 4.1 | GO:0003743 | translation initiation factor activity(GO:0003743) |
| 0.1 | 0.3 | GO:0047391 | alkylglycerophosphoethanolamine phosphodiesterase activity(GO:0047391) |
| 0.1 | 0.7 | GO:0016423 | tRNA (guanine) methyltransferase activity(GO:0016423) |
| 0.1 | 1.7 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
| 0.1 | 0.2 | GO:0042799 | histone methyltransferase activity (H4-K20 specific)(GO:0042799) |
| 0.1 | 4.0 | GO:0032813 | tumor necrosis factor receptor superfamily binding(GO:0032813) |
| 0.1 | 0.4 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
| 0.1 | 0.2 | GO:0000990 | transcription factor activity, core RNA polymerase binding(GO:0000990) |
| 0.1 | 0.1 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
| 0.1 | 1.3 | GO:0008308 | voltage-gated anion channel activity(GO:0008308) |
| 0.1 | 2.7 | GO:0035255 | ionotropic glutamate receptor binding(GO:0035255) |
| 0.1 | 1.2 | GO:0042169 | SH2 domain binding(GO:0042169) |
| 0.1 | 0.8 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
| 0.1 | 3.0 | GO:0005484 | SNAP receptor activity(GO:0005484) |
| 0.1 | 1.2 | GO:0001227 | transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001227) |
| 0.1 | 0.3 | GO:0047179 | platelet-activating factor acetyltransferase activity(GO:0047179) |
| 0.1 | 0.7 | GO:0008607 | phosphorylase kinase regulator activity(GO:0008607) |
| 0.1 | 0.3 | GO:0036310 | annealing helicase activity(GO:0036310) |
| 0.1 | 0.3 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
| 0.1 | 0.3 | GO:0005222 | intracellular cAMP activated cation channel activity(GO:0005222) |
| 0.1 | 0.1 | GO:0070568 | guanylyltransferase activity(GO:0070568) |
| 0.1 | 6.1 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
| 0.1 | 0.3 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
| 0.1 | 0.2 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
| 0.1 | 0.3 | GO:0061649 | ubiquitinated histone binding(GO:0061649) |
| 0.1 | 0.3 | GO:0004771 | sterol esterase activity(GO:0004771) |
| 0.1 | 1.0 | GO:0004971 | AMPA glutamate receptor activity(GO:0004971) |
| 0.1 | 0.5 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
| 0.1 | 0.9 | GO:0050700 | CARD domain binding(GO:0050700) |
| 0.1 | 0.7 | GO:0004969 | histamine receptor activity(GO:0004969) |
| 0.1 | 0.2 | GO:0019107 | glycylpeptide N-tetradecanoyltransferase activity(GO:0004379) myristoyltransferase activity(GO:0019107) |
| 0.1 | 0.5 | GO:0019894 | kinesin binding(GO:0019894) |
| 0.1 | 0.1 | GO:0017018 | myosin phosphatase activity(GO:0017018) |
| 0.1 | 0.1 | GO:0051731 | polynucleotide 5'-hydroxyl-kinase activity(GO:0051731) |
| 0.1 | 0.6 | GO:0036122 | BMP binding(GO:0036122) |
| 0.1 | 0.2 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
| 0.1 | 0.6 | GO:1990948 | ligase inhibitor activity(GO:0055104) ubiquitin ligase inhibitor activity(GO:1990948) |
| 0.1 | 0.5 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
| 0.1 | 0.3 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
| 0.1 | 1.2 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
| 0.1 | 0.3 | GO:0008097 | 5S rRNA binding(GO:0008097) |
| 0.1 | 15.1 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
| 0.1 | 0.1 | GO:0017057 | 6-phosphogluconolactonase activity(GO:0017057) |
| 0.1 | 0.3 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
| 0.1 | 2.4 | GO:0008188 | neuropeptide receptor activity(GO:0008188) |
| 0.1 | 0.4 | GO:0010859 | calcium-dependent cysteine-type endopeptidase inhibitor activity(GO:0010859) |
| 0.1 | 0.2 | GO:0009383 | rRNA (cytosine-C5-)-methyltransferase activity(GO:0009383) |
| 0.1 | 0.3 | GO:0030151 | molybdenum ion binding(GO:0030151) |
| 0.1 | 6.6 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
| 0.1 | 0.2 | GO:0005350 | pyrimidine nucleobase transmembrane transporter activity(GO:0005350) pyrimidine- and adenine-specific:sodium symporter activity(GO:0015389) |
| 0.1 | 7.9 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
| 0.1 | 0.7 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
| 0.1 | 0.4 | GO:0071532 | ankyrin repeat binding(GO:0071532) |
| 0.1 | 1.0 | GO:0004549 | tRNA-specific ribonuclease activity(GO:0004549) |
| 0.1 | 1.3 | GO:0031593 | polyubiquitin binding(GO:0031593) |
| 0.1 | 0.6 | GO:0070182 | DNA polymerase binding(GO:0070182) |
| 0.1 | 0.4 | GO:0043426 | MRF binding(GO:0043426) |
| 0.1 | 4.2 | GO:0030674 | protein binding, bridging(GO:0030674) |
| 0.1 | 0.6 | GO:0005537 | mannose binding(GO:0005537) |
| 0.1 | 0.6 | GO:0030296 | protein tyrosine kinase activator activity(GO:0030296) |
| 0.1 | 0.4 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
| 0.1 | 0.1 | GO:0008263 | pyrimidine-specific mismatch base pair DNA N-glycosylase activity(GO:0008263) |
| 0.1 | 3.2 | GO:0070888 | E-box binding(GO:0070888) |
| 0.1 | 0.4 | GO:0008474 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
| 0.1 | 0.2 | GO:0004727 | prenylated protein tyrosine phosphatase activity(GO:0004727) |
| 0.1 | 0.1 | GO:1990763 | arrestin family protein binding(GO:1990763) |
| 0.1 | 0.2 | GO:0016530 | metallochaperone activity(GO:0016530) |
| 0.1 | 0.2 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
| 0.1 | 1.4 | GO:0015301 | anion:anion antiporter activity(GO:0015301) |
| 0.1 | 0.2 | GO:0004492 | methylmalonyl-CoA decarboxylase activity(GO:0004492) |
| 0.1 | 2.4 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
| 0.1 | 0.1 | GO:0005137 | interleukin-5 receptor binding(GO:0005137) |
| 0.1 | 0.2 | GO:0004853 | uroporphyrinogen decarboxylase activity(GO:0004853) |
| 0.1 | 0.2 | GO:0051990 | (R)-2-hydroxyglutarate dehydrogenase activity(GO:0051990) |
| 0.1 | 0.2 | GO:0047273 | galactosylgalactosylglucosylceramide beta-D-acetylgalactosaminyltransferase activity(GO:0047273) |
| 0.1 | 0.1 | GO:0001032 | RNA polymerase III type 3 promoter DNA binding(GO:0001032) |
| 0.1 | 5.1 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
| 0.1 | 0.2 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
| 0.1 | 0.7 | GO:0015037 | peptide disulfide oxidoreductase activity(GO:0015037) |
| 0.1 | 4.0 | GO:0098811 | transcriptional activator activity, RNA polymerase II transcription factor binding(GO:0001190) transcriptional repressor activity, RNA polymerase II activating transcription factor binding(GO:0098811) |
| 0.1 | 0.4 | GO:0015501 | glutamate:sodium symporter activity(GO:0015501) |
| 0.1 | 0.2 | GO:0097603 | temperature-gated ion channel activity(GO:0097603) |
| 0.1 | 0.8 | GO:0051400 | BH domain binding(GO:0051400) |
| 0.1 | 0.2 | GO:0000033 | alpha-1,3-mannosyltransferase activity(GO:0000033) |
| 0.1 | 0.4 | GO:0019237 | centromeric DNA binding(GO:0019237) |
| 0.1 | 0.8 | GO:0003678 | DNA helicase activity(GO:0003678) |
| 0.1 | 0.7 | GO:0005283 | sodium:amino acid symporter activity(GO:0005283) |
| 0.1 | 0.3 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
| 0.1 | 0.2 | GO:0003827 | alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity(GO:0003827) |
| 0.1 | 0.2 | GO:0019200 | carbohydrate kinase activity(GO:0019200) |
| 0.1 | 0.1 | GO:0005167 | neurotrophin TRK receptor binding(GO:0005167) |
| 0.1 | 0.1 | GO:0015235 | cobalamin transporter activity(GO:0015235) |
| 0.0 | 0.4 | GO:0030275 | LRR domain binding(GO:0030275) |
| 0.0 | 0.5 | GO:0031386 | protein tag(GO:0031386) |
| 0.0 | 0.5 | GO:0046965 | retinoid X receptor binding(GO:0046965) |
| 0.0 | 0.3 | GO:0008656 | cysteine-type endopeptidase activator activity involved in apoptotic process(GO:0008656) |
| 0.0 | 0.3 | GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity(GO:0003857) |
| 0.0 | 5.5 | GO:0005178 | integrin binding(GO:0005178) |
| 0.0 | 0.4 | GO:0004046 | aminoacylase activity(GO:0004046) |
| 0.0 | 0.3 | GO:0019212 | phosphatase inhibitor activity(GO:0019212) |
| 0.0 | 0.0 | GO:0099609 | microtubule lateral binding(GO:0099609) |
| 0.0 | 1.4 | GO:0016702 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen(GO:0016702) |
| 0.0 | 0.2 | GO:0070259 | tyrosyl-DNA phosphodiesterase activity(GO:0070259) |
| 0.0 | 0.1 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
| 0.0 | 14.6 | GO:0045296 | cadherin binding(GO:0045296) |
| 0.0 | 2.0 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
| 0.0 | 0.0 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
| 0.0 | 0.2 | GO:0047238 | glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047238) |
| 0.0 | 1.1 | GO:0005528 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
| 0.0 | 0.2 | GO:0034046 | poly(G) binding(GO:0034046) |
| 0.0 | 0.1 | GO:0034511 | U3 snoRNA binding(GO:0034511) |
| 0.0 | 1.0 | GO:0001972 | retinoic acid binding(GO:0001972) |
| 0.0 | 0.2 | GO:0052836 | inositol 5-diphosphate pentakisphosphate 5-kinase activity(GO:0052836) inositol diphosphate tetrakisphosphate kinase activity(GO:0052839) |
| 0.0 | 0.7 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
| 0.0 | 0.3 | GO:0035800 | deubiquitinase activator activity(GO:0035800) |
| 0.0 | 0.1 | GO:0015173 | aromatic amino acid transmembrane transporter activity(GO:0015173) |
| 0.0 | 0.1 | GO:0004936 | alpha-adrenergic receptor activity(GO:0004936) alpha1-adrenergic receptor activity(GO:0004937) |
| 0.0 | 0.2 | GO:0016595 | glutamate binding(GO:0016595) |
| 0.0 | 0.2 | GO:0016402 | pristanoyl-CoA oxidase activity(GO:0016402) |
| 0.0 | 0.7 | GO:0000062 | fatty-acyl-CoA binding(GO:0000062) |
| 0.0 | 1.0 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
| 0.0 | 0.2 | GO:0016635 | oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor(GO:0016635) |
| 0.0 | 0.3 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
| 0.0 | 0.7 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
| 0.0 | 0.1 | GO:0015157 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
| 0.0 | 0.2 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
| 0.0 | 0.5 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
| 0.0 | 0.3 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
| 0.0 | 0.3 | GO:0015926 | glucosidase activity(GO:0015926) |
| 0.0 | 0.2 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
| 0.0 | 0.1 | GO:0001596 | angiotensin type I receptor activity(GO:0001596) |
| 0.0 | 0.5 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
| 0.0 | 0.1 | GO:0001849 | complement component C1q binding(GO:0001849) |
| 0.0 | 4.7 | GO:0051015 | actin filament binding(GO:0051015) |
| 0.0 | 0.2 | GO:0004310 | farnesyl-diphosphate farnesyltransferase activity(GO:0004310) squalene synthase activity(GO:0051996) |
| 0.0 | 0.1 | GO:0015928 | alpha-L-fucosidase activity(GO:0004560) fucosidase activity(GO:0015928) |
| 0.0 | 0.5 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
| 0.0 | 0.2 | GO:0030507 | spectrin binding(GO:0030507) |
| 0.0 | 0.3 | GO:0004340 | glucokinase activity(GO:0004340) hexokinase activity(GO:0004396) fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
| 0.0 | 0.4 | GO:0005328 | neurotransmitter:sodium symporter activity(GO:0005328) |
| 0.0 | 0.2 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
| 0.0 | 0.1 | GO:0003826 | alpha-ketoacid dehydrogenase activity(GO:0003826) 3-methyl-2-oxobutanoate dehydrogenase (2-methylpropanoyl-transferring) activity(GO:0003863) |
| 0.0 | 0.1 | GO:0047617 | acyl-CoA hydrolase activity(GO:0047617) |
| 0.0 | 0.2 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
| 0.0 | 0.3 | GO:0099604 | calcium-release channel activity(GO:0015278) ligand-gated calcium channel activity(GO:0099604) |
| 0.0 | 0.1 | GO:0043813 | phosphatidylinositol-3,5-bisphosphate 5-phosphatase activity(GO:0043813) |
| 0.0 | 0.1 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
| 0.0 | 0.4 | GO:0003906 | DNA-(apurinic or apyrimidinic site) lyase activity(GO:0003906) |
| 0.0 | 0.2 | GO:0005521 | lamin binding(GO:0005521) |
| 0.0 | 0.0 | GO:0070878 | primary miRNA binding(GO:0070878) |
| 0.0 | 0.2 | GO:0017069 | snRNA binding(GO:0017069) |
| 0.0 | 1.0 | GO:0017025 | TBP-class protein binding(GO:0017025) |
| 0.0 | 0.1 | GO:0047150 | betaine-homocysteine S-methyltransferase activity(GO:0047150) |
| 0.0 | 0.3 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
| 0.0 | 0.6 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
| 0.0 | 11.8 | GO:0005096 | GTPase activator activity(GO:0005096) |
| 0.0 | 0.2 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) C-palmitoyltransferase activity(GO:0016454) |
| 0.0 | 0.6 | GO:0030695 | GTPase regulator activity(GO:0030695) |
| 0.0 | 0.1 | GO:0034584 | piRNA binding(GO:0034584) |
| 0.0 | 0.4 | GO:0015297 | antiporter activity(GO:0015297) |
| 0.0 | 0.6 | GO:0015929 | hexosaminidase activity(GO:0015929) |
| 0.0 | 0.4 | GO:0043422 | protein kinase B binding(GO:0043422) |
| 0.0 | 0.1 | GO:0008410 | CoA-transferase activity(GO:0008410) |
| 0.0 | 0.2 | GO:0043237 | laminin-1 binding(GO:0043237) |
| 0.0 | 0.3 | GO:0097108 | hedgehog family protein binding(GO:0097108) |
| 0.0 | 0.1 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
| 0.0 | 0.2 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
| 0.0 | 0.2 | GO:0005267 | potassium channel activity(GO:0005267) |
| 0.0 | 0.3 | GO:0038052 | RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding(GO:0038052) |
| 0.0 | 0.0 | GO:0051021 | GDP-dissociation inhibitor binding(GO:0051021) Rho GDP-dissociation inhibitor binding(GO:0051022) |
| 0.0 | 0.6 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
| 0.0 | 1.3 | GO:0015485 | cholesterol binding(GO:0015485) |
| 0.0 | 0.1 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
| 0.0 | 0.5 | GO:0019956 | chemokine binding(GO:0019956) |
| 0.0 | 0.1 | GO:0030350 | iron-responsive element binding(GO:0030350) |
| 0.0 | 0.5 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
| 0.0 | 0.1 | GO:0051525 | NFAT protein binding(GO:0051525) |
| 0.0 | 0.1 | GO:0004144 | diacylglycerol O-acyltransferase activity(GO:0004144) |
| 0.0 | 0.2 | GO:0004972 | NMDA glutamate receptor activity(GO:0004972) |
| 0.0 | 0.1 | GO:0051377 | mannose-ethanolamine phosphotransferase activity(GO:0051377) |
| 0.0 | 1.3 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
| 0.0 | 0.3 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
| 0.0 | 0.4 | GO:0008483 | transaminase activity(GO:0008483) |
| 0.0 | 0.1 | GO:0005536 | glucose binding(GO:0005536) |
| 0.0 | 0.7 | GO:0042043 | neurexin family protein binding(GO:0042043) |
| 0.0 | 0.1 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
| 0.0 | 0.1 | GO:0010484 | H3 histone acetyltransferase activity(GO:0010484) |
| 0.0 | 0.1 | GO:0001134 | transcription factor activity, transcription factor recruiting(GO:0001134) transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
| 0.0 | 0.1 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
| 0.0 | 0.3 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
| 0.0 | 0.1 | GO:0051183 | vitamin transporter activity(GO:0051183) |
| 0.0 | 0.1 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
| 0.0 | 0.0 | GO:0019239 | deaminase activity(GO:0019239) |
| 0.0 | 0.8 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
| 0.0 | 0.3 | GO:0044213 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) intronic transcription regulatory region DNA binding(GO:0044213) |
| 0.0 | 0.1 | GO:0004047 | aminomethyltransferase activity(GO:0004047) |
| 0.0 | 0.0 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
| 0.0 | 0.1 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
| 0.0 | 0.1 | GO:0019841 | retinol binding(GO:0019841) |
| 0.0 | 1.5 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
| 0.0 | 2.7 | GO:0019888 | protein phosphatase regulator activity(GO:0019888) |
| 0.0 | 1.1 | GO:0043130 | ubiquitin binding(GO:0043130) |
| 0.0 | 0.2 | GO:0043021 | ribonucleoprotein complex binding(GO:0043021) |
| 0.0 | 2.8 | GO:0005125 | cytokine activity(GO:0005125) |
| 0.0 | 0.4 | GO:0001191 | transcriptional repressor activity, RNA polymerase II transcription factor binding(GO:0001191) |
| 0.0 | 0.1 | GO:0032090 | Pyrin domain binding(GO:0032090) |
| 0.0 | 1.0 | GO:0042826 | histone deacetylase binding(GO:0042826) |
| 0.0 | 0.2 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
| 0.0 | 0.5 | GO:0004190 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
| 0.0 | 0.1 | GO:0004794 | L-threonine ammonia-lyase activity(GO:0004794) |
| 0.0 | 0.1 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
| 0.0 | 0.1 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
| 0.0 | 0.1 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
| 0.0 | 0.1 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
| 0.0 | 0.8 | GO:0015002 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
| 0.0 | 0.1 | GO:0016671 | oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor(GO:0016671) peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
| 0.0 | 7.9 | GO:0046982 | protein heterodimerization activity(GO:0046982) |
| 0.0 | 0.1 | GO:0001164 | RNA polymerase I regulatory region DNA binding(GO:0001013) RNA polymerase I regulatory region sequence-specific DNA binding(GO:0001163) RNA polymerase I CORE element sequence-specific DNA binding(GO:0001164) |
| 0.0 | 0.0 | GO:0001091 | RNA polymerase II basal transcription factor binding(GO:0001091) |
| 0.0 | 0.3 | GO:0019992 | diacylglycerol binding(GO:0019992) |
| 0.0 | 0.1 | GO:0016863 | intramolecular oxidoreductase activity, transposing C=C bonds(GO:0016863) |
| 0.0 | 0.3 | GO:0003684 | damaged DNA binding(GO:0003684) |
| 0.0 | 0.2 | GO:0016638 | oxidoreductase activity, acting on the CH-NH2 group of donors(GO:0016638) |
| 0.0 | 0.1 | GO:1990259 | protein-glutamine N-methyltransferase activity(GO:0036009) histone-glutamine methyltransferase activity(GO:1990259) |
| 0.0 | 0.1 | GO:0005042 | netrin receptor activity(GO:0005042) |
| 0.0 | 0.4 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
| 0.0 | 0.3 | GO:0019843 | rRNA binding(GO:0019843) |
| 0.0 | 0.1 | GO:0019534 | toxin transporter activity(GO:0019534) |
| 0.0 | 0.1 | GO:0017040 | ceramidase activity(GO:0017040) |
| 0.0 | 0.3 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
| 0.0 | 0.1 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
| 0.0 | 0.1 | GO:0005113 | patched binding(GO:0005113) |
| 0.0 | 0.4 | GO:0015175 | neutral amino acid transmembrane transporter activity(GO:0015175) |
| 0.0 | 0.1 | GO:0000182 | rDNA binding(GO:0000182) |
| 0.0 | 0.1 | GO:0047555 | 3',5'-cyclic-GMP phosphodiesterase activity(GO:0047555) |
| 0.0 | 0.1 | GO:0004365 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
| 0.0 | 0.1 | GO:0005497 | androgen binding(GO:0005497) |
| 0.0 | 0.1 | GO:0001595 | angiotensin receptor activity(GO:0001595) angiotensin type II receptor activity(GO:0004945) |
| 0.0 | 0.1 | GO:0003947 | (N-acetylneuraminyl)-galactosylglucosylceramide N-acetylgalactosaminyltransferase activity(GO:0003947) |
| 0.0 | 0.2 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
| 0.0 | 0.1 | GO:0004647 | phosphoserine phosphatase activity(GO:0004647) |
| 0.0 | 0.2 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
| 0.0 | 0.1 | GO:0004022 | alcohol dehydrogenase (NAD) activity(GO:0004022) |
| 0.0 | 0.3 | GO:0070492 | oligosaccharide binding(GO:0070492) |
| 0.0 | 0.0 | GO:0001042 | RNA polymerase I core binding(GO:0001042) |
| 0.0 | 0.1 | GO:0016657 | GMP reductase activity(GO:0003920) oxidoreductase activity, acting on NAD(P)H, nitrogenous group as acceptor(GO:0016657) |
| 0.0 | 0.1 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
| 0.0 | 0.1 | GO:0044547 | DNA topoisomerase binding(GO:0044547) |
| 0.0 | 0.5 | GO:0001085 | RNA polymerase II transcription factor binding(GO:0001085) |
| 0.0 | 0.0 | GO:0035254 | glutamate receptor binding(GO:0035254) |
| 0.0 | 0.3 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
| 0.0 | 0.4 | GO:0016876 | aminoacyl-tRNA ligase activity(GO:0004812) ligase activity, forming carbon-oxygen bonds(GO:0016875) ligase activity, forming aminoacyl-tRNA and related compounds(GO:0016876) |
| 0.0 | 0.0 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
| 0.0 | 0.4 | GO:0004622 | lysophospholipase activity(GO:0004622) |
| 0.0 | 0.1 | GO:0004057 | arginyltransferase activity(GO:0004057) |
| 0.0 | 0.1 | GO:0031432 | titin binding(GO:0031432) |
| 0.0 | 0.0 | GO:0050815 | phosphoserine binding(GO:0050815) |
| 0.0 | 0.1 | GO:0046920 | alpha-(1->3)-fucosyltransferase activity(GO:0046920) |
| 0.0 | 0.0 | GO:0015562 | efflux transmembrane transporter activity(GO:0015562) |
| 0.0 | 0.0 | GO:0003943 | N-acetylgalactosamine-4-sulfatase activity(GO:0003943) |
| 0.0 | 0.4 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
| 0.0 | 0.0 | GO:0016517 | interleukin-12 receptor activity(GO:0016517) |
| 0.0 | 0.1 | GO:0008428 | ribonuclease inhibitor activity(GO:0008428) |
| 0.0 | 0.2 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
| 0.0 | 0.2 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
| 0.0 | 0.1 | GO:1990599 | 3' overhang single-stranded DNA endodeoxyribonuclease activity(GO:1990599) |
| 0.0 | 1.7 | GO:0008234 | cysteine-type peptidase activity(GO:0008234) |
| 0.0 | 0.5 | GO:0000175 | 3'-5'-exoribonuclease activity(GO:0000175) |
| 0.0 | 0.1 | GO:0008821 | crossover junction endodeoxyribonuclease activity(GO:0008821) |
| 0.0 | 0.1 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
| 0.0 | 0.1 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
| 0.0 | 0.2 | GO:0003714 | transcription corepressor activity(GO:0003714) |
| 0.0 | 0.0 | GO:0016603 | glutaminyl-peptide cyclotransferase activity(GO:0016603) |
Gene overrepresentation in C2:CP category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 1.0 | 2.0 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
| 0.9 | 0.9 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
| 0.5 | 12.0 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
| 0.5 | 32.4 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
| 0.4 | 10.8 | PID S1P S1P1 PATHWAY | S1P1 pathway |
| 0.4 | 10.0 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
| 0.3 | 18.2 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
| 0.3 | 4.6 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
| 0.3 | 1.6 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
| 0.3 | 1.0 | PID S1P META PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
| 0.3 | 2.5 | PID IL5 PATHWAY | IL5-mediated signaling events |
| 0.3 | 4.5 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
| 0.2 | 5.9 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
| 0.2 | 3.5 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
| 0.2 | 8.8 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
| 0.2 | 1.4 | ST STAT3 PATHWAY | STAT3 Pathway |
| 0.2 | 14.7 | PID AURORA B PATHWAY | Aurora B signaling |
| 0.2 | 18.3 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
| 0.2 | 8.9 | PID IGF1 PATHWAY | IGF1 pathway |
| 0.2 | 4.9 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
| 0.2 | 2.6 | PID TRAIL PATHWAY | TRAIL signaling pathway |
| 0.2 | 1.1 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
| 0.2 | 10.0 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
| 0.2 | 4.0 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
| 0.2 | 0.5 | PID INSULIN PATHWAY | Insulin Pathway |
| 0.2 | 5.7 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
| 0.2 | 6.9 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
| 0.2 | 2.0 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
| 0.2 | 0.7 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
| 0.2 | 1.1 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
| 0.2 | 3.4 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
| 0.2 | 4.0 | PID NECTIN PATHWAY | Nectin adhesion pathway |
| 0.2 | 47.7 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
| 0.1 | 5.8 | PID EPHB FWD PATHWAY | EPHB forward signaling |
| 0.1 | 10.8 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
| 0.1 | 6.2 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
| 0.1 | 2.8 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
| 0.1 | 6.4 | PID IL2 1PATHWAY | IL2-mediated signaling events |
| 0.1 | 3.7 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
| 0.1 | 4.0 | PID IL1 PATHWAY | IL1-mediated signaling events |
| 0.1 | 3.2 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
| 0.1 | 1.0 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
| 0.1 | 5.2 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
| 0.1 | 4.1 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
| 0.1 | 2.6 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
| 0.1 | 0.5 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
| 0.1 | 10.2 | PID CDC42 PATHWAY | CDC42 signaling events |
| 0.1 | 5.3 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
| 0.1 | 10.2 | PID LKB1 PATHWAY | LKB1 signaling events |
| 0.1 | 3.4 | PID ARF 3PATHWAY | Arf1 pathway |
| 0.1 | 3.3 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
| 0.1 | 1.5 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
| 0.1 | 2.1 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
| 0.1 | 0.6 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
| 0.1 | 2.5 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
| 0.1 | 4.6 | PID FOXO PATHWAY | FoxO family signaling |
| 0.1 | 4.9 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
| 0.1 | 10.6 | PID E2F PATHWAY | E2F transcription factor network |
| 0.1 | 3.2 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
| 0.1 | 5.1 | PID PLK1 PATHWAY | PLK1 signaling events |
| 0.1 | 1.4 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
| 0.1 | 1.7 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
| 0.1 | 2.3 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
| 0.1 | 1.4 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
| 0.1 | 3.2 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
| 0.1 | 1.5 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
| 0.1 | 0.7 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
| 0.1 | 0.7 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
| 0.1 | 3.8 | PID ILK PATHWAY | Integrin-linked kinase signaling |
| 0.1 | 6.4 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
| 0.1 | 0.5 | PID BARD1 PATHWAY | BARD1 signaling events |
| 0.1 | 1.5 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
| 0.1 | 1.2 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
| 0.1 | 1.2 | ST G ALPHA S PATHWAY | G alpha s Pathway |
| 0.1 | 3.5 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
| 0.1 | 1.7 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
| 0.1 | 2.4 | PID FANCONI PATHWAY | Fanconi anemia pathway |
| 0.1 | 2.7 | PID RAS PATHWAY | Regulation of Ras family activation |
| 0.1 | 5.0 | PID NOTCH PATHWAY | Notch signaling pathway |
| 0.1 | 1.1 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
| 0.1 | 0.8 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
| 0.1 | 0.7 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
| 0.1 | 2.6 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
| 0.1 | 0.1 | PID S1P S1P4 PATHWAY | S1P4 pathway |
| 0.1 | 1.6 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
| 0.1 | 2.0 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
| 0.1 | 1.0 | PID ATM PATHWAY | ATM pathway |
| 0.1 | 0.4 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
| 0.1 | 0.3 | PID ENDOTHELIN PATHWAY | Endothelins |
| 0.1 | 1.8 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
| 0.1 | 1.0 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
| 0.1 | 1.2 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
| 0.1 | 1.6 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
| 0.1 | 0.5 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
| 0.0 | 0.5 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
| 0.0 | 0.7 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
| 0.0 | 1.8 | PID ATR PATHWAY | ATR signaling pathway |
| 0.0 | 2.4 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
| 0.0 | 2.8 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
| 0.0 | 1.2 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
| 0.0 | 0.8 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
| 0.0 | 1.1 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
| 0.0 | 0.3 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
| 0.0 | 0.3 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
| 0.0 | 0.4 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
| 0.0 | 0.2 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
| 0.0 | 0.4 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
| 0.0 | 0.4 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
| 0.0 | 1.2 | PID P53 REGULATION PATHWAY | p53 pathway |
| 0.0 | 0.1 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
| 0.0 | 0.3 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
| 0.0 | 1.2 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
| 0.0 | 0.1 | PID ERBB4 PATHWAY | ErbB4 signaling events |
| 0.0 | 0.0 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
| 0.0 | 1.2 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
| 0.0 | 0.7 | PID CONE PATHWAY | Visual signal transduction: Cones |
| 0.0 | 1.4 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
| 0.0 | 1.9 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
| 0.0 | 5.0 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
| 0.0 | 0.2 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
| 0.0 | 0.4 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
| 0.0 | 0.3 | PID EPHA FWDPATHWAY | EPHA forward signaling |
| 0.0 | 0.8 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
| 0.0 | 0.4 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
| 0.0 | 0.4 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
| 0.0 | 0.3 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
| 0.0 | 0.3 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
| 0.0 | 0.1 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
| 0.0 | 0.3 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
| 0.0 | 0.0 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
| 0.0 | 0.1 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
| 0.0 | 0.2 | PID TNF PATHWAY | TNF receptor signaling pathway |
| 0.0 | 0.2 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
Gene overrepresentation in C2:CP:REACTOME category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 0.7 | 11.7 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
| 0.6 | 6.6 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
| 0.6 | 0.6 | REACTOME CDC6 ASSOCIATION WITH THE ORC ORIGIN COMPLEX | Genes involved in CDC6 association with the ORC:origin complex |
| 0.5 | 0.9 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
| 0.4 | 0.4 | REACTOME NEP NS2 INTERACTS WITH THE CELLULAR EXPORT MACHINERY | Genes involved in NEP/NS2 Interacts with the Cellular Export Machinery |
| 0.4 | 0.8 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
| 0.4 | 16.8 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
| 0.4 | 8.7 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
| 0.4 | 6.7 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
| 0.4 | 0.7 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
| 0.4 | 1.1 | REACTOME APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | Genes involved in APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 |
| 0.4 | 2.8 | REACTOME RAF MAP KINASE CASCADE | Genes involved in RAF/MAP kinase cascade |
| 0.3 | 4.5 | REACTOME P75NTR RECRUITS SIGNALLING COMPLEXES | Genes involved in p75NTR recruits signalling complexes |
| 0.3 | 5.6 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
| 0.3 | 5.1 | REACTOME REVERSIBLE HYDRATION OF CARBON DIOXIDE | Genes involved in Reversible Hydration of Carbon Dioxide |
| 0.3 | 8.5 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
| 0.3 | 5.9 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
| 0.3 | 7.7 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
| 0.3 | 7.6 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
| 0.3 | 5.8 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
| 0.3 | 0.6 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
| 0.3 | 5.3 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
| 0.3 | 0.9 | REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
| 0.3 | 9.5 | REACTOME FATTY ACYL COA BIOSYNTHESIS | Genes involved in Fatty Acyl-CoA Biosynthesis |
| 0.3 | 4.6 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
| 0.3 | 17.9 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
| 0.3 | 11.1 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
| 0.3 | 1.9 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
| 0.3 | 3.5 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
| 0.3 | 7.0 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
| 0.3 | 4.3 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
| 0.3 | 2.6 | REACTOME ASSOCIATION OF LICENSING FACTORS WITH THE PRE REPLICATIVE COMPLEX | Genes involved in Association of licensing factors with the pre-replicative complex |
| 0.2 | 6.5 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
| 0.2 | 6.4 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
| 0.2 | 7.7 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
| 0.2 | 0.9 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
| 0.2 | 4.9 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
| 0.2 | 5.5 | REACTOME SHC1 EVENTS IN ERBB4 SIGNALING | Genes involved in SHC1 events in ERBB4 signaling |
| 0.2 | 4.4 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
| 0.2 | 9.0 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
| 0.2 | 6.3 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
| 0.2 | 7.5 | REACTOME KERATAN SULFATE BIOSYNTHESIS | Genes involved in Keratan sulfate biosynthesis |
| 0.2 | 4.0 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
| 0.2 | 4.6 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
| 0.2 | 0.2 | REACTOME REMOVAL OF THE FLAP INTERMEDIATE FROM THE C STRAND | Genes involved in Removal of the Flap Intermediate from the C-strand |
| 0.2 | 27.4 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
| 0.2 | 2.9 | REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
| 0.2 | 1.8 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
| 0.2 | 3.6 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
| 0.2 | 7.4 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
| 0.2 | 3.1 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
| 0.2 | 2.0 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
| 0.2 | 4.1 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
| 0.2 | 3.1 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
| 0.2 | 2.6 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
| 0.2 | 3.3 | REACTOME ACTIVATION OF THE PRE REPLICATIVE COMPLEX | Genes involved in Activation of the pre-replicative complex |
| 0.2 | 1.6 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
| 0.2 | 2.1 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
| 0.2 | 1.2 | REACTOME NFKB ACTIVATION THROUGH FADD RIP1 PATHWAY MEDIATED BY CASPASE 8 AND10 | Genes involved in NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |
| 0.2 | 2.3 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
| 0.2 | 1.1 | REACTOME RNA POL I TRANSCRIPTION INITIATION | Genes involved in RNA Polymerase I Transcription Initiation |
| 0.2 | 3.0 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
| 0.2 | 3.0 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
| 0.2 | 1.4 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
| 0.2 | 2.7 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
| 0.2 | 5.3 | REACTOME KINESINS | Genes involved in Kinesins |
| 0.2 | 2.3 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
| 0.2 | 2.8 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
| 0.2 | 2.1 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
| 0.2 | 1.0 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
| 0.2 | 4.8 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
| 0.2 | 4.8 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
| 0.2 | 16.7 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
| 0.2 | 0.6 | REACTOME N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE | Genes involved in N-glycan trimming in the ER and Calnexin/Calreticulin cycle |
| 0.2 | 5.5 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
| 0.2 | 3.7 | REACTOME VIRAL MESSENGER RNA SYNTHESIS | Genes involved in Viral Messenger RNA Synthesis |
| 0.2 | 4.4 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
| 0.2 | 3.6 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
| 0.1 | 4.7 | REACTOME TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | Genes involved in Trafficking of GluR2-containing AMPA receptors |
| 0.1 | 5.9 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
| 0.1 | 5.8 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
| 0.1 | 1.8 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
| 0.1 | 0.6 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
| 0.1 | 0.3 | REACTOME FORMATION OF TRANSCRIPTION COUPLED NER TC NER REPAIR COMPLEX | Genes involved in Formation of transcription-coupled NER (TC-NER) repair complex |
| 0.1 | 1.9 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
| 0.1 | 1.1 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
| 0.1 | 0.5 | REACTOME SHC1 EVENTS IN EGFR SIGNALING | Genes involved in SHC1 events in EGFR signaling |
| 0.1 | 7.7 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
| 0.1 | 2.2 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
| 0.1 | 3.3 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
| 0.1 | 2.3 | REACTOME ADENYLATE CYCLASE INHIBITORY PATHWAY | Genes involved in Adenylate cyclase inhibitory pathway |
| 0.1 | 1.1 | REACTOME REPAIR SYNTHESIS FOR GAP FILLING BY DNA POL IN TC NER | Genes involved in Repair synthesis for gap-filling by DNA polymerase in TC-NER |
| 0.1 | 3.9 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
| 0.1 | 1.8 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
| 0.1 | 2.8 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
| 0.1 | 3.1 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
| 0.1 | 3.3 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
| 0.1 | 1.2 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
| 0.1 | 0.4 | REACTOME JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1 | Genes involved in JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 |
| 0.1 | 3.7 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
| 0.1 | 3.0 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
| 0.1 | 1.6 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
| 0.1 | 3.2 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
| 0.1 | 0.7 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
| 0.1 | 1.6 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
| 0.1 | 4.6 | REACTOME CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | Genes involved in Cytochrome P450 - arranged by substrate type |
| 0.1 | 2.1 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
| 0.1 | 2.8 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
| 0.1 | 3.4 | REACTOME G1 PHASE | Genes involved in G1 Phase |
| 0.1 | 0.9 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
| 0.1 | 1.9 | REACTOME ELONGATION ARREST AND RECOVERY | Genes involved in Elongation arrest and recovery |
| 0.1 | 2.4 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
| 0.1 | 3.1 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
| 0.1 | 2.6 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
| 0.1 | 2.5 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
| 0.1 | 2.3 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
| 0.1 | 5.6 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |
| 0.1 | 7.0 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
| 0.1 | 5.0 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
| 0.1 | 4.1 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
| 0.1 | 0.6 | REACTOME METABOLISM OF STEROID HORMONES AND VITAMINS A AND D | Genes involved in Metabolism of steroid hormones and vitamins A and D |
| 0.1 | 7.6 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
| 0.1 | 1.4 | REACTOME GAB1 SIGNALOSOME | Genes involved in GAB1 signalosome |
| 0.1 | 5.9 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
| 0.1 | 1.4 | REACTOME SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS | Genes involved in SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs |
| 0.1 | 5.3 | REACTOME GLUCOSE METABOLISM | Genes involved in Glucose metabolism |
| 0.1 | 1.1 | REACTOME DIABETES PATHWAYS | Genes involved in Diabetes pathways |
| 0.1 | 2.5 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
| 0.1 | 0.3 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
| 0.1 | 0.7 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
| 0.1 | 0.5 | REACTOME IKK COMPLEX RECRUITMENT MEDIATED BY RIP1 | Genes involved in IKK complex recruitment mediated by RIP1 |
| 0.1 | 1.2 | REACTOME RNA POL I TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase I Transcription Termination |
| 0.1 | 0.7 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
| 0.1 | 4.6 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
| 0.1 | 1.1 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
| 0.1 | 2.6 | REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING | Genes involved in p75 NTR receptor-mediated signalling |
| 0.1 | 2.0 | REACTOME TRIGLYCERIDE BIOSYNTHESIS | Genes involved in Triglyceride Biosynthesis |
| 0.1 | 0.6 | REACTOME SIGNAL TRANSDUCTION BY L1 | Genes involved in Signal transduction by L1 |
| 0.1 | 2.2 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
| 0.1 | 0.7 | REACTOME ACTIVATION OF CHAPERONES BY ATF6 ALPHA | Genes involved in Activation of Chaperones by ATF6-alpha |
| 0.1 | 2.0 | REACTOME FORMATION OF FIBRIN CLOT CLOTTING CASCADE | Genes involved in Formation of Fibrin Clot (Clotting Cascade) |
| 0.1 | 24.2 | REACTOME CLASS I MHC MEDIATED ANTIGEN PROCESSING PRESENTATION | Genes involved in Class I MHC mediated antigen processing & presentation |
| 0.1 | 1.0 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
| 0.1 | 1.1 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
| 0.1 | 1.0 | REACTOME OPSINS | Genes involved in Opsins |
| 0.1 | 1.2 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
| 0.1 | 3.4 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
| 0.1 | 1.1 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
| 0.1 | 1.2 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
| 0.1 | 4.9 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
| 0.1 | 0.6 | REACTOME NEF MEDIATES DOWN MODULATION OF CELL SURFACE RECEPTORS BY RECRUITING THEM TO CLATHRIN ADAPTERS | Genes involved in Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters |
| 0.1 | 1.5 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
| 0.1 | 0.6 | REACTOME INTEGRATION OF PROVIRUS | Genes involved in Integration of provirus |
| 0.1 | 1.1 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
| 0.1 | 1.0 | REACTOME NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Neurotransmitter Release Cycle |
| 0.1 | 0.3 | REACTOME TRANSPORT OF MATURE MRNA DERIVED FROM AN INTRONLESS TRANSCRIPT | Genes involved in Transport of Mature mRNA Derived from an Intronless Transcript |
| 0.1 | 7.6 | REACTOME SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | Genes involved in SRP-dependent cotranslational protein targeting to membrane |
| 0.1 | 1.4 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
| 0.1 | 0.2 | REACTOME 3 UTR MEDIATED TRANSLATIONAL REGULATION | Genes involved in 3' -UTR-mediated translational regulation |
| 0.1 | 0.5 | REACTOME CELL SURFACE INTERACTIONS AT THE VASCULAR WALL | Genes involved in Cell surface interactions at the vascular wall |
| 0.1 | 2.1 | REACTOME PROTEIN FOLDING | Genes involved in Protein folding |
| 0.1 | 2.0 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
| 0.1 | 2.1 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
| 0.1 | 1.8 | REACTOME RNA POL II PRE TRANSCRIPTION EVENTS | Genes involved in RNA Polymerase II Pre-transcription Events |
| 0.1 | 7.9 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
| 0.1 | 2.7 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
| 0.1 | 0.5 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
| 0.1 | 2.8 | REACTOME PACKAGING OF TELOMERE ENDS | Genes involved in Packaging Of Telomere Ends |
| 0.1 | 0.2 | REACTOME RNA POL I TRANSCRIPTION | Genes involved in RNA Polymerase I Transcription |
| 0.1 | 0.1 | REACTOME APC CDC20 MEDIATED DEGRADATION OF NEK2A | Genes involved in APC-Cdc20 mediated degradation of Nek2A |
| 0.1 | 0.8 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
| 0.1 | 1.4 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
| 0.0 | 1.7 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
| 0.0 | 0.8 | REACTOME LATE PHASE OF HIV LIFE CYCLE | Genes involved in Late Phase of HIV Life Cycle |
| 0.0 | 1.3 | REACTOME REGULATION OF AMPK ACTIVITY VIA LKB1 | Genes involved in Regulation of AMPK activity via LKB1 |
| 0.0 | 0.5 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
| 0.0 | 2.2 | REACTOME MUSCLE CONTRACTION | Genes involved in Muscle contraction |
| 0.0 | 4.0 | REACTOME METABOLISM OF CARBOHYDRATES | Genes involved in Metabolism of carbohydrates |
| 0.0 | 0.3 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
| 0.0 | 2.5 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
| 0.0 | 0.1 | REACTOME ENERGY DEPENDENT REGULATION OF MTOR BY LKB1 AMPK | Genes involved in Energy dependent regulation of mTOR by LKB1-AMPK |
| 0.0 | 0.1 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
| 0.0 | 1.2 | REACTOME PYRUVATE METABOLISM AND CITRIC ACID TCA CYCLE | Genes involved in Pyruvate metabolism and Citric Acid (TCA) cycle |
| 0.0 | 2.9 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
| 0.0 | 0.7 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
| 0.0 | 0.5 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
| 0.0 | 0.3 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
| 0.0 | 2.7 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
| 0.0 | 2.2 | REACTOME EXTRACELLULAR MATRIX ORGANIZATION | Genes involved in Extracellular matrix organization |
| 0.0 | 3.8 | REACTOME G ALPHA S SIGNALLING EVENTS | Genes involved in G alpha (s) signalling events |
| 0.0 | 0.4 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
| 0.0 | 0.1 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
| 0.0 | 0.6 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
| 0.0 | 0.4 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
| 0.0 | 0.7 | REACTOME APOPTOTIC EXECUTION PHASE | Genes involved in Apoptotic execution phase |
| 0.0 | 0.8 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
| 0.0 | 0.3 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
| 0.0 | 4.8 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
| 0.0 | 0.4 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
| 0.0 | 1.1 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
| 0.0 | 0.9 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
| 0.0 | 0.3 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
| 0.0 | 0.4 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
| 0.0 | 0.2 | REACTOME CREB PHOSPHORYLATION THROUGH THE ACTIVATION OF CAMKII | Genes involved in CREB phosphorylation through the activation of CaMKII |
| 0.0 | 0.6 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
| 0.0 | 0.6 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
| 0.0 | 0.2 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
| 0.0 | 0.6 | REACTOME TRANSPORT OF MATURE TRANSCRIPT TO CYTOPLASM | Genes involved in Transport of Mature Transcript to Cytoplasm |
| 0.0 | 0.2 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
| 0.0 | 0.1 | REACTOME CD28 DEPENDENT PI3K AKT SIGNALING | Genes involved in CD28 dependent PI3K/Akt signaling |
| 0.0 | 0.5 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
| 0.0 | 0.1 | REACTOME DAG AND IP3 SIGNALING | Genes involved in DAG and IP3 signaling |
| 0.0 | 1.6 | REACTOME TRANS GOLGI NETWORK VESICLE BUDDING | Genes involved in trans-Golgi Network Vesicle Budding |
| 0.0 | 2.2 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
| 0.0 | 0.2 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
| 0.0 | 0.1 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
| 0.0 | 0.2 | REACTOME NUCLEAR SIGNALING BY ERBB4 | Genes involved in Nuclear signaling by ERBB4 |
| 0.0 | 0.2 | REACTOME NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR NLR SIGNALING PATHWAYS | Genes involved in Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways |
| 0.0 | 0.1 | REACTOME MEMBRANE TRAFFICKING | Genes involved in Membrane Trafficking |
| 0.0 | 0.3 | REACTOME TRANSLATION | Genes involved in Translation |
| 0.0 | 0.1 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |